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ABSTRACT 
Ischemic diseases affect more than 100 million people in the United States alone (NDFS 
2011, Roger et al. 2011).  Current interventions include: ablation, angioplasty, revascularization 
and bypass surgery.  The invasive nature of these techniques excludes patients with who are not 
amenable to surgical intervention.  For this reason, alternative methods of revascularization in 
ischemic cardiac muscle have been explored.  Over the past two decades, cellular, molecular, and 
genetic therapy attempts have been made in order to find a clinically relevant treatment.  
Ultimately, it is the invasiveness or lack of site specificity that provides the largest obstacle for 
therapeutic effectiveness of angiogenic treatments.   
Current research suggests that ultrasound-ultrasound contrast agent treatment can be 
therapeutically beneficial, providing a noninvasive way to spatially and temporally target 
ischemic tissues.  This type of angiogenic therapy can be used as an alternative to high risk 
percutaneous intervention or bypass graft surgery.   Several studies report a reparative response 
to ultrasound-ultrasound contrast agent exposure and state that inertial cavitation, or microbubble 
collapse, is possibly required for angiogenesis to occur.  Numerous small-scale studies have 
shown promising results; however, when large scale double blind studies were conducted, they 
showed limited effects.  A major impediment for progress to clinical applicability is, perhaps, the 
lack of understanding the biophysical mechanisms that connect ultrasound-ultrasound contrast 
agent to neovascularization.  
This thesis seeks to explore the biophysics of ultrasound-ultrasound contrast agent-
induced capillary angiogenesis, specifically examining the role of the ultrasound contrast agent 
in creating bioeffects that lead to subsequent angiogenesis.  The mechanistic exploration 
examines both the necessity and concentration of ultrasound contrast agents, bubble dynamics, 
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the biophysical effects of ultrasound contrast agents and several ultrasound parameters on 
causing/enhancing ultrasound-induced angiogenesis. 
A series of experiments were conducted to examine the biophysics of ultrasound and 
ultrasound contrast agent induced angiogenesis.  The first experiment explores the effect of 
ultrasound contrast agents on ultrasound-induced angiogenesis with a 3 x 2 x 4 factorial study 
assessing survival day, infusion media (saline or ultrasound contrast agent) and acoustic 
pressure, respectively.  Then, several exposure-effect studies are presented to examine the 
specific parameters on the bioeffect and subsequent angiogenic response, both acutely (at 0 day) 
and at 5 days post exposure.  Ultrasound contrast agent concentration is initially explored, 
followed by a revisit of pressures involvement at a higher contrast agent concentration.  In an 
effort to further understand the biophysical mechanism, a collapse threshold study was 
conducted, narrowing the pressure range to determine if/ the extent to which collapse was 
necessary for angiogenesis.  Then theoretical models were used to connect the ultrasound 
contrast agent biophysics to the bioeffects for the therapy. To establish a trail of evidence leading 
from ultrasound-ultrasound contrast agent induced bioeffects to angiogenesis and characterize 
the biological motivation, a tissue effect histological study was conducted to establish if the 
angiogenic response is damage driven.  Several other parameters, pulse repetition frequency, 
exposure duration and the total number of pulses, are also discussed in terms of their influence 
on the angiogenic response.   
All of the data gathered herein lead to several conclusions: 1) ultrasound contrast agents 
increase the angiogenic response, 2) ultrasound contrast agent collapse is required for the 
increased angiogenic response, 3) increases in vascular permeability occur acutely with collapse, 
4) shear stresses during exposure are likely involved in the induction of acute bioeffects, 5) 
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acoustic pressures equal to or greater than 1.3 MPa demonstrate a deleterious effect, and 6) there 
is a concurrent increase in vascular endothelial growth factor expression and capillary density at 
5 days post exposure that suggests an peak range of parameters for ultrasound-ultrasound 
contrast agent induced angiogenesis.  For the studies conducted herein, the optimal window for 
the angiogenic response was a number of pulses < 3000, a duty factor on the order of 10-2, 
acoustic pressure ~ 0.7 MPa, pulse repetition frequency ~ 10 Hz, and exposure duration between 
2 to 5 minutes.  This compilation of studies not only provides some biophysical mechanistic 
information but also a bit of predictive information when determining appropriate settings for 
ultrasound-ultrasound contrast agent induced angiogenesis. 
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CHAPTER 1: INTRODUCTION 
 
 Ischemic diseases affect more than 100 million people in the United States alone (NDFS 
2011, Roger et al. 2011).  These diseases include cardiovascular and diabetic complications. The 
people suffering from such illnesses would benefit from some form of proangiogenic therapy 
(Lloyd-Jones et al. 2009, Roger et al. 2011).  There are presently three scenarios for which 
proangiogenic therapies are used clinically: chronic wounds, peripheral artery disease and 
ischemic heart disease (Li et al. 2004, Li et al. 2005), where the goal is to increase 
neovascularization, or new blood vessel growth, to promote healing.  The number of individuals 
who could benefit from proangiogenic therapy increases drastically when including patients with 
atherosclerotic disease and hypertension.  In addition to these, proangiogenic therapy has another 
realm of application in plastic surgery and dermatology with the minimization of scars and 
increased healing time.   The benefits of researching novel ways of promoting angiogenesis and 
the potential impact are tremendous. 
1.1 Clinical treatments for ischemia 
Ischemia is currently treated by either amputation or restoration of blood flow.  Because 
amputation is undesirable, efforts are made to restore blood flow.  Clinically, blood flow 
restoration is accomplished mechanically or with surgical intervention.   
Mechanical stimulation methods involve methods that apply shear stress, perturb the 
vessel walls or produce muscle contractions.  Mechanical stimulation is typically a treatment for 
mild forms of ischemia resulting from diabetic complications or patients with intermittent 
claudication of limbs.  Generally the mechanical stimulation comes in the form of exercises to 
increase blood flow, tissue perfusion, and to some extent muscle hypertrophy (which necessitates 
angiogenesis).  Recently, the clinical use of ultrasound (US) as an external mechanical stimulus 
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has been used to enhance bone healing, presumably via angiogenesis.  Its exact mechanism of 
action, however, remains unclear.  Both exercise and US are used in mild ischemic scenarios, but 
are not useful when blood supply has been severely diminished.  Therefore, surgical intervention 
is another method for treating ischemia. 
Surgical interventions include endovascular surgery such as by-pass and 
revascularization by way of wounding (where angiogenesis occurs secondary to wounding) 
(Estvold et al. 2010, Lucas et al. 2011).  In by-pass surgery a vascular graft is either 
manufactured or removed from the veins of the patient and a conduit allowing blood to by-pass 
the occluded vessel is attached.  By-pass surgery involves maximal invasiveness because it 
requires not only open heart surgery, but often times additional surgery to be performed on the 
limb from which the venous graft is taken.   
Endovascular surgery includes angioplasty and the placement of stents to fortify and 
widen vascular lumens in an effort to increase blood flow and cause capillary growth.  The 
endothelial cells of vasculature are sensory cells that respond to increases and decreases in flow, 
and at the capillary level growth and regression, respectively.  While endovascular techniques 
are minimally invasive, not all patients qualify for the procedure.  Also angioplasty increases risk 
of other complications like arterial dissection, aneurysms, and general weakening of the vascular 
wall. 
Revascularization was introduced for patients who did not qualify for bypass or 
angioplasty.  Revascularization can be direct or transmyocardial, where an incision is made to 
expose the heart and a laser is used to drill a series of holes in the left ventricle.  This procedure 
uses secondary wound healing angiogenesis to treat pain caused due to ischemia, where damage 
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is created to boost the normal wound healing response and cause capillary growth.  
Revascularization is associated with the risk of death, stroke and MI. 
Currently clinical methods for inducing angiogenesis in cardiac and skeletal muscle 
remain invasive, and are contraindicated for certain populations as a result. Typically the 
procedures require reintervention that ultimately has more risks. Therefore less invasive and less 
exclusive methods have been researched.   
1.2 Research-based methods for treating ischemia 
Research-based techniques for increasing angiogenesis include: the use of growth factors, 
genes, or stem cells and mechanical stimulation.  Stimulation by growth factors, genes, or stem 
cells typically involves direct injection or infusion of proangiogenic molecules.  Infusion is 
challenging because factors can diffuse throughout the body, having a nontargeted effect.   
Similarly, direct muscular injection may cause complications with absorption (it may diffuse 
away) or discomfort associated with multiple injection sites.  In the last few decades other forms 
of therapeutic stimulations evolved, including cellular and genetic methods where stem cells or 
DNA are injected at the ischemic site (Messina et al. 2002, Halkos et al. 2008).  These injections 
also pose difficulty with absorption and stability of the injected substance.  It is therefore 
important to explore spatially specific, noninvasive methods for treating ischemia.   
Mechanical stimulation has been the most promising method for the induction of 
noninvasive spatially specific angiogenesis.   Literature dating back to the 1970s showed US to 
provide spatial specificity and a noninvasive way of treating ischemia. This enhancement of 
wound healing was hypothesized to be angiogenesis driven (Dyson et al. 1968).  With the advent 
of ultrasound contrast agents (UCAs), researchers were able to spatially distribute angiogenesis 
promoting factors and track their absorption into the tissue.  While some researchers use UCAs 
4 
 
to deliver growth factors or stem cells to ischemic areas, others utilize UCAs for noninvasive 
secondary wound healing angiogenesis.   Secondary wound healing angiogenesis, in this case, is 
defined as the local, focal cause of damage to the peripheral vasculature of the ischemic area in 
an effort to boost the normal wound healing responses and cause an ingrowth of capillaries.  A 
limiting factor of applicability with using US and UCAs to induce angiogenesis is that there 
remains a lack of consensus regarding dosage that ultimately prevents its transition to clinical 
use. Specifically, a wide range of peak rarefactional pressures (Pr) and UCA concentrations have 
been used and demonstrated some level of effect.  Pr is of particular importance when UCAs are 
used because as Pr increases the UCAs responses change from a regime of oscillation to 
collapse. These physical microbubble responses affect the surrounding medium leading to a 
range of bioeffects.  Potentially, it is these bioeffects that motivate the angiogenic response noted 
with US and UCA therapy.  However, no investigation of the biophysical mechanism by which 
US and UCA-induced angiogenesis occurs has been conducted.  Therefore the biophysical 
mechanism of bubble dynamics that lead to the bioeffects and result in an angiogenic response 
are explored herein. 
1.3 Overview 
This thesis seeks to explore the biophysics of US and UCA-induced capillary 
angiogenesis, specifically examining the role of the UCA in creating bioeffects that lead to 
subsequent angiogenesis.  The scope of this study is confined to using a normal rodent model in 
vivo to explore mechanisms of the UCA effects.  The mechanistic exploration examines both the 
necessity and concentration of UCAs, bubble dynamics, the biophysical effects of UCAs and 
several US parameters on causing/enhancing US-induced angiogenesis. 
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This thesis will begin by discussing angiogenesis, its primary molecular motivators and 
its various stages.  Next, there will be a discussion of current proangiogenic techniques, the 
angiogenic stage at which the procedure acts and the short comings of current techniques.  The 
thesis will then shift focus to a discussion of US and UCAs, and in particular the physical 
responses of UCAs to US exposure.  Mathematical models for free and shelled bubble dynamics 
will be discussed as well as experimental models for oscillation and collapse.  A brief 
introduction to complex clouds of bubbles with a particular volume fraction is also included. 
After introducing US and UCAs, a discussion of the current understanding of how US-UCAs 
relate to the induction of angiogenesis will be given followed by identification of areas that 
remain unexplored. 
This thesis will provide the methods used for the seven experiments presented herein, and 
then detail each of those seven experiments.  The overall goals of the experiments are to explore 
the role of the UCA and then examine the mechanism of US and UCA induced angiogenesis.  
The first experiment explores the effect of UCAs on US-induced angiogenesis with a 3 x 2 x 4 
factorial study assessing survival day, infusion media (saline or UCA), and acoustic pressure 
(Pr), respectively.  Then, several exposure-effect studies are presented to examine the specific 
parameters on the bioeffect and subsequent angiogenic response, both acutely (at 0 day) and at 5 
days post exposure (DPE).  UCA concentration ([UCA]) is initially explored, followed by a 
revisit of Prs involvement at a higher [UCA].  In an effort to further understand the biophysical 
mechanism, a collapse threshold study was conducted, narrowing the Pr range to determine if/ 
the extent to which collapse was necessary for angiogenesis.  In order to establish a trail of 
evidence leading from US exposure to angiogenesis and characterize the biological motivation, a 
tissue effect histological study was conducted to establish if the angiogenic response is damage 
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driven.  Finally, several other parameters, pulse repetition frequency, exposure duration and the 
total number of pulses, are also discussed in terms of their influence on the angiogenic response.  
The final chapter provides a summary of all experiments, and then contextualizes and interprets 
the results. 
1.4 Clinical significance 
 Understanding the biophysical mechanism by which UCAs operate to induce acute 
bioeffects that lead to angiogenesis is integral to not only therapy optimization, but also aids in 
its transition to clinical use.  Currently various UCAs with varying [UCA]s and wide ranges of 
US exposure parameters are used.  The attempt herein is to control the variation, such that not 
only can a physical mechanism be elucidated, but also to determine which of the tested 
parameters motivate the angiogenic response.  In addition, a biological mechanism is explored.  
Understanding the mechanistic motivators and investigating the extent to which UCA and US 
parameters interact to cause angiogenesis is of importance in gauging adequate exposure 
parameters.  Ultimately this information will be vital to figuring out how to clinically implement 
US and UCA induced angiogenesis. 
 
  
7 
 
CHAPTER 2: ANGIOGENESIS & CURRENT PROANGIOGENIC 
TECHNIQUES 
 
 This chapter discusses angiogenesis beginning with its definition, followed by the 
mechanistic triggers, angiogenic stages and the molecules involved in potentiating new blood 
vessel formation.  The chapter will extend the discussion of angiogenesis and its importance to 
ischemic diseases and cover the use of proangiogenic techniques as a method of restoring blood 
supply to hypoxic and nutrient deprived tissues.  These techniques will be discussed with respect 
to their current use, invasiveness, specificity, and effectiveness. 
2.1 Angiogenesis 
Angiogenesis is primarily defined as the sprouting of blood vessels from preexisting 
vessels, but can also involve nonsprouting mechanisms called intussusceptive microvascular 
growth (Augustin et al. 2001).  In angiogenesis there are several overlapping stages including: 
inflammation, formation of granulation tissue, reepithelialization, matrix formation, and 
remodeling (Barrientos et al. 2008). 
The protagonists in angiogenesis are the endothelial cell (EC) and extracellular matrix 
(ECM) components.  ECs serve as sensory cells for vasculature ultimately controlling 
constriction, dilation, and growth.  These sensory cells respond to the demand of growing or 
healing tissues in response to angiogenic triggers.   
The triggers for angiogenesis include: metabolic stressors, mechanical forces, and 
inflammatory cells.  Metabolic stressors include low oxygen tension, low extracellular pH and 
low glucose concentration (Mariotti et al. 2006).  One study found that angiogenesis is triggered 
by low oxygen levels itself as opposed to hypoxia-dependent events in energy metabolism (Pugh 
et al. 2003).  Mechanical forces from the shear stress of blood flow also play an important role 
providing perfusion feedback, where poorly perfused vessels undergo regression, and highly 
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perfused vessels proliferate (Reynolds et al. 1998).  Finally, most inflammation cells are 
proangiogenic and their specific role in angiogenesis is contingent upon the balance of 
mechanistic modulators including endothelial cells and angiogenic markers. 
For all angiogenesis triggers, the pathways merge at the increased production of vascular 
endothelial growth factor (VEGF).  In the case of wound healing, both the low oxygen and 
inflammatory cell pathways motivate angiogenesis.  When the blood vessel lumen is disturbed 
homeostasis is the initial objective.  Platelets degranulate to release VEGF, platelet derived 
growth factor (PDGF) and transforming growth factor-beta (TGF-β) (Mariotti et al. 2006, 
Barrientos et al. 2008).  These growth factors attract neutrophils and monocytes (inflammation 
cells) to the area and release nitric oxide (NO).  Monocytes mature to macrophages that initiate 
granulation tissue development.  These macrophages infiltrate the perturbed tissues and secrete 
angiogenic factors such as HIF-1, IL-8, and matrix metalloproteinase 1, 2, and 9 (MMPs) to aid 
in potentiating angiogenesis (Mizrahi et al. 2007, Barrientos et al. 2008).  The trigger for 
angiogenesis in wound healing is primarily the result of low oxygen levels leading to hypoxia 
inducible factor (HIF-1α) upregulation. 
HIF-1α is normally manufactured in the EC (Figure 2.1).  It is regulated by proline 
hydroxylases in the presence of oxygen.  In normoxia, HIF-1α is hydroxylated by proline 
hydroxylases (PHD 1, 2 and 3) in the presence of O2, Fe2+, 2-oxoglutarate (2-OG) and ascorbate. 
Hydroxylated HIF-1α (OH) is recognized by pVHL (the product of the von Hippel–Lindau 
tumor suppressor gene), which, together with a multisubunit ubiquitin (Ub) ligase complex, tags 
HIF-1α with polyubiquitin; this allows recognition by the proteasome and subsequent 
degradation. Acetylation of HIF-1α (OAc) also promotes pVHL binding (Carroll et al. 2005).  
9 
 
However, in the absence of oxygen, proline hydroxylation is inhibited and HIF-1α 
accumulates. VHL is no longer able to bind and target HIF-1α for proteasomal degradation, 
which leads to HIF-1α accumulation and translocation to the nucleus. There, HIF-1α dimerises 
with HIF-1β, binds to hypoxia-response elements (HREs) within the promoters of target genes 
and recruits transcriptional co-activators such as p300/ CREB-binding protein (CBP) for full 
transcriptional activity (Carroll et al. 2005).  Initiation ends with the production of the critical 
driver of angiogenesis: VEGF (Figure 2.1). 
 
Figure 2.1: HIF-1α regulation in a) normoxic and b) hypoxic conditions (Carroll et al. 2005). 
VEGF can also be mechanically stimulated. The mechanical stimulation of VEGF can be 
categorized as internal or external.  Limited work has been performed on internal stimulation via 
shear stressors, but external stimulation has not been well characterized at all with respect to 
angiogenesis.  With regard to internal stimulation, one study demonstrated that endothelial 
proliferation was correlated to high rates of blood flow in the female reproductive system 
(Reynolds et al. 1998), and others have noted the shear stress induction of reactive oxygen 
species (ROS), Rac-1, CDC-42, αvβ3, and Akt increasing VEGF expression (Girard et al. 1995, 
Gavard et al. 2006, Frey et al. 2009, Kasten et al. 2010).   
VEGF
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These factors, in turn, attract endothelial and other cells contributing to the formation of 
new vessels (Figure 2.4).  VEGF is also secreted from the endothelial cells in response 
mechanical perturbation not involving blood flow and metabolic stress (Mariotti et al. 2006).  
VEGF causes the activation of four stages that culminate in angiogenesis:  increased 
vascular permeability, EC remodeling, EC proliferation and migration, and EC survival for the 
newly formed vasculature.  Increased permeability most often occurs via MMPs causing 
dissolution of the basement membrane to allow for the remodeling and migration of ECs.  
Vascular permeability is accomplished by the angiopoietin-2 (Ang-2) activation.  Ang-2 binds to 
a TIE-2 receptor to block the steady state Ang-1 receptor that maintains the activity of vascular 
endothelial (VE) cadherin (an adhesion molecule between ECs) (Mukherjee et al. 2006, Mizrahi 
et al. 2007).  VEGF assists in the inactivation of VE-cadherin by causing β-arrestin to form a 
complex with actin subunits (Gavard et al. 2006) (Figure 2.2).  
 
Figure 2.2: Vascular endothelial (VE) cadherin’s role in destabilizing the endothelial barrier 
(adapted from Gavard et al. 2006, Mukherjee et al. 2006, and R&D Systems 2007). 
 
EC remodeling occurs through several pathways, but of importance is the focal adhesion 
kinase (FAK) enzyme pathway.  VEGF, along with PDGF, activates FAKs.  FAK disassembles 
the structural proteins (vinculin, talin) of cell-cell and cell-ECM junctions.  FAKs include cell 
division and control (CDC) and transcription factors (ie. Rac-1) that allows for filopodal 
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extension and actin rearrangements (Figure 2.3). Upon activation, CDC-42 activates PAK-1 
(protein activating kinase) which binds to actin fibers within the cell and at the adhesion junction 
to increase their activity (Jimenez et al. 2000).  Stress fibers are cytoskeletal structures, tensile 
actomyosin bundles which allow sensing and production of force, provide cells with adjustable 
rigidity and participate in various processes such as wound healing.  Focal adhesions anchor the 
EC to the ECM and serve to direct signals to the EC via integrins.  CDC-42 also activates N-
Wasp (Wiskott-aldrich syndrome proteins) that rearranges actin to motivate filopodial extension 
through the action of actin-related protein (ARP) 2 & 3 (an actin filament component) (Klemke 
et al. 1997) (Figure 2.3).   Rac-1 acts similarly (activated by GTP) promoting basement 
membrane equivalents of filopodia (Jones et al. 2000). (Rac-1 also generates ROS via NADPH 
oxidase, and stimulates more CDC-42 production) (Figure 2.3).  All of these actin 
rearrangements and remodeling lead ultimately to cell migration, which is part of the next step of 
angiogenesis. 
 
Figure 2.3: EC remodeling, and cellular migration molecular involvement of cell division control 
(CDC 42) and transcription factor Rac-1 (adapted from Klemke et al. 1997, Sells et al. 1997, 
Jimenez et al. 2000, Jones et al. 2000, Biocarta 2001). 
 
As alluded to previously, VEGF causes activation of PDGF and basic fibroblast growth 
factor (b-FGF) to cause endothelial cell proliferation and capillary growth (Sunderkotter et al. 
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1994, Mariotti et al. 2006).  These growth factors are the key players in EC proliferation and 
migration via phospholipase C (PLC, an enzyme).  PLC is cleaved into second messengers, 
diacylglycerol (DAG) and inositol triphosphate (IP3).  DAG activates mitogen activating protein 
kinase (MAPK) through protein kinase C (PKC) (Figure 2.4).  IP3 increases the intracellular 
calcium and NO.  The final substances, calcium, NO and MAPK, potentiate the mitogenic 
proliferation and cellular contraction to facilitate movement (Brown et al. 1992, Wahl et al. 
1994, Liekens et al. 2001, Ferrara et al. 2005).  Finally, once the vessel is established the Akt 
(also called the protein kinase B) pathway prevents apoptosis and promotes Ang-1 binding and 
vascular stabilization (Figure 2.4). 
 
Figure 2.4: Flow chart of events in angiogenesis.  Low oxygen pathway is shown in black, 
mechanical forces in blue, and inflammation’s role is shown in red.  
Numerous researchers study the importance of VEGF and bFGF in mediating wound 
angiogenesis.  Mariotti, Ferrara and Dvorak assert that VEGF is a predominant, necessary, and 
essential regulator of angiogenesis (Dvorak et al. 1995, Ferrara et al. 1996, 2005, Mariotti et al. 
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2006, Mizrahi et al. 2007).  In wound healing, capillary density exponentially increases in time 
then decreases, with VEGF playing the key role, and then endothelial cell survival signals are 
maintained to ensure adequate blood supply.  It is speculated that antiangiogenic factors are 
expressed once healing has resolved to prevent excess angiogenesis and its complications 
(Tandar et al. 2002).  
Ultimately, angiogenesis is a balancing act between proangiogenic and antiangiogenic 
molecules to ensure that the body maintains adequate oxygen and nutrient supply.  See Figure 
2.5. 
 
Figure 2.5: Balancing of proangiogenic (stimulators) and antiangiogenic (inhibitors) molecular 
signals.  Blue bar indicates biological response to ischemia/hypoxia. 
 
2.2 Overview of current proangiogenic therapies 
 Typically, in ischemic cases such as peripheral arterial disease (PAD) or cardiovascular 
disease (CVD), surgery or endovascular methods are used (Tandar et al. 2002, Sabti et al. 2007) 
to restore blood flow in the clinic.  As discussed previously, these include by-pass, stent 
placement and angioplasty (Landolfo et al. 1999, Chu et al. 1999, Leon et al. 2000, Yamamoto et 
al. 2000, Dallan et al. 2008, Estvold et al. 2010, Lucas et al. 2011).  Surgical techniques like by-
pass promote angiogenesis by providing an alternate route for blood flow such that the 
downstream endothelial cells sensing more shear stress due to blood flow.  This increase in shear 
may promote angiogenesis to the ischemic area through the pathways discussed in 2.1.  For early 
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PAD or CVD, exercise shows promise, but this treatment is contraindicated for advanced disease 
(Hansen et al. 2010).  Exercise would lead to muscular development, creating a hypoxic 
environment which would facilitate new blood vessel growth.   
Other techniques that show promise include laser revascularization and radiofrequency 
ablation (Burkhoff et al. 1996, Yamamoto et al. 2000).  These techniques utilize the method of 
secondary wound healing angiogenesis—revascularization prompted by minor wounding, again 
promoting the hypoxic trigger for blood vessel growth.  Because of the associated risk due to the 
invasive nature of the procedures, many patients do not qualify for any of the mentioned 
procedures, and others may be nonresponsive to the surgery (Bridges et al. 2006).  For these 
reasons, alternative methods of revascularization in cardiac and skeletal muscle ischemia have 
been explored.  The delivery of growth factors (Hershey et al. 2003, Idirs et al. 2004, 
Efthimiadou et al. 2006), cellular, molecular, and genetic therapy attempts have been made in 
order to find a clinically relevant treatment (Takeshita et al. 1996, Assmus et al. 2002, Messina et 
al. 2002, Iwaguro et al. 2002, van Royen et al. 2002, Lebherz 2003, Grines et al. 2003, Hiasa et 
al. 2004, Halkos et al. 2008, Kang et al. 2008).  
Table 2.1 summarizes the surgical, cellular, molecular and genetic techniques represented 
in the literature over the last 15 years.  Takeshita et al. (1996), Yamamoto et al. (2000), Lebherz 
et al. (2003), Hershey et al. (2003), and Kang et al. (2008) all used growth factors known to be 
involved with angiogenesis (Table 2.1 and Figure 2.4).  Of them, only Yamamoto et al. (2000) 
combined the growth factor with transmyocardial revascularization which demonstrated a greater 
level of effectiveness than the others.  In Chapter 1 it was noted that growth factor infusion alone 
shows minimal effectiveness.  The table also shows that over time, the effectiveness of 
transmyocardial revascularization has decreased by about 50% (Table 2.1).  Though part of the 
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apparent decrease is attributable to differences in experimental setup and controls, there is also 
variation in the type of revascularization (ie. direct, mechanical, the addition of growth factors) 
that makes a one to one comparison difficult.  The majority of the techniques used to treat 
ischemia by inducing angiogenesis are invasive, site specific and temporal, but effectiveness 
varies from 0 to 80% (Table 2.1).  The trends show that the less invasive procedures have not 
been as effective.  Chapter 1 discussed that the invasiveness of current procedures like bypass are 
contraindicated for certain populations, therefore these alternatives do not provide a feasible 
alternative for those patients.  It is generally the invasiveness or lack of site specificity that 
provides the largest obstacle for therapeutic effectiveness with angiogenesis.  As a result, a 
noninvasive, spatially specific technique that is safe and effective would be highly medically 
significant. 
 
This chapter gave an overview of angiogenesis and defined its protagonists and 
mechanistic triggers.  It also expounded upon the importance of VEGF as the critical driver of 
angiogenesis.  Supplemental involvement of PDGF, TGF-β, MMPs, and HIF-1α were discussed 
Table 2.1. Surgical, cellular, molecular, genetic techniques and effectiveness.  Effectiveness is measured in percent 
increase in perfusion or increased capillary/vessel density from control. 
Citation Technique Invasive Site Specific Temporal Effectiveness 
Takeshita et al. 1996 Gene transfer of VEGF Yes No No ~40% 
Landolfo et al 1999 Transmyocardial revascularization Yes Yes Yes 0% 
Chu et al 1999 Mechanical transmyocardial 
revascularization Yes Yes Yes ~80% 
Leon et al. 2000 Direct myocardial revascularization Yes Yes Yes 0% 
Yamamoto et al. 2000 Transmyocardial laser revascularization + 
bFGF Yes Yes Yes 75% 
Lebherz et al. 2003 IV bFGF infusion No No No ~33% 
Hershey et al. 2003 Adenovirus-delivered VEGF No Yes No ~43% 
Dallan et al 2008 Cell therapy + Transmyocardial 
revascularization Yes Yes Yes 50% 
Halkos et al 2008 IV infusion of stem cells No No No ~30% 
Kang et al 2008 Nanosphere-mediated delivery of VEGF 
(gene therapy) No Yes No ~67% 
Estvold et al 2010 Transmyocardial laser revascularization Yes Yes Yes ~40% 
Lucas et al 2011 Bypass & Endovascular surgery Yes Yes Yes ~45% 
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to show the progression of blood vessel formation.  Next, a flow chart (Figure 2.4) placed the 
key elements in order of their appearance in the angiogenic process.  Finally, a brief discussion 
of current proangiogenic treatments including: gene transfer, transmyocardial revascularization, 
and growth factor infusion was presented in an effort to demonstrate that the development of a 
noninvasive, spatially specific therapy for angiogenesis induction is warranted.  
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CHAPTER 3: ULTRASOUND & ULTRASOUND CONTRAST AGENTS 
 This chapter defines and gives a brief history of ultrasound (US).  It discusses US 
bioeffects and relevant calculated quantities.  Further, this chapter gives an overview of 
ultrasound contrast agents (UCAs) and their responses to US as a segue to US-UCA induced 
bioeffects. 
3.1 Ultrasound 
 Ultrasound (US) is a general term for sound with frequencies greater than 20 kHz, which 
is the upper limit of the audible range for most people.  The concept of sound existing above the 
range of human hearing has been known since the late 1800s (Rayleigh et al. 1945, O’Brien et al. 
1998).  Initially, US was developed to echo-locate icebergs (French et al. 1951, Hunt et al. 1982).  
Interestingly, in the mid-1910s, Langevin observed two unique events with US: a detrimental 
effect where fish in the beam of the source were killed immediately, and the development of 
cavitations in water (Hunt et al. 1982, O’Brien. et al. 1998).  From this observation, it was noted 
that US has the ability to induce biological effects.  Though the bioeffects of US were noticed in 
the 1910s, the research to examine the biophysical mechanisms of these effects did not begin 
until several decades later (Harvey et al. 1930, O’Brien et al. 1998).   
3.2 Ultrasound bioeffects 
The biological effects (bioeffects) of US include tissue but are not limited to ablation (Xu 
et al. 2005), lung lesions (O’Brien et al. 2001), hemorrhage (Miller et al. 2008), and arrhythmias 
(Fujikura et al. 2006).  US is also capable of inducing cellular level events such as changes in 
diffusion rate, increased protein synthesis, membrane damage, mast cell degranulation and 
histamine release (Miller et al. 2007, Paliwal et al. 2008).  Bioeffects were found to result from 
varying ultrasonic parameters such as: acoustic pressure (Pr), pulse repetition frequency (PRF), 
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and exposure duration (ED).  A few acute studies have looked at relationships between the 
exposure parameters in the lung, muscle, intestine and in cell-based models.   
Pr is an important parameter of ultrasound; it has been positively correlated with the 
severity of bioeffects in both tissue and cellular models.  Muscle erosion was found to occur with 
pressures of exposure above 10 MPa at 0.8 MHz (Xu et al. 2005), but membrane damage was 
reported at a much lower Pr = 0.07 MPa with 1 MHz exposure (Miller et al. 2004).  In another 
cellular study, membrane damage was determined to increase with increasing Pr from 0.6 to 3.0 
MPa (Guzman et al. 2001).  An in vivo study using frog heart found that Prs from 5 to 10 MPa 
during systole and diastole caused reduced aortic pressure and premature ventricular 
contractions, respectively (Dalecki et al. 1993).  Unlike Pr, PRF does not demonstrate as strong 
of a correlation to bioeffects. 
In rat lung, O’Brien et al. used a range of PRFs (50 – 1700 Hz) and demonstrated that 
PRF by itself was insignificant (O’Brien et al. 2001, O’Brien et al. 2003). Contrary to O’Brien et 
al., it was found that there was a significant PRF dependence with the cell viability and free 
radical formation in vitro when 0.5 to 100 Hz was examined; this study found that lower values 
(5 Hz) were associated with less bioeffects (Buldakov et al. 2008).   In a rat ex vivo cardiac 
muscle, lesion width, but not size was positively correlated with PRF (Fujikura et al. 2006).  
With various experimental models and US settings, PRFs role in inducing bioeffects remains 
unclear.  However, the product of PRF and ED, the total number of pulses (TNP) does reveal 
trends. 
Several studies have demonstrated a positive correlation between TNP and bioeffects.  In 
vitro studies on blood clots showed that TNP was positively correlated to thrombolysis rate (1 
MHz, duty cycle = 10%, PRF = 1Hz) (Frenkel et al. 2006).  A renal model (PRF = 100 Hz, PD = 
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20 µs) found that low TNP (10 or 100) was correlated to focal hemorrhage and cellular injury 
and large TNP (1000 or 10000) showed complete destruction (Roberts et al. 2006).  Other 
research performed a study on PRF and ED that demonstrated significance for the interaction 
term, TNP (6.1 MPa, 2.8 and 5.6 MHz) (O’Brien et al. 2005).  Likewise ED demonstrated a 
positive trend with bioeffect generation, although this trend only emerges in excess of 3 minutes 
(O’Brien et al. 2005, Miller et al. 2008).  However, this threshold seems to be lower for in vitro 
models.  A prostate cancer cell viability study found that ED was positively correlated with 
prostate cancer cell viability (0.1 to 10 s) at Pr = 0.1 to 1 MPa (Cochran et al. 2001).  Ultrasound 
was found to completely eradicate gram negative bacteria like E. coli with ED > 5 min, but gram 
positive bacteria like S. aureus were more resistant to US exposure, demonstrating only moderate 
declines at EDs up to 60 minutes (Monsen et al. 2009).  Longer EDs allow for more US energy 
to be absorbed by the tissue that is exposed.  This energy absorption can produce heating.   
3.2.1 Thermal effects of US 
US bioeffects are generally categorized as thermal or non-thermal (mechanical) in nature.  
Thermal effects result from the interaction of the applied Pr, PRF and ED are considered to play 
a role in bioeffect induction.  The thermal dose is a concept that was introduced by Sapareto et 
al. (1984) and is comprised of both the temperature applied and ED, where with higher 
temperature, less time is necessary to create a bioeffect  (O’Brien et al. 2007, ter Haar et al. 
2009).  With US, thermal effects can be exacerbated by increasing Pr.  Higher Prs place more 
energy into the system and therefore can cause more heating.  The maximal temperature increase 
for no heat removed processes (ΔTmax) from US exposure can be approximated by (Fry and Fry 
et al. 1953, O’Brien 2007, NEMA 2009a): 
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where Qሶ  is the amount of heat generated per unit volume, ITA is the temporal average intensity, α 
is the absorption coefficient, Δt is the ED, Cv is the heat capacity per unit volume, ρ is the 
density, c is the speed of sound, and Pr is the applied acoustic pressure. 
 3.2.2 Mechanical effects of US 
One of the mechanical effects of US is due to radiation force. (Nyborg et al. 1953, 1965, 
1975, Hoff et al. 2001, Yang and Church 2005, ter Haar 2009).  Radiation force is contingent 
upon the amount of US energy absorbed.  The absorbed energy manifests as force on the object.  
Radiation force is defined as a small, steady force that is produced when a sound beam strikes a 
reflecting or absorbing surface.  It is exerted on any body immersed in the acoustic field and may 
cause bulk movement of cells and tissue displacement (Nyborg et al. 1965, Nightingale et al. 
1995, Postema et al. 2004).  Dyson et al.  (1971) demonstrated that red blood cells in large 
vessels formed bands when exposed to continuous wave US.  Dalecki et al. (1997) showed that 
radiation force caused reduced aortic pressure and disturbed cardiac rhythm in a frog heart.  
Radiation torque, related to radiation force, is a twisting action that may be caused when a sound 
wave hits a suspended object.  Symmetrical objects have been shown to rotate, while others will 
tend toward a preferred orientation.  This phenomenon is not as well characterized. 
Another mechanical effect is due to acoustic cavitation.  Cavitation is defined as the 
formation of gas filled cavities or ‘free bubbles’ in a medium exposed to an ultrasonic field (ter 
Haar et al. 1986).  These free bubbles can oscillate with the applied pressure.  One form of 
∆ ௠ܶ௔௫ ൌ
ሶܳ ∆ݐ
ܥ௩  (3.1) 
ሶܳ ൌ 2ߙܫ்஺ (3.2a) 
ܫ்஺ ൌ ߙ ௥ܲ
ଶ
ߩܿ  (3.2b) 
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oscillation is stable cavitation.  Stable (linear) oscillation displays equal magnitude expansion 
and contraction phases in response to the applied pressure (Pr and Pc, respectively). 
A basic approximation to bubble dynamics views a bubble as a linear oscillator, where 
forces are both internal and external (Figure 3.1).  These forces include the force on the bubble 
surface, Fs, the force on the bubble from the surrounding liquid, FL, and the frictional forces from 
damping, Ff.  Beginning with instantaneous radius, ܽሺݐሻ, equilibrium radius, ܽ௘, and equilibrium 
volume, V: 
ܽሺݐሻ ൌ ܽ௘ ൅ ߦሺݐሻ (3.3) 
ܸ ൌ 	43ߨܽ
ଷ ܽ݊݀ Δܸ ൌ 4ߨܽଶߦ (3.4) 
where ߦ is radial displacement, which is assumed to be much smaller than the bubble equilibrium 
radius, ܽ௘.  Equations 3.3 and 3.4 show that changes in the radius will cause volume changes.   
 
Figure 3.1: Forces acting at the bubble surface at equilibrium radius. 
The volume change causes a change in pressure, Δp, inside the bubble.   
Δ݌ ൌ െ3ߢ݌௚ ߦܽ  (3.5) 
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where ߢ  is the polytropic gas exponent, ݌௚	 is the equilibrium (gas) pressure inside the bubble. 
The force on the bubble surface, ܨ௦, is equivalent to the integral of pressure inside the bubble on 
the surface: 
ܨ௦ ൌ ඵ݌௦	݀ܵ
ௌ
ൌ 4ߨܽଶ݌௦ ൌ െ12ߨܽߢ݌௚	ߦ ൌ ݏ ߦ (3.6) 
ݏ ൌ െ12ߨܽߢ݌௚ (3.7) 
where s is the “spring constant” of the bubble. 
The pressure radiating from the oscillating bubble at radius r, ݌௦ሺݎሻ, is determined from: 
݌௦ሺݎሻ ൌ ݌௦ሺܽሻ ܽ݁
௜ሺఠ௧ି௞௥ሻ
ݎ  (3.8) 
where ݌௦ሺܽሻ is the pressure at the surface of the bubble, ω is the frequency, t is time, k is the 
wavenumber, and r is the radius.  Relating this pressure outside the bubble to the radial 
displacement can be accomplished by using the Euler equation: 
ߩߦሷ ൌ 	െ׏݌ ൌ ݌௦ሺܽሻܽ ሺ1 ൅ ݅݇ܽሻ (3.9) 
 ݌௦ሺܽሻ ൌ ߦሶ߱ߩܽ ሺ݅ ൅ ݇ܽሻ (3.10) 
where ρ is the density of the liquid, ߦሶ is the velocity, ߦሷ is the second time derivative of ߦ, and  ׏݌ 
is the partial derivative of ps with respect to radius.  These equations assume linearity and ka << 
1. Then the mechanical force on the bubble, Fm can be solved from the integral of ps over the 
bubble surface: 
ܨ௠ ൌ െ4ߨܽଶ݌௦ ൌ 	െ4ߨܽଷߦሶ߱ߩܽ ሺ݅ ൅ ݇ܽሻ ൌ െܴߦሶ െ ݉ߦሷ (3.11) 
ܨ௙ ൌ െܴߦሶ (3.12) 
ܨ௅ ൌ െ݉ߦሷ (3.13) 
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where ܨ௙ are the frictional forces from radiation and viscosity, ܨ௅ is the force from the liquid, 
݉ ൌ 4ߨܽଷߩ  is the effective mass of the oscillating bubble, and the mechanical resistance is 
defined as:	ܴ ൌ 4ߨܽଶߩܿሺ݇ܽሻଶ.  With an applied acoustic pressure, pA, this force balance 
becomes: 
ܨ௦ ൅	ܨ௙ ൅	ܨ௅ ൌ 	ݏߦ ൅ 	ܴߦሶ ൅ ݉ߦሷ ൌ ඵ݌஺ ሺݐሻ ݀ܵ
ௌ
ൌ െ4ߨܽଶ݌஺ (3.14) 
This equation describes a free bubble as a linear mechanical oscillator.  It does not incorporate 
surface tension at the gas-liquid interface.  
 Another way to theoretically describe bubble dynamics is to begin with an equation to 
describe liquid flow, the Bernoulli equation (3.15), and the continuity equation (3.16): 
߲߰
߲ݐ ൅	
1
2 ሺ׏߰ሻ
ଶ ൌ െ݄ሺݎሻ (3.15) 
ݑሺݎ, ݐሻ ൌ ݂ሺݐሻݎଶ  (3.16) 
߰ሺݎ, ݐሻ ൌ െ݂ሺݐሻݎ  (3.17) 
where ߰ሺݎ, ݐሻ, is the velocity potential, ݄ሺݎሻ is the enthalpy,	ݑሺݎ, ݐሻ is the velocity of the liquid, 
and ݂ሺݐሻ is an arbitrary function of time. From the continuity equation we see that ݑሺݎ, ݐሻ can be 
derived from ߰ሺݎ, ݐሻ as described by: 
ݑ ൌ ׏߰ (3.18) 
The enthalpy term was described in terms of pressure and density by Prosperetti et al. (1984), 
and simplified by assuming an incompressible liquid (ρ = constant) by Hoff (2001) as: 
݄ ൌ ݌ሺݎሻ െ ݌ஶߩ  (3.19) 
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where ݌ሺݎሻ is the pressure at radius, r, and ݌ஶ is the pressure in the liquid far from the bubble.  
Therefore, the Bernoulli equation can be rewritten as: 
߲߰
߲ݐ ൅	
1
2 ሺ׏߰ሻ
ଶ ൌ െ݌ሺݎሻ െ ݌ஶߩ  (3.20) 
 
which describes a relationship between the velocity potential and pressures (in the surrounding 
media and at the bubble surface).  To solve these equations in terms of radius varying with time, 
boundary conditions must be set: 
ݑሺݎ ൌ ܽሻ ൌ ߲߲߰ݎ |௥ୀ௔ ൌ ሶܽ  (3.21) 
݌ሺݎሻ|௥ୀ௔ ൌ ݌௦ (3.22) 
 
where ሶܽ  is the radial velocity and ps is the pressure at the bubble surface.  From Eq 3.17 and 3.21 
we find that: 
ܽଶ ሷܽ ൅ 2ܽ ሶܽ ଶ ൌ ݂ᇱሺݐሻ (3.23) 
 
Placing Eq. 3.23 into 3.20 with: 
∂߰ሺݎ, ݐሻ
߲ݐ ൌ െ
݂ᇱሺݐሻ
ݎ  (3.24) 
 
(from Eq 3.17), and noting that ׏߰ ൌ ݑ ൌ ሶܽ , from Eq. 3.18 and Eq. 3.21. If Eq. 3.24 is evaluated 
at r = a, we find the Rayleigh-Plesset equation (Plesset et al. 1949, Hoff  et al. 2001): 
ܽ ሷܽ ൅ 	32 ሶܽ ൌ െ
݌ஶ െ ݌௦
ߩ  
(3.25) 
This equation describes the relationship between the radius and pressure.  It assumes 
spherical symmetry and purely radial and irrotational flow.  Stable linear cavitation describes the 
steady, continuous oscillation (expansion and contraction) of bubbles in response to US (Figure 
3.2).   
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Figure 3.2: The changes in bubble radius with applied acoustic pressure.  The linear case is valid 
when the acoustic amplitude is low, and the nonlinear case is for high amplitude waveforms, 
though only one waveform is depicted here. 
 
This type of cavitation progresses to a nonlinear regime when the Pr is further increased, where 
there is a slow expansion caused by the peak rarefactional pressure, followed by a rapid 
contraction phase (peak compressional pressure) as seen in Figure 3.2 in blue. Equation 3.25 
allows for the derivation of theoretical models that describe both linear and nonlinear oscillation.   
Incorporating a driving acoustic field (Plesset et al. 1949) ݌ஶ ൌ ݌௢ ൅ ݌஺ሺݐሻ, the Raleigh-
Plesset equation for an oscillating free bubble becomes:  
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ܽ ሷܽ ൅	32 ሶܽ
ଶ ൌ െ ݌௢ ൅ ݌஺ሺݐሻ െ ݌௦ߩ  (3.26a) 
where ݌஺ሺݐሻ is the driving acoustic pressure, ݌௢ is the atmospheric pressure.  In response to an 
applied acoustic field bubbles will oscillate with the pressure wave (Figure 3.2).  Equation 3.26a 
assumes spherical symmetry, purely radial and irrotational flow.  It neglects the contribution of 
viscosity in the bulk of the liquid.  This equation also does not directly account for contributions 
from the acoustic radiation, gas, viscosity, or surface tension, and assumes an incompressible 
liquid.   
Other models like Trilling et al. (1952) or the Keller-Miksis et al. (1980) added a constant 
speed of sound in the liquid, linear compressibility and acoustic radiation damping advantages 
over the Rayleigh-Plesset model.  The left side of Eq. 3.26a was later modified to include the 
radiation damping term from the Trilling and Keller-Miksis models; the modified Rayleigh-
Plesset equation is described by: 
ܽ ሷܽ ൅	32 ሶܽ
ଶ ൌ െ ݌௢ ൅ ݌஺ሺݐሻ െ ݌௦ߩ ൅
ܽ݌ሶ௦
ߩܿ  (3.26b) 
Understanding bubble dynamics began with the derivation of an equation to describe radius, ܽ, 
in terms of pressure with respect to time.  This equation was further modified to include viscosity 
of the liquid, µ (Leighton et al. 1994): 
ߩ ൬ܽ ሷܽ ൅ 	32 ሶܽ
ଶ൰ ൌ ݌௦ െ ݌஺ሺݐሻ െ ݌௢ െ 4ߤ ሶܽܽ  (3.27) 
When including the contributions of surface tension, σ, and constant vapor pressure, ݌௩, we find 
(Leighton et al. 1994): 
ߩ ൬ܽ ሷܽ ൅ 	32 ሶܽ
ଶ൰ ൌ ൬݌௢ ൅	2ߪܽ௘ െ ݌௩൰ ቀ
ܽ௘
ܽ ቁ
ଷ఑
൅ ݌௩ െ ݌௢ െ 2ߪܽ െ
4ߤ ሶܽ
ܽ െ ݌஺ሺݐሻ (3.28) 
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This equation, like Eq. 3.27, defines the change in bubble radius with time when acoustic 
pressure is applied.  It assumes the following: the bubble radius is small with respect to the 
acoustic wavelength, spherically symmetrical oscillation of a free bubble in an incompressible 
liquid, and that the density of the liquid is large compared to the gas. 
As the acoustic pressure is further increased, the nonlinear expansion and contraction 
may transition to inertial cavitation (IC).  At high pressures, IC is described by a slow expansion 
followed by a rapid contraction when the free bubble is dominated by the inertia of the 
surrounding fluid; this rapid contraction approaches the speed of sound (Flynn et al. 1975, 
Forbes 2009).  Highly localized, short duration (nanosecond) collapses cause high temperatures 
(> 4300 K) and high pressures (Didenko et al. 1999).  The fluid volume above the bubble can be 
accelerated and focused during the collapse to produce a microjet (Postema et al. 2004).  Also 
this bubble collapse is associated with generation of free radicals (NCRP 2002, Miller and 
Thomas et al. 1994).   
Several parameters have been investigated with respect to the effect on IC.  The Pr 
threshold for which IC occurs has been shown to be positively correlated with frequency (Ammi 
et al. 2006b, King et al. 2010, King et al. 2011), viscosity (Coakley & Nyborg et al. 1978), and 
weakly with pulse duration (Church et al. 2005, Haak & O’Brien 2007) and number of cycles 
(Flynn & Church 1988, Forbes 2009).  The occurrence of IC has been negatively correlated with 
PRF (Buldakov et al. 2008), temperature and gas content (Coakley & Nyborg 1978).  Numerous 
studies have demonstrated  the dependence of IC on a bubbles change in radius, noting that the 
threshold is reached when the microbubble expansion reaches two times its equilibrium radius 
(ie. amax/ae > 2) (Flynn et al. 1975, Church et al. 2005, Forbes 2009). 
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While posed as separate entities, there is the potential for considerable overlap with 
thermal and mechanical bioeffects.  One can see that the two are not perfectly disjointed because 
the calculation estimates for both types of effects involve Pr (Fry and Fry 1953, Nyborg et al. 
1981, Cavicchi and O’Brien 1984, O’Brien 2007, ter Haar et al. 2009).  Both thermal and 
mechanical bioeffects were implicated in the mentioned studies and research continues to be 
conducted regarding the safety limits of ultrasound.   
This section described US and US-induced thermal and biological effects.   US was 
linked to both local temperature increases and free bubble development that induces mechanical 
effects.  Section 3.2 began by listing the quantified bioeffects to US exposure.  These phenomena 
have been studied since the 1950s, but the connection of the physical mechanisms to biological 
effect has not been examined.  Theoretical equations were presented such that US’s physical 
effects could be linked to bioeffects.  Hemorrhage, lesions, arrhythmias, membrane damage, and 
protein synthesis changes were discussed to be initiated via thermal or mechanical effects of US.  
The theoretical models and maximal temperature estimate allow one to assess a likely 
mechanism.   
3.3 Ultrasound contrast agents 
 In the early 1990s, shelled bubbles were developed to improve contrast in acquired 
images.  These shelled bubbles were called ultrasound contrast agents (UCAs).  UCAs opened 
many new fields of US research, namely UCA responses to US, UCA bioeffects and UCA 
therapeutic effects/applications.  UCAs can generally be described as a thin elastic shell 
approximately 1-200 nm thick encapsulating a gas core.  UCAs are microbubbles that range from 
2-20 μm in diameter.  There are two commercially available UCAs in the United States: 
Definity® and OptisonTM.  Definity® is a lipid shell microbubble encapsulating 
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octafluoropropane with a median diameter of approximately 2 μm.  OptisonTM is an albumin 
shell contrast agent encapsulating octofluoropropane with a median diameter of approximately 4 
μm.  Due to recirculation, both Definity® and OptisonTM are detectable for up to 10 minutes and 
have a mean half-life of 1.3 minutes in humans (Definity Package Insert, Optison Package 
Insert).  Definity® was the UCA chosen to be used in this thesis because commercially available 
UCAs have been characterized, and Definity® was the only UCA consistently available for 
purchase.   
3.4 UCA responses to US 
Spontaneously formed free bubbles (cavitation) were described previously.  Here the 
discussion is extended to shelled bubbles introduced into the system.  UCAs fundamentally 
behave like free bubbles (Section 3.2), however the shell and enclosed gas make additional terms 
necessary to describe the bubble behavior.  Along with US exposure, UCAs, like free bubbles, 
have been shown to oscillate, expanding in response to peak compressional pressure and 
contracting in response to peak rarefactional pressure.  As Pr increases, UCAs progress from 
linear oscillation, to nonlinear oscillation, to inertial cavitation (IC).   
For linear oscillation undamped natural resonant frequency, fo, of encapsulated bubbles is 
described as (Goertz et al. 2007): 
௢݂ ൌ 12ߨඨ
3ߢ݌௢
ߩܽଶ ൅
2ܵ௣
ߩܽଷ (3.29) 
where ܵ௣ is a shell restoring force accounting for shell elastic (stiffness) effects, ݌௢ is the 
atmospheric pressure (101 kPa), κ is the polytropic exponent, and ܽ is the bubble radius.  UCAs 
typically oscillate most efficiently (resonate) at frequencies from 1 to 8 MHz at relatively low 
Prs.  The resonant frequency is dependent upon the UCA size and capsule composition (Moran et 
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al. 2002, Wu et al. 2008).  Because there is a shell, the effective surface tension changes as a 
function of the bubble radius, and the shell of a UCA both constrains and raises the resonant 
frequency, which, in turn, affects the collapse threshold.  Also, commercially available UCAs 
bubble diameters vary in size (Goertz 2007, Overvelde et al. 2010).  For microbubbles with small 
diameter, surface tension adds to the restoring force along with the shell stiffness making 
collapse require higher Prs (AIUM 2000). Wu et al. (2002) derived an equation to determine the 
resonant frequencies for exposures in the MHz ranges where viscous forces dominate.  
Incorporating damping terms that result from the shell surface tension and viscosity we find the 
damped resonant frequency (Wu et al. 2002, Goertz et al. 2007): 
௥݂௘௦ ൌ 	 12ߨඨ
3ߢ
ߩܽ௢ଶ ൬݌௢ ൅
2ߪ
ܽ௢൰ ൅
2ܵ௣
ߩܽ௢ଷ െ
2ߪ
ߩܽ௢ଷ (3.30) 
≅	 ௢݂ඨ1 െ
ሺߜ௩௜௦௖ െ ߜ௦௛௘௟௟ሻଶ
2  (3.31) 
where the shell elastic parameter is ܵ௣= 6Gsx ≈ 1.1 N/m, Gs is the shear elastic modulus, x is the 
shell thickness, σ is the surface tension, and ௢݂ is described in Eq. 3.29.  The Goertz equation 
includes the damping terms: 
ߜ௩௜௦௖ ൌ 4ߤ߱ߩܽଶ (3.32) 
ߜ௦௛௘௟௟ ൌ ௙ܵ4ߨߩ߱ܽଷ (3.33) 
and the shell friction effects, ௙ܵ ൌ 48ݔߨߤ௦௛௘௟௟ ≈ 0.5 x 10-6 (Goertz et al. 2007). The two 
equations above yield similar results as seen in Figure 3.3 for Definity® with a median bubble 
diameter range of 1.1 – 3.3µm, fres = 0.3 – 2 MHz: 
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Figure 3.3: Resonant frequency for a range of diameters.  The red portion represents the median 
range for Definity® microbubbles (ߩ = 1060 kg/m for blood,	݌௢ = 101.3E3,	ߪ = 0.073 N/m (Wu 
et al. 2002), Sp = 1.1 N/m (Goertz et al. 2007)).  The black asterisks are fres from Goertz 2007. 
The right figure is a zoomed in version of the left figure. 
 
In addition, a UCA’s robustness for oscillation is affected by other US parameters.  The 
resonance describes the frequency at which the bubble oscillates most efficiently, or linearly.  
The resonant frequency is dependent upon the applied pressure, because, as discussed before 
linear oscillation is only valid for low pressures.  For example, when a range of microbubbles (2 
to 11 µm) was exposed to 1.7 MHz, oscillation started at 30 to 120 kPa, below which, little or no 
oscillation was observed (Emmer et al. 2007).   
For this thesis, UCAs are infused intravenously.  Research has shown that cylindrical 
confinement may affect resonant frequency due to viscous and thermal damping.  Energy is 
absorbed from acoustic field that goes into random motion and internal molecular energy.  Oguz 
et al. (1998) demonstrated that the exact confinement conditions play a role in how the resonant 
frequency is affected.  For the infinitely thin, pen vessel with a 0.5 bubble radius to blood vessel 
radius ratio (which is most similar to capillaries) the fres drops by ~ 50%, but this model does not 
consider the biomechanics of capillary blood vessels.  Another study showed that if the initial 
bubble radius is much smaller than the blood vessel radius, fres remains relatively constant, even 
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when assuming that the capillary is relatively rigid due to the surrounding tissue (Sassaroli et al 
2004).  It should be noted that Definity® ’s mean radius is ~ 1 µm and the mean capillary radius 
is ~ 4 µm.  However, Definity® radii ranges from 1—10 µm and capillaries in vivo can have 
diameters smaller than the diameter of a red blood cell (~7 µm) at rest.  Since cylindrical 
confinement can affect the resonant frequency researchers continued to study how the 
confinement affects the progression of a bubble from oscillation to collapse and the elicitation of 
bioeffects. 
Sassaroli et al. (2004) wrote, “… it is extremely difficult to make in vivo measurements 
in these small blood vessels…to check bubble dynamics” therefore mathematical modeling at the 
micron scale or large scale models has been used.  One such mathematical model found that 
decreasing tube thickness and tube radius, while increasing Pr lead to increased stress and 
microvascular rupture (Miao et al 2008).  The Miao et al (2008) study studied peak hoop stress 
with vessel wall thickness of 1 µm, f = 1 MHz and a Pr = 0.5 MPa; at these settings, the hoop 
stress was found to be greater than the strength of the capillary (Young’s modulus of capillary ~ 
2 MPa (Smaje et al. 1980)).  When hoop stress exceeds capillary strength, it’s postulated that 
capillary rupture occurs (Miao et al. 2008).  Recent studies with UCA radii smaller than the 
confining vessel argue that in capillaries the collapse threshold is not considerably affected 
because the Young’s modulus of capillaries is low (compliant tubing), and the wall thickness is 
less than the bubble diameter (minimal damping) (Miao 2008, Martynov 2009).  Existing 
literature maintains that the average sized capillary does not significantly change the resonant 
frequency; therefore cylindrical confinement is not of particular concern with regard to its effect 
on bubble dynamics.  However, other research shows that as pressure is increased, nonlinearity 
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and collapse occur, regardless whether the driving frequency is resonant or not (King et al. 
2011).   
Progressing from oscillation to collapse, a study on OptisonTM and Definity® shell rupture 
found that the collapse threshold for postexcitation acoustic emissions (a rebound signal 
proposed to occur with an inertial cavitation event) increased with frequency and decreased with 
pulse duration (Ammi et al. 2006, King et al. 2010).   Studies also report that the most likely 
destruction process for Definity® is that exposure produces a defect in the microbubble shell and 
breaks the microbubble into smaller bubbles (daughter bubbles) (Moran et al. 2000, Sarkar et al. 
2009).   
Various models have been generated for shelled bubbles; they account for inner and outer 
radii (for an incompressible shell) (Church et al. 1995), shell thickness with constant volume 
(Hoff et al. 2000), and equations to express shear loses (Church et al. 1995, Leighton et al. 
2008).  The Church et al. (1995) model included shear modulus and shear viscosity shell terms, 
but neglected surface tension for an albumin shelled UCA.  When a gas is encapsulated by a lipid 
shell, the hydrophobic nature of the shell requires surface tension be included.  Also lipid shells 
cause the bubble to undergo higher amplitude oscillations with increases in pressure.  Shell 
properties aside, the main limitation of the previously described equations is that they do not 
incorporate collapse.  As previously stated, when Pr is increased the expansion slows reaching 
large amplitudes and is followed by a rapid contraction.   
In 2005, Marmottant defined a model for large amplitude oscillations that lipid shelled 
bubbles undergo that includes rupture of the microbubble.  This model includes surface tension, 
surrounding liquid viscosity and the surface dilatational viscosity from the bubble’s shell.  These 
terms are incorporated by the boundary condition (Marmottant et al. 2005): 
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݌௚ሺݐሻ െ ݌௅ሺݐሻ ൌ 2ߪሺܽሻܽ ൅ 4ߤ
ሶܽሶ
ܽ ൅ 4ߟ௦
ሶܽሶ
ܽଶ (3.34) 
where pg is gas pressure in the bubble, pL is liquid pressure, ߟ௦ is the shell surface dilatational 
viscosity, and σ is surface tension. Equation 3.34 assumes that the shell is thin with respect to the 
bubble radius and therefore not included.  Thickness measurements of phospholipid monolayers 
range between 1 – 2 nm (Minones et al. 2002, Goertz et al. 2007) so a thin shelled approximation 
(neglecting the inner radius) for UCAs is appropriate. 
Assuming an ideal polytropic gas with ݌௚	ߙ	ܽିଷ఑, where κ is the polytropic gas exponent, 
and combining Eq. 3.28 with Eq. 3.34 the Marmottant equation to describe lipid shelled bubbles 
in a surrounding liquid is described with: 
ܽ ሷܽ ൅	32 ሶܽ
ଶ ൌ 1ߩ ቊ൤݌௢ ൅
2ߪሺܽ௘ሻ
ܽ௘ ൨ ൬
ܽ
ܽ௘
ିଷ఑
൰ ൬1 െ 3ߢ ሶܽܿ ൰ െ
2ߪሺܽሻ
ܽ െ
4ߤ ሶܽ
ܽ െ
4ߢ௦ ሶܽ
ܽଶ െ ݌௢
െ ݌஺ሺݐሻቋ 
(3.35) 
Marmottant also defined shell surface tension in terms of bubble radius: 
ߪሺܽሻ ൌ
ە
ۖۖ
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ۖۖ
ۓ 0 ݂݅ ܽ ൑ ܽ௕௨௖௞௟௜௡௚
߯	 ቆ ܽ
ଶ
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(3.36) 
 
ݓ݅ݐ݄	ܽ௥௨௣௧௨௥௘ ൌ ܽ௕௨௖௞௟௜௡௚ඨ൬1 ൅ ߪ௪௔௧௘௥߯ ൰ (3.37) 
Equation 3.35 has been popular in describing Definity®, because it closely approximates the 
experimental bubble behavior (King et al. 2010).  The Marmottant equation also takes into 
consideration the thin shell behavior during oscillation.   
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One property the Marmottant equation neglects is the initial gas pressure in the bubble.  
While fluorocarbons are common to UCAs, other gases like sulfur hexafluoride have been used 
(SonoVue package insert).  Because of their low solubility in blood and high vapor pressure, 
various types of perfluorochemical gases like perfluorocarbon, perfluorobutane, 
perfluoropropane, and perfluorohexane are used to improve the stability and plasma longevity of 
the agents. The properties of the internal gases partially determine the oscillatory patterns.  
King et al. (2011) proposed a modified Marmottant equation to include a van der Waals 
gas rather than an ideal gas: 
ܽ ሷܽ ൌ 1ߩ
ۏێ
ێێ
ۍቆ݌௢	 ൅ 	2ߪሺܽ௢ሻܽ௢ ቇ ቆ
ܽଷ െ ݕଷ
ܽ௢ଷ െ ݕଷቇ
ି఑
ቆ1 െ 3ߢܽ
ଷ ሶܽ
ܿሺܽଷ െ ݕଷሻቇ
െ2ߪሺܽሻܽ െ
4ߤ ሶܽ
ܽ െ
4ߢ௦ ሶܽ
ܽଶ െ ݌௢ െ ݌஺ሺݐሻ ے
ۑۑ
ۑې െ 32 ሶܽ
ଶ (3.38) 
where y, the van der Waals hard core radius, accounted for large amplitude responses such as 
inertial cavitation and rebound.  Experimentally, the King equation did not fit well with the 1 
MHz driving frequency that will be used in this thesis, therefore the standard Marmottant 
equation will be used to investigate the physical mechanisms with ܽ௘ ൌ 1.0	ߤ݉, ߯ ൌ
0.85	 ே௠	and with ߪ௕௟௢௢ௗ ൌ 0.046	
ே
௠  instead of ߪ௪௔௧௘௥ (Harkins et al. 1929, Marmottant et al. 
2005, Definity® Package insert). 
3.5 Physical regimes of bubble responses 
3.5.1 Radiation forces 
A bubble in a sound field experiences the spatial variation of the change in pressure.  In 
theory, the pressure is greater on the side facing the acoustic pressure than the other.  Therefore 
the pressure drop can cause translation.  UCAs are often much smaller than the acoustic 
wavelength, with UCA diameters ~2 µm and the wavelength, λ = c/f = 1500 µm for a 1 MHz 
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driving frequency.  When the amplitude of the acoustic pulse is low, both the UCA and the 
sound wave oscillate sinusoidally.  The magnitude of the radiation force is dependent upon the 
bubble radius for a traveling wave; the direction is in the propagation of the wave.  These waves 
depend on both bubble radius and location, because the amplitude of the sound wave varies with 
location.  Therefore bubbles that are less than the resonant size are translated in the direction of 
pressure maxima, and bubbles that are larger than resonant size are translated toward pressure 
minima (AIUM 2000).  As acoustic pressure is increased, the force on the smaller bubbles is 
increased (as they have been translated to pressure maxima), and the pressure on larger bubbles 
is decreased. 
Radiation force is also responsible for UCA coalescence.  UCAs scatter energy affecting 
other nearby UCAs and tissues in vivo.  Secondary radiation forces (Bjerknes forces) cause 
microbubble translations toward each other.  When two bubbles are both either above or below 
the resonance sized bubble, these bubbles are attracted together.  When a larger than resonance 
bubble is near a smaller than resonance bubble, they oscillate out of phase and the net force 
between the two bubbles is repulsive (Leighton et al. 1994, Postema et al. 2004).  For biological 
structures (which are normally denser than blood plasma) the force is directed toward the bubble, 
perhaps causing cells to accumulate on the UCAs surface increasing the likelihood of cellular 
lysis.   
The calculation of the radiation force acting on a UCA to cause translation is defined by 
(Postema et al. 2004): 
ܨ௥௔ௗ ൅ ܨௗ െ ݀
ሺܯݒሻ
݀ݐ ൌ 0 (3.39) 
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averaging over one acoustic cycle, 	ܨ௥௔ௗ ൌ
௉ೝమ௔೐ఋ೟೑ೝ೐ೞ೑
ఘ௖௙൤ቀ೑ೝ೐ೞ೑ ቁ
మିଵ൨
మ
ାቀഃ೟೑ೝ೐ೞ೑ ቁ
మ 
(3.40) 
 
ܯ ≅ 2ߨ3 ߩܽ௘
ଷ 
(3.41) 
 
ܨௗ ൌ ߨߤ4 ܥௗܴ݁ܽ௘ݒሺݐሻ (3.42) 
where M is the added mass of the translating bubble, Frad is the primary radiation force, Fd is the 
drag force, v  is the velocity of a bubble in a steady fluid in an US field, c is the speed of sound, 
Pr is the peak rarefactional pressure,  ߜ௧ is the dimensionless total damping coefficient (Medwin 
et al. 1977), fres is the bubble resonant frequency, ߤ is the shear viscosity of the liquid, ܴ݁ ൌ
ଶఘ௔೐|௩ሺ௧ሻ|
ఓ  is the Reynolds number, and ܥௗ ൌ
ଶସ
ோ௘ ሺ1 ൅ 0.15	ܴ݁଴.଺଻଼ሻ is the drag coefficient of the 
contrast agent (Postema et al. 2004). 
Miri et al. (2011) investigated radiation force on UCAs near a porous vessel and 
demonstrated that the radiation force increased with increasing UCA shell thickness and with 
driving frequencies up to about 15 MHz.  Also larger bubble radii were associated with larger 
radiation forces up to 5 MHz.  At 1 MHz (the approximate frequency used in this thesis) shell 
thickness changed the radiation force by less than 5%.  A 2 µm-diameter bubble demonstrated no 
radiation force, while a 10 µm bubble showed ~ 0.5 N radiation force at a distance-to-radius ratio 
of 1.5 and a reflection coefficient of 0.5 (Miri et al. 2011).  Extending these findings to the 
median range distribution of Definity®, the increase in radiation force, when near a boundary, is 
only moderate. 
3.5.2 Microstreaming 
US not only exerts an effect on the UCA causing oscillation or collapse, but also exerts 
an indirect effect upon the media through the contrast agent.  Microstreaming is a major effect of 
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insonation in which the fluid around the vibrating bubble forms eddies of flow, or turbulence, 
adjacent to an oscillating bubble (Gormley and Wu 1998, Baker et al. 2001, Sarkar et al. 2009).  
The pulsation amplitude of a bubble in a traveling wave field varies with bubble radius, being 
greatest for resonant bubbles and less for either larger or smaller ones.  Oscillating bubbles that 
are also being translated by the acoustic pressure may produce shearing flow in the surrounding 
medium.  Both microstreaming-induced and translation-induced shear is greatest near the bubble 
surface (where the fluid velocity is greatest).  Thus biological tissues experience a stronger 
velocity gradient when they are closer to the UCA resulting in shearing stresses that can distort a 
tissue’s endothelium provided the stress exceeds some minimal time or shear stress level.   
Because oscillation was shown to produce microstreaming, it has been theorized to be 
involved with cellular changes and/or damage.  Microstreaming has been under investigation 
since the late 1960s, though induction was typically via a vibrating wire or needle (Hughes & 
Nyborg 1962, Rooney et al. 1970, 1972, Williams et al. 1971, Crowell et al. 1977).  Bioeffects of 
the vibrating wire or needle included high shear stress responsible for hemolysis (Williams et al. 
1970), injury to bacteria and E. coli (Hughes & Nyborg 1962). Microstreaming was also found to 
induce membrane damage in Elodea leaves with the critical shear stress being on the order of 50 
Pa for 100 second exposures (Miller et al. 1985).  Studies have shown that microstreaming 
generates stress from the tens of Pascal’s (Wu et al. 2002) to hundreds of Pascal’s (Williams et 
al. 1971), with exposure duration being negatively correlated to critical shear stress (Miller et al. 
1985).  Theoretical models for estimating shear stress induction with UCAs predicted shear 
stress to be greater than the stress that causes hemolysis in blood and several orders of magnitude 
(1000 times) greater than the physiological stress induced on the blood vessel wall by blood flow 
(Krasovitski et al. 2004).  These stresses induced by an acoustic frequency of 4 MHz and a 
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pressure of 20 kPa generated a steady shear stress of several kiloPascals (Krasovitski et al. 
2004).   
Microstreaming has been associated with a range of shear stresses, and the theoretical 
model for adding UCAs exacerbates the effect.  Therefore, it is suggested that the endothelium in 
blood vessels may be particularly prone to disturbance.  It remains unknown if the negative 
correlation between shear stress and ED exists in vivo, but because biological tissues 
demonstrate viscoelasticity it could remain valid. 
To theoretically describe shear stress,߬, first we must consider the boundary layer.  A 
pulsating bubble near a boundary has a sharp velocity drop across the boundary layer with 
thickness, dv, this is also known as a viscous boundary layer (Nyborg et al. 1958, Wu et al. 
2002): 
݀௩ ൌ ඨ2ߤߩ߱ 
(3.43) 
 
To calculate the shear stress from microstreaming we also need to know the velocity gradient 
across the boundary.  The velocity gradient across the boundary layer associated with 
microstreaming is denoted vgrad (Lewin & Bjorno 1982, Wu et al. 2002): 
ݒ௚௥௔ௗ ൌ ߱
ሺܽ െ ܽ௘ሻଶ
ܽ௘݀௩  (3.44) 
Now the shear stress,߬, can be found by: 
߬ ൌ 	ߤݒ௚௥௔ௗ ൌ ߤ߱
ሺܽ െ ܽ௘ሻଶ
ܽ௘݀௩  (3.45) 
where ߤ is the viscosity of the liquid, ߬ is the shear stress, ߩ is the density of the liquid, ߱ is the 
frequency, ܽ is the instantaneous radius, and ܽ௘ is the equilibrium radius.  This equation was 
developed to describe the shear stress associated with a pulsing bubble near a living cell as a 
40 
 
solid boundary (Lewin & Bjorno 1982).  It should be noted that smaller than resonant bubbles 
exhibit particularly strong changes in oscillatory patterns in response to slight pressure increases, 
therefore the shear stress dependence upon the bubble radius is a direct result of the underlying 
physics.  For Definity® ܽ௘ ≈ dv= 1 µm, which means that the streaming speeds are similar for 
both a free bubble and a bubble resting on a solid boundary (Davidson et al. 1971, Leighton et al. 
1994). 
The shearing stresses may be exacerbated when oscillation becomes nonlinear.  
Nonlinearity may be induced by off-resonance oscillation, or by the microbubble being near a 
boundary.  While most of the theory represented in this chapter assumes spherical symmetry of 
oscillation, UCAs that are near a semi-rigid boundary (ie. vascular endothelium) do not oscillate 
symmetrically Figure 3.4.   The pressure difference across the bubble is asymmetrical because 
the surface restricts the motion of fluid on that side of the UCA.  This asymmetry results in the 
formation of a microjet, an invagination of fluid on the UCA side that is opposite the boundary.  
With increasing pressures, the invagination flows through the UCA and may violently hit the 
boundary.  Microjets have been demonstrated to cause significant damage (Kodama & 
Takayama 1998, Fletcher et al. 2002).  These microjects (overpressure = 10.5 MPa) caused liver 
parenchymal cells to split in the direction of the liquid jet (Kodama & Takayama 1998).  
Microjets have also been shown to travel at more than 60 m/s to penetrate, but not perforate the 
wall of a small diameter blood vessel (Fletcher et al. 2002).   
Although liquid microjets have been observed, they are difficult to predict.  The force 
generated from the inertia is dependent not only upon the bubble but the bubble’s location and 
the pressure gradient that develops across the bubble.  Even when a boundary is present a liquid 
microjet may or may not occur, as some inconsistency has been seen near the threshold 
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(Prosperetti et al. 1997).  Liquid jets have been visualized with high speed cameras and have 
been shown to behave erratically.  Tomita and Shima (1990) captured a series of photograph 
showing the development in bubbles collapsing very close to a wall and with a bit of separation 
from a wall.  The bubble adjacent to the wall demonstrated the invagination seen in Figure 3.4, 
but the bubble with separation demonstrated invagination then collapse disintegration.  Because 
the exact location of a UCA cannot always be known, predicting jetting is difficult in biological 
scenarios. 
 
Figure 3.4: Asymmetric collapse profile of a microbubble near a semi-solid boundary.  
Reproduced from (Postema et al. 2004). 
3.5.3 Inertial cavitation 
When a UCA is exposed to sufficiently high acoustic pressure it induces high amplitude 
nonlinear oscillations.  These oscillations occur as a slow maximal expansion to a rapid 
contraction.  Because this radial max to min occurs quickly, the surrounding liquid may build up 
inertia that exceeds that within the bubble resulting in collapse.  Collapse can produce 
mechanical shock waves in the bubble and surrounding fluid, more powerful perforating liquid 
jets, high temperatures, free radical production, and high velocity shell fragments.  Holland and 
Apfel (1989) and Apfel et al. (1991) examined bubble responses to one cycle of acoustic 
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pressure with respect to the effect of the liquid’s viscosity and surface tension including a 
criterion of the generation of a 5000 K temperature inside the bubble.  The likelihood that 
cavitation would occur (in terms of a pressure threshold) was derived from their original work 
(Apfel et al. 1991, Holland et al. 1996): 
0.06 ൌ ൫ ௢ܲ௣௧൯
ଵ.଺଻
݂  (3.46) 
where Popt is the smallest peak negative pressure threshold required for an optimal sized bubble, 
at a given frequency, f (MHz), and 1.67 and 0.06 are constants for blood.  This equation 
underwent further modification to be normalized to pressure and frequency (1 MPa and 1 MHz, 
respectively).  Then the following index was obtained (Apfel et al. 1991): 
ܫ ൌ ܲ
ଶ
݂  (3.47) 
where P is the peak negative pressure (MPa).  In 1998 AIUM/NEMA described the following as 
the mechanical index (AIUM/NEMA 1998, NEMA 2009b): 
ܯܫ ൌ ௥ܲ,ଷඥ݂  (3.48) 
defined as the likelihood of  nonthermal biological effect with an intervening tissue path, where 
Pr,3 is the derated peak rarefactional pressure measured in water.  The FDA recommends the MI 
not exceed 1.9.  The mechanical index was devised for US exposure only in the induction of 
cavitation; it assumes the existence of stabilized gas pockets or free bubbles as nuclei of 
cavitation. Therefore the MIs usefulness is questioned when UCAs are added, given that UCAs 
can respond differently to US than do free bubbles. A few other researchers have experimented 
with integrating viscoelastic properties into the MI (Jimenez-Fernandez et al. 2005) or 
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determining the IC threshold using shell chemistry (Dicker et al. 2010), but these incorporations 
are not standardized or used frequently. 
Shock waves resulting from IC are generated from the speed of the gas-liquid interface 
estimated to be 40 m/s (Brujan et al. 2005).  Shock waves are on the order of a few nanoseconds 
but may reach pressures up to 40 MPa (Brujan et al. 2005).  Therefore, biological tissues that are 
exposed to the shock may briefly (nanosecond time scale) experience large stresses as a result of 
IC.  
Free radical production results from the contraction phase of collapse where the pressure 
inside the bubble reaches several megapascals and the temperature may reach thousands of 
Kelvin.  In a UCA’s core there exists a fluorocarbon gas; however the shell is comprised of 
several components containing nitrogen, hydrogen, phosphates and oxygen.  High temperatures 
may lead to the chemical dissociation of these elements to form hydride and hydroxide (Verral & 
Sehgal 1988).  The typical lifetime of these free radicals in vivo are ~10 ns, and thus should not 
affect the surrounding tissue.  However, hydrogen peroxide, which can be produced by the 
combination of these free radicals has a substantially longer lifetime and has been shown to 
induce DNA damage (Miller et al. 1995).  Kondo et al. (1988) observed cell killing induced by 
1.0 MHz CW US at 5.8 W/cm2 and determined that a small percentage of the killing was caused 
by the production of free radicals.  A 300 kHz US exposure induced the production of hydroxyl 
radicals, hydroperoxyl radicals and hydrogen peroxide  (Merouani et al. 2010).  Miller et al. 
(1995) also demonstrated DNA breaks when exposing Chinese hamster ovary cells to 2.17 MHz 
US at 0.82 MPa.  In producing free radicals there does not appear to be an association with 
acoustic pressure or US frequency per se, but rather a direct link to collapse.   
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Also, with IC daughter bubbles may be generated that oscillate add to the range of bubble 
sizes represented in a system.  Daughter bubbles are primarily the result of fragmentation 
followed by shell coalescence.  As with the formation of smaller daughter bubbles, there are also 
other theories regarding changes in the bubble size population.  One suggests that microbubble 
fusion occurs with the expansion of adjacent bubbles (Postema et al. 2004). Dayton et al. (1997b) 
constructed a velocity of approach equation to describe the speed at which two bubbles exposed 
to US approach one another, at an equal distance from the transducer due to the radiation force.  
Equating Stokes drag force  
ܨ௦ௗ ൌ 6ߨߤܽ௘ݒ௔ (3.49) 
to the secondary Bjerknes force: 
ܨଶ௥ ൌ െ2ߨߩ
ሺ߱݌஺ሻଶ߳ଶܽଵଷܽଶଷ
9݀௢ଶ  (3.50) 
The velocity of approach for two equal sized bubbles would be: 
ݒ௔ ൌ 	െ
ሺ2ߨ݂݌஺ሻଶߩ߳ଶܽ௘଺
27ߤ݀௢ଶ  (3.51) 
where ߳ is the compressibility of the bubble, and do is the distance between the centers of the 
bubbles.  This equation assumes the bubbles are of the same size, which is the resonant size.  
Chesters et al. (1982) and Postema et al. (2004) state that bubbles will fuse only when the Weber 
number is greater than 0.5.  The Weber number is a dimensionless number used to describe fluid 
flows between two fluids.  It is defined as the inertial force relative to the surface tension force: 
ܹ݁ ൌ ߩݒ௔ܽߪ  (3.52) 
when ܽଵ ൌ ܽଶ . 
Because collapse may occur as fragmentation or simply be due to gas leakage (Chomas et 
al. 2001, Bouakz et al. 2005), which changes the size of the bubble and pressure inside the 
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bubble, oscillation and collapse regimes are affected.  Bouakaz et al. (2005) found that after 
intense compressions, the shell fissures and gas escapes (sonic cracking (Postema et al. 2004)), 
and found a correlation between exposure and the dynamic change in microbubble diameter.  
Other research details another bubble event that counteracts diffusion: rectified diffusion, where 
a bubble may grow by active pumping of gas, initially dissolved in the liquid surrounding the 
bubble, into the bubble by the energy of the sound field (Eller et al 1965, Leighton 1997).  UCAs 
size population can affect the surrounding tissue because of the acoustically active nature of 
exposure (Figure 3.6). 
While the effects due to oscillation and IC are not entirely separable, determination of the 
IC threshold is useful for establishing mechanistic motivation for therapy or bioeffects. To date, 
there exists a range of bioeffects for which a particular mechanistic motivation is unknown.   
3.6 Uncategorized bioeffects of US and UCAs 
 The bioeffects of US alone were discussed previously.  This section extends the 
discussion to include bioeffects of US and UCAs.  Because it is difficult to monitor bubble 
dynamics in vivo, some of what is known about bubble behavior is derived from in vitro 
experiments.  The bioeffects of US-UCAs, have been observed in vivo, but typically without 
mechanistic motivation—where an effect is observed, with no discussion of the role of the UCA.  
Various factors interact to produce the observable biological, chemical and/or physical 
manifestations of US-UCA interaction (Figure 3.6).   
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Figure 3.5: The interaction of US with UCAs to produce cavitation-induced bioeffects. 
 
UCAs have the potential to exacerbate bioeffects due to the increased number of 
cavitation bodies.  Research shows that adding UCAs diminishes the pressure threshold for 
bioeffects (Hwang et al. 2005).  Albunex®, an albumin shelled UCA, was shown to increase 
petechial hemorrhage in mouse intestine when used in conjunction with pulsed US with respect 
to US alone (Miller et al. 1998c).  This study noted that the hemorrhage increased with UCA 
addition showing 30 times more hemorrhage than when UCAs were not used (Pr = 2.8 MPa, US 
frequency = 1.09 MHz) (Miller et al. 1998c).  In a review published by Miller et al. (2008), 
bioeffects induced by US and UCAs on skeletal and cardiac muscle ranges from Pr = 1.0 to 2.8 
MPa for OptisonTM, and a narrower range of Pr = 1.1 to 1.6 MPa for Definity® (Miller et al. 
2008).  Bioeffects ranged from microvessel rupture to cell killing to arrhythmias in cardiac 
muscle.  Miller et al. (2008) reported that petechiae were positively correlated with UCA 
concentration [UCA] for Definity®, Imagent and OptisonTM with a Pr = 1.9 MPa and US 
frequency of 1.7 MPa.  Definity® also caused glomerular capillary hemorrhage and blood filled 
urinary tubules when the porcine kidney was exposed (Miller et al. 2010).  Song et al. (2004) 
used a rat hindlimb model with 1 MHz ultrasound and found that capillary disruptions were 
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positively correlated with UCA concentration (Pr = 0.7 MPa).  These observations demonstrate 
that not only is the addition of UCAs important to bioeffects, but also the [UCA] can increase the 
magnitude of the bioeffect. 
Ultrasound pressure (Pr) has been shown to be highly correlated with petechaie and 
hemorrhage when Definity® UCAs are involved (Miller et al. 1998, Song et al. 2004, Miller et al. 
2008).  Also, in mice, Albunex® and OptisonTM behaved similarly, showing more hemorrhage at 
higher Pr values (Miller et al. 1998).  Therefore Pr (and IC, while not directly stated) has been 
correlated to bioeffects. 
Numerous other bioeffects have been observed to be intensified by the use of UCAs.  
These include increases in temperature (ns duration) (Stride et al. 2004), production of free 
radicals (Wu et al. 2008), arrhythmias in cardiac muscle (Kobayashi et al. 2002), endothelial cell 
damage (Rota et al. 2006).   
These findings, however, may be tissue dependent because a study performed on rat 
lungs, showing that OptisonTM, per se, did not increase lung damage (O’Brien et al. 2004).  
When Albunex® was used hemorrhage was found to depend on the tissue type, with fat being the 
most susceptible to damage, followed by muscle, stomach, skin and mesentery tissue (100 
pulses, Pr = 3.6 MPa) (Dalecki et al. 2000).  Similarly, bioeffect with MIs ranging from 0.31 to  
1.7 with a variety of UCAs have been associated with hemorrhage in skeletal or cardiac muscle, 
whereas wider MI range (0.1 to 1.9) exists for other tissues (ie. intestine, mesentery, brain, 
kidney, liver, lung, and tumor) (Miller et al. 2008).   
Aside from possible tissue differences, in a study on membrane permeability it was found 
that albumin bubbles cause more cellular lysis than lipid under the same conditions, but that 
lipids induce apoptosis and affect cellular stability to a lesser extent (Korosoglu et al. 2006). 
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There is limited research stating major differences in bioeffect induction using commercially 
available UCAs.  Some researchers use non-commercial UCAs, but do not characterize their 
inertial cavitation thresholds or other important properties; therefore there may be greater 
variation in effects.  Because the non-commercial UCAs are not characterized to the extent to 
which commercially available UCAs are, comparisons between studies are difficult.    
Cellular damage, changes in permeability, and hemorrhage are recurring themes in the 
study of US and UCA induced bioeffects, and many of these studies suggest that bioeffects occur 
as a result of US-UCA interactions involving cavitation (Dalecki et al. 2000, Song et al. 2002, 
Rota et al. 2006, Wu et al. 2008).  But Church et al. (2001) pointed out that IC requires high Pr, 
but hemorrhage occurs in skeletal muscle at 0.6 MPa at 2.5 MHz (below the IC threshold).  
Because cavitation is a property that depends on microbubble properties, it is important to 
control the type of microbubble used to ascertain mechanistic information for the induction of 
bioeffects.  
To examine the collapse threshold for the UCA used in this thesis, a logistic regression 
analysis on single bubble experiments was conducted to analyze the dependence of ruptured 
contrast agent occurrence rates as a function of Pr(in vitro).  The 5% occurrence rate was used to 
quantify the shell rupture, or inertial cavitation, threshold in vitro.  A postexcitation signal (PES) 
was used as the qualifier of shell rupture, because it was found that this type of rebound signal 
occurs for free (unshelled) gas bubbles emitted during rebound of the UCA and consequently is 
linked to shell rupture and transient collapse of the UCA (King et al. 2010).  At an approximate 
US frequency of 1 MHz, the collapse threshold of Definity® was determined at a PD of 3 cycles 
(Haak et al. 2007, King et al. 2010) (Figure 3.6).  Definity® was found to demonstrate a 5% 
occurrence rate of collapse at approximately 0.2 MPa.   
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Figure 3.6: Percent collapse versus Pr: Definity® inertial cavitation thresholds (MPa) at 1.0 MHz.  
(King et al. 2010). 
 
The data in Figure 3.6 represents repeated experiments conducted by three separate 
individuals, as such, the variance in the data is quite large.  As a guide, however, the logistic 
regression fit can be used to discern a collapse trend.  The 5% and 100% (~0.9 MPa, the point 
where the regression plateaus) collapse occurrence was consistent amongst trials. 
3.7 Bubble clouds 
A complexity of modeling US and UCAs interaction are the population effects or bubble 
clouds that are often present in vivo. Inertial cavitation depends on several parameters: the 
acoustic frequency, the acoustic pressure at the bubble, and the equilibrium size (Leighton et al. 
1994).  Previously discussed was the wide variation in potential bubble sizes with US interaction. 
The acoustic frequency herein has been set to approximately 1 MHz per previous research, but 
the Pr at the bubble is difficult to control when there are multiple bubbles in the sonicated area.  
Bubble aggregations are acoustically active; they may shield, channel, or scatter the acoustic 
field (Leighton et al. 1994) (Figure 3.6).   
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A few researchers have attempted to construct theoretical models for bubble clouds.  
Some of these studies observe the effects that two bubbles have on one another in terms of 
primary and secondary Bjerknes forces (Mettin et al. 1997), while others examine these forces 
between bubble clouds (Yasui et al. 2008).  The results gathered from each of these studies vary 
significantly, and even within a single study two separate bubble clouds display different levels 
of radial expansion and responses to the applied US.  Because, as Leighton (1994) described, the 
acoustic energy can be shielded, channeled or scattered, the pressure at an individual bubble’s 
surface may be significantly lower than or equal to the measured output pressure.  In addition, 
these types of studies have, to the knowledge of the author, not been conducted with shelled 
bubbles. 
Shelled microbubbles are injected (bolus) intravascularly in vivo, and subjected to flow.  
The modified Rayleigh Plesset Equation is difficult to solve for bubbly cavitating flow.  Hoff et 
al. (2001) stated that: “[it] can, in theory, be solved to find unknowns for any bubbly cavitating 
flow. However, in practice the nonlinearities in the equation present difficulties except when 
simple geometry is used”.   
Experimentally optical methods (LIDAR) and nonlinear US scattering have been 
explored for exploring size distribution and concentration of bubbles (Mari et al. 2007, Li et al. 
2009).  Estimating the acoustic activity of bubble clouds has been attempted mathematically 
using numerical simulations of bubble pulsations exposed to an acoustic horn (Yasui et al. 2008), 
but even quantifying concentration in in vitro flow systems remains elusive. The spatial temporal 
dynamics of bubble clouds has been experimentally studied and it was shown that bubble 
activation has a spatial preference.  Chen et al. (2006) found that the focal region followed by the 
post then pre-focal region was the order in which bubbles were activated using 1.2 MHz focused 
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US.  The conclusions from such studies are that bubble pulsation can be strongly reduced by the 
interaction with the surrounding bubbles.  Yasui et al. (2008) found that the isolated bubble 
model (modified Keller equation, Mentin et al. 1997) predicted bubbles expanding up to 120 µm, 
whereas when the bubble-bubble interactions were considered, this expanded radius dropped to 
40 µm, while these findings are not directly applicable to Definity microbubbles one can note 
how drastically a cloud of bubbles can affect bubble dynamics.   
From Eq. 3.51 and 3.52, the distance that is necessary between two bubbles for the 
attractive velocity within a non-coalescent Weber number is 0.021 µm (using f = 1 MHz, ρblood = 
1060 kg/m3, a = 1 µm, pA = 0.1 MPa, µblood = 0.005 Pa-s, σdefinity = 0.025 N/m, ߳ = 5 x 10-7 m2/N, 
(de Jong et al. 1993).  The volume fraction (volume of gas/mL) is often calculated to estimate the 
distance between two bubbles.  This fraction needs to be less than 0.001% for the attractive 
velocity to not spontaneously coalesce (see calculation in Chapter 5: Materials and Methods).  
While setting bubble coalescence as the determinant of bubble-bubble interaction does not 
account for the dynamic movements of the bubbles, it is used here to illustrate the spread of 
bubbles in vivo.  This thesis uses an infusion of UCA solution, which is allowed to reach a steady 
state volume.  The resulting volume fraction of the Definity® microbubbles to blood volume was 
calculated to be a maximum of 0.00008% for the infusion used herein, which represents a 
sufficiently low volume fraction that is within limitations (see details in Chapter 5: Materials and  
Methods).  Therefore, the single bubble approximation used herein explores mechanistic 
motivation, because, to date, no models exist to accurately describe the effects of multiple 
bubbles.   The main purpose of this thesis is to gain insight to the mechanisms, not necessarily to 
obtain concrete values.   
3.8 Therapeutic effects of US and UCAs 
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Though bioeffects are reported from US exposure (via thermal and nonthermal effects), 
therapeutic effects of US have been shown as well (Porter et al. 2001, Kost et al. 2002, Chappell 
et al. 2006, Pang et al. 2010).  The nondestructive effects (increased cell permeability, minor 
hemorrhage, slightly increased temperature, etc.) could be used to motivate therapeutic 
treatments.  US has been used in the treatment of diabetic ulcerations (Dyson et al. 1976) to 
stimulate tissue regeneration (Dyson et al. 1968), and for bone regeneration (Hasuike et al. 
2011).  
UCAs have opened up the possibility to provide more types of therapy through 
bioeffects. Surprisingly, limited work has been done to connect the known UCA responses to US 
to bioeffects, and no work to establish the link between bioeffect and therapy has been explored.  
Studies have shown that UCAs are involved in sonoporation, sonothrombolysis, increasing 
perfusion and permeability (Postema et al. 2005, Forbes 2009, Choi et al. 2010, Hitchcock et al. 
2010, Hernot et al. 2010).  Sonoporation, for example, has been used for over 10 years to aid in 
drug delivery with ultrasound, yet the physical mechanism of it remained unexplored until 
recently (Bednarski et al. 1997, Forbes 2009, Forbes et al. 2011).   
One study linked inertial cavitation to blood vessel rupture at high Pr (Ohl and Ikink 
2003, Chen et al. 2010) which could be the mechanism by which drugs are locally introduced in 
vivo.  IC has also been linked to increased nitric oxide (NO), calcium permeability, and cell-cell 
permeability (Juffermans et al. 2008, Juffermans et al. 2009, Shang et al. 2010).   
While there has been extensive research on the therapeutic effects of US and UCAs, most 
of the studies were conducted in vitro and only assess acute effects.  A few studies have used 
animal models to study other therapeutic effects such as blood brain barrier disruption for drug 
delivery (Yang et al. 2010) and arteriogenesis (Song et al. 2004).  Nonthermal mechanisms have 
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been proposed to aid in tissue regeneration, and soft tissue repair (Paliwal et al. 2008).  At the 
cellular level it has been hypothesized that changes in diffusion rates and membrane permeability 
due to microstreaming stimulates cells to increase protein synthesis essential for repair (Paliwal 
et al. 2008). One study even suggested that the acute bioeffect studied, hemorrhage, initiated a 
reparative response (Chappell et al. 2006), but no UCA mechanisms were discussed.  
This chapter began by discussing US and associated bioeffects. Then UCAs were 
introduced and the physical and biological effects of UCA responses to US explored.  While US 
bioeffects have been studied for quite some time, the advent of UCAs opened many new areas of 
research.  All of the same underlying physical mechanisms remain (thermal and nonthermal 
effects) but UCAs introduce more cavitational bodies that behave differently than free bubbles.  
UCAs have been studied to understand bioeffects and utilized to promote therapy.  However, the 
connection between the UCA behavior has not been correlated to the bioeffects or therapy, nor 
has the bioeffect been related to the therapy.   
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CHAPTER 4: ULTRASOUND & ULTRASOUND CONTRAST AGENT-
INDUCED ANGIOGENESIS AND SPECIFIC AIMS 
 This chapter focuses on ultrasound alone, and with the addition of ultrasound contrast 
agents in the induction of a specific therapy, angiogenesis.  It extends the discussion to include 
an overview of the wide range of parameters used in this therapeutic application, and describes 
the areas of research that remain open as possible reasons for the slow transition to clinical use.  
Next, this chapter states a hypothesis for the biophysical mechanism with respect to ultrasound 
contrast agents, and potential mechanistic motivation of US-UCA-induced angiogenesis.  
Concluding the chapter are the specific aims to be addressed in this thesis, along with a flow 
chart of proposed events. 
4.1 US-induced angiogenesis 
 
Ultrasound was first researched as a means for inducing vascular changes, and in particular 
angiogenesis, in the late 1960s (Dyson et al. 1968, 1976, Hogan et al. et al. 1981, Dyson et al. et 
al. 1987).  It provided a way to spatially target ischemic tissue.  US disturbs tissue by bulk 
streaming, and was initially used for its ability to accelerate healing, presumably by 
proangiogenic methods (Dyson et al. 1976).  Conflicting levels of angiogenic responses have 
been noted with the various techniques—none of which have transitioned well into the clinic.  
US-induced angiogenesis is an existing phenomenon that has been documented for over 50 
years.  However, a major impediment to progress in the field is the deficit in biophysical 
understanding apparent from the lack of unified exposure conditions.  Therapeutic applications 
typically use 1—3 MHz for US exposure (Dyson et al. 1976, Hogan et al. 1982, Young & Dyson 
1990, Barzelai et al. 2005, O’Brien 2007).  Though US frequency is consistent, Pr, repeated 
exposure conditions, pulsed vs. continuous, and even the day at which the angiogenic effect is 
observed all vary (Table 4.1). Exposure conditions with peak rarefactional pressures (Pr) ranging 
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from 40 kPa to 5 MPa, continuous US to pulsed US, and EDs ranging from 30 seconds to 20 
minutes have been used and increased angiogenic effects to some extent.  How these parameters 
influence the response has not been assessed (Table 4.1). The extent to which US affects the 
tissue for therapeutic benefit is also undetermined, as exposure conditions are influenced by 
whether or not there is overlaying skin during the exposure, the area of exposure, and the tissue 
being exposed. With that stated, several studies report a reparative response to US with repeated 
exposures (Dyson et al. 1976, Hogan et al. 1982, Barzelai et al. 2005, Sugita et al. 2008).  The 
significance of understanding the biophysics of the mechanism to establish a standard protocol 
for exposure is therefore of importance. 
Table 4.1: Ultrasound–mediated angiogenesis and effectiveness 
Citation Transducer Frequency 
Pulsed/ 
Continuous Pressure 
Angiogenic 
effect @ 
Repeated 
Exposures Effectiveness 
Dyson, et al. 1976 3 MHz 
Pulsed (2ms on; 
10ms off) 
0.18 MPa 28-d 3 times/week ~28% 
Hogan, et al. 1982 1 MHz 
Pulsed (100us, 
DC=50%) 
0.2, 0.3, 0.4, 
0.6 MPa 
3 wks 
~3 
times/week 
~10% 
Young & Dyson 
1990 
0.75, 3 
MHz 
Pulsed (2ms on, 
8ms off) 
0.06 MPa 5-d 7 times/week ~40% 
Reher et al. 1999 1 MHz 
Pulsed (2ms on; 
8 ms off) 
0.5 – 5 MPa 18 hours Not repeated ~50% 
Barzelai, et al. 
2005 
2 MHz Continuous 0.04 MPa 7-d 3 times 30% 
 
 Johns et al. (2002) hypothesized that angiogenesis is induced by a mechanical effect of 
low-intensity US based on radiation force and cavitation bubbles acting on the cellular 
membrane and the molecular structures within the cell.  Another study stated that because bovine 
aortic endothelial cells display an angiogenic phenotype in response to US stimulation in bubble 
minimizing media, there is a mechanism other than cavitation that promotes angiogenesis 
(Mizrahi et al. 2007).  Yet another hypothesis is that the US radiation force promotes 
inflammation and apoptosis to encourage angiogenesis (Barzelai et al. 2005).   
56 
 
 The induction of angiogenesis with US has only been directly studied by Young and 
Dyson et al. (1990) and Barzelai et al. (2005).  Both studies examined ischemic models that were 
relatively well calibrated.  Other studies (Hogan et al. 1982, Reher et al. 1999) focused on the 
wound healing—which involves new blood vessel growth, but angiogenesis was not necessarily 
quantified.  The US Prs used vary from 40 kPa to 5 MPa, pulsing regimes vary, and there is 
variability with the time point which the angiogenic effect was observed.  Therefore, there still 
remains a disconnect assessing ‘appropriate’ exposure conditions.  One reason for this 
disconnect could be that the US physical parameters and their connection to the biological 
response remains systematically uninvestigated. 
4.2 US-UCA-induced angiogenesis 
 
With the development of UCAs, research seeking to establish models for the use of 
microbubble-enhanced ultrasound induced angiogenesis surfaced (Korpanty et al. 2005, 
Chappell et al. 2006).  US and UCAs have been used for site specific delivery of factors and/or 
controlled damage, where the logic was to cause controlled damage to areas peripheral to the 
ischemia such that the normal angiogenic response caused an ingrowth of vasculature.  With the 
deposition of angiogenic factors, this response would presumably be enhanced. Upon US 
irradiation the UCA would oscillate or collapse and release a proangiogenic agent (Zen et al. 
2005, Yoshida et al. 2005).  Various agents have been used in cardiac or skeletal muscle models.  
Korpanty et al. (2005) destroyed (UCAs underwent IC) microbubbles to offer site specific 
delivery of VEGF to the myocardium.  In addition, endothelial progenitor cells were delivered to 
the myocardium and it was found that via an angiogenic response, cardiac function was 
improved (Zen et al. 2005).    Bone marrow derived stem cells (BMSCs) have also been used to 
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promote blood vessel growth by being attached to UCAs (Song et al. 2008).  These studies use a 
one-time exposure to induce the reported effects (Table 4.2). 
The most recent work using contrast agents shows promising results for a future lacking 
ischemic diseases and myocardial degeneration.  Note that the effectiveness has improved over 
the past several years with the addition of growth factors or DNA plasmids (Table 4.2).  The 
literature also suggests that inertial cavitation is required for angiogenesis to occur or for 
angiogenic factors to be deposited (Song et al. 2002, Korpanty et al. 2005, Chappell et al. 2006, 
Hwang et al. 2005, Miyake et al. 2007, Leong-Poi et al. 2007).   
 
In comparing US-induced (Table 4.1) with US-UCA induced angiogenesis (Table 4.2) 
we note several things: the necessity for repeated exposures to achieve similar levels (if not 
more) of effectiveness has been eliminated, the therapeutic range for US transducer frequencies 
when UCAs are involved is about 1-2 MHz, the average pressure of US exposure is higher, and 
Table 4.2: Ultrasound–mediated angiogenesis and effectiveness 
Citation Transducer Frequency 
Pulsed/ 
Continuous Pressure UCA Type 
Angiogenic 
effect at Effectiveness 
Song, et al. 
2004 
1 MHz 
Pulsed 
(100us, 5Hz) 
0.5 MPa 
Albumin shelled 
UCA 
7-d ~33% 
Korpanty, et al 
2005 
1.3 MHz Pulsed 1.8 kPa 
hVEGF tagged 
lipid shell 
10-d 33% 
Zen, et al. 2005 1 MHz 
Pulsed (50% 
DC) 
0.25 MPa 
BM-
MNC+Optison 
20 wks ~5% 
Chappell, et al. 
2006 
1 MHz 
Pulsed (100us, 
5Hz) 
0.79 MPa 
Albumin shelled 
UCA 
3-d ~15% 
Leong-Poi et al. 
2007 
1.3 MHz Pulsed (5s) 
Not 
Provided 
VEGF tagged 
MP1950 
4 wks ~30% 
Song et al. 2008 1 MHz 
Pulsed (50% 
DC) 
1 MPa 
SonoVue + 
BMSC 
28-d ~20% 
Chappell et al. 
2008 
1 MHz Pulsed 0.8 MPa 
bFGF tagged 
lipid shell 
7 & 14-d ~50% 
Fuji et al. 2009 8 MHz Pulsed 4.5 MPa Definity + DNA 21-d ~44% 
Kobulink et al. 
2009 
1.3 MHz Pulsed (5s) 2.1 MPa 
VEGF tagged 
lipid shell 
17-d ~50% 
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stem cells or growth factors were added.  For researchers using contrast agents to elicit a 
response, understanding how the US and UCA parameters influence the response is important.   
As mentioned in Chapter 3 of this thesis, ultrasound contrast agents undergo dynamic 
responses when exposed to ultrasound.  Part of understanding an effect is determining the 
mechanism by which the effect is occurring.  With sufficiently high Pr, UCAs undergo collapse, 
but some researchers expose at a pressures well below the UCA collapse threshold, where 
microstreaming is the dominating bubble response (Korpanty et al. 2005, King et al. 2010).  
When UCAs are used, Table 4.2 shows that Pr = 0.18—4.5 MPa have been used to elicit an 
angiogenic response.  There is no discernable for effectiveness with Pr, but the use of this range 
of Pr supports the suggestion that IC is required.  However, microstreaming has been correlated 
to increases in shear stress that may activate FAK and Akt stress pathways in angiogenesis 
induction.   
Davies et al.  (1986) found that turbulent fluid shear stress induces vascular endothelial 
cell turnover or proliferation—an important step of angiogenesis.  Further, high shear stress has 
been linked to increased permeability and enhanced EC biosynthetic capabilities (DeForrest et al. 
1980, Davies et al. 1986, Paszkowiak et al. 2003).  This increased shear stress could be caused 
by microstreaming.  Also the wall shear stress of blood vessels has been linked to decreased EC 
alignment resulting in increased pore size (Paszkowiak et al. 2003).  Figure 4.1 shows the 
proposed sequence of events (Hudlicka et al. 2006). Capillary shear stress promotes EC cell 
growth by activating VEGFR-2 and VEGF (Hudlicka et al. 2006, Jin et al. 2003, Shay-Salit et al. 
2002, Urbich et al. 2003, Wang et al. 2004) and has a critical role in initiating angiogenesis.  ECs 
sense shear stress via cytoskeletal elements, microfilaments and shear stress response elements.  
Normal vascular shear is ~ 1.5 Pa, but as little as 0.075 Pa can transiently activate transcription 
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factors for VEGF, PDGF and MAPK (Braddock et al. 1998) (Figure 2.4).  Therefore it remains 
unknown whether inertial cavitation (or a particular amount of cavitation) induced 
damage/turbulence or if microstreaming induced shear stresses potentiate the angiogenic 
response.    
 
Figure 4.1: Hypothesized biological mechanisms resulting from physical effect of 
microstreaming.  Adapted from Hudlicka et al. (2006). 
 
With UCAs involved, infusion rate and UCA concentration ([UCA]) should also be 
considered.  Infusion rate and [UCA] are related in that if there is a bolus injection many 
microbubbles reach a particular portion of the vasculature all at once, and the simultaneous 
collapse of several could result in massive damage to the capillary walls; this is analogous to 
infusion of high doses of contrast agent.  
Other non-UCA parameters may also affect the response.  Pulsed US has been widely 
used over continuous exposure (presumably to minimize heating) of inducing angiogenesis, but 
the ED and PRF vary significantly (Song et al. 2004, Leong-Poi et al. 2007, Kobulink et al. 
2009).  A mouse model using UCAs had an ED of 3 minutes (Chappell et al. 2006), but another 
mouse study (same strain) used an ED of 20 minutes (Fuji et al. 2009) (Table 4.2).  US-UCA-
induced angiogenesis also shows a range of effectiveness from 5 to 50%.  The range could be 
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because of the different time points at which angiogenesis was observed (Johnson et al. 2010), 
ED, PRF, [UCA], the type of contrast agent used, or the involvement of UCA collapse (ie. Pr).   
To the knowledge of the author, only two studies have been conducted without the use of 
proangiogenic agents (Song et al. 2004, Chappell et al. 2006), and only one of these two used a 
normal animal model (Chappell et al. 2006).  Both Song et al. (2004) and Chappell et al. (2006) 
report relatively low effectiveness for reasons that remain unknown.  If the mechanism is 
explored in a normal model, the effectiveness of all studies can potentially increase.  For the 
purposes of this thesis, only one UCA, Definity® was explored, as others were inconsistently 
available for purchase. 
 None of the studies displayed in Table 4.2 linked the acute bioeffects to the subsequent 
angiogenesis or exposed the UCA behavior for mechanistic motivation.  The goal of this thesis is 
to explore the role of the UCA and the mechanism by which angiogenesis is induced beginning 
with the bioeffects. 
4.3 Hypothesis 
 
 From the literature, the hypothesized physical mechanism for the angiogenic response 
occurs through inertial cavitation.  Precautions were taken to eliminate the thermal effects such 
that the nonthermal bioeffects leading to angiogenic response could be investigated.  Therefore it 
is proposed that in the normal rat model ICs lead to capillary damage/rupture and controlled 
tissue damage.  This damage elicits the VEGF (and hypoxia) that potentiates angiogenesis.  See 
Figure 4.2. 
4.4 Specific aims 
 
Numerous studies demonstrate the real, reproducible proangiogenic therapy that US 
provides; however, the mechanism has not been elucidated.  Barzelai et al. (2005) states that 
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"lack of consensus regarding the optimal dose needed to produce maximal protective effect is 
evident from different studies that have used a wide range of US energy and intensities."   
 
Figure 4.2: Hypothesized effect of ultrasound exposure to muscle 
For proangiogenic US therapy to transition to clinic, minimally an exposure-effect understanding 
must be known with some basis for an operative mechanism. Therefore, the objective of this 
project is to explore the physical and biological mechanisms of US-UCA induced angiogenesis 
via exposure-effect studies.  Specifically, the objective is to explore the biophysics of the UCA 
in inducing angiogenesis including the role of UCAs, some US parameter optimization and 
connecting the bioeffects to the therapy for potential predictive and mechanistic motivation 
value.   These aims will be assessed using capillary density, vascular endothelial growth factor 
(VEGF), and EBD extravasation (vascular permeability measurement) as measurement end 
points. 
4.4.1 Specific aim #1.  To determine the role of UCAs in US-induced angiogenesis  
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 Whether UCAs are necessary for an angiogenic response is unclear.  A variety of UCA 
concentrations have been used in the literature (no UCAs to bolus injection) (Barzelai et al. 
2006, Chappell et al. 2006, Zen et al. 2005, Miller et al. 2008); effects noted may have been 
contingent upon [UCA].  Therefore it is important to understand how the angiogenic effect varies 
with increasing number of microbubbles.  It is hypothesized that as UCA concentration 
increases, the angiogenic effect will increase. Also, it is hypothesized that an angiogenic 
response can occur without UCAs, but UCAs enhance the angiogenic response above that of US 
alone.   
4.4.2 Specific aim #2.  Explore the mechanism of US and UCA induced angiogenesis 
 
 US-induced angiogenesis can be affected by multiple parameters, and their dependencies 
on angiogenesis will provide insight into biophysical mechanisms.  The objective of this aim is 
to correlate the acute bioeffects of US-UCA with the physical behavior of the UCA.  This 
objective will examine collapse and microstreaming as potentiating factors for bioeffects.  The 
secondary goal is to assess the biological mechanism by correlating the acute bioeffects to the 
angiogenic response. 
Sub-Aim A: To connect the acute bioeffects to UCA behavior (physical mechanism) 
If UCAs are needed, whether or not microstreaming or IC (increased shear stress, eddies 
in flow, local turbulence) are essential to neovascularization is unknown.  It is hypothesized that 
IC causes a reduction in capillary density, hemorrhage, and tissue damage necessary for an 
angiogenic response.  Whereas microstreaming, along with increased shear stress causes 
increases in permeability, but not angiogenesis. 
Sub-Aim B: To assess the biological mechanism 
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The literature, to date, has either focused on the acute effects of US, US and UCAs, or the 
angiogenic response (AR) at some time point.  The initial effect of US and UCA that potentiates 
the AR has not been studied.  Thus far possible mechanistic motivators of angiogenesis have 
been speculated to be damage induced by the combined effect of US and UCAs.  Literature 
hypothesizes inflammation, apoptosis, hemorrhage, cellular membrane perturbation/disruption, 
stimulation of molecular structures within the cell to be involved in the process.  This aim seeks 
to specifically determine if damage, defined as coagulative necrosis and/or a reduction in 
capillary density precedes the angiogenic response (Figure 4.3).  It is hypothesized that a 
reduction in capillary density that boosts the normal wound healing response precedes the 
angiogenic response.  This connection is not only important to understanding the mechanism, but 
also provides risk/benefit and potential predictive information. 
 
Figure 4.3: Proposed mechanism for US and UCA induced angiogenesis.  The blue items 
indicate shear stress activated pathways. 
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4.4.3 Specific aim #3: US parameter optimization: examine the effects of PRF and ED 
 
Conflicting results concerning the PRF and ED on bioeffects have been reported (Song et 
al. 2002, Fujikura et al. 2006, O’Brien et al. 2005, Miller et al. 2008).  Below 3 minutes, 
bioeffects are generally uncorrelated to ED, however as this value increases a positive trend 
emerges (Miller et al. 2008, O’Brien et al. 2005). The interaction of PRF and ED, the total 
number of pulses, was significant for all studies in which it was tested (Song et al. 2002, O’Brien 
et al. 2005).  It is therefore hypothesized that the total number of pulses will be positively 
correlated with the angiogenic effect and that ED and PRF will not be significant. 
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CHAPTER 5: MATERIALS AND METHODS 
5.1 Experimental Setup 
 
A 1.0 MHz single element focused (f/3) transducer (Valpey Fisher E1051, 0.75” 
diameter, 2.25 S.F; Hopkinton, MA) connected to a power source (RAM5000, Ritec, Inc., 
Warwick, RI) was used for the exposures.  The base was removed from a cylindrical bowl, and 
Syran® wrap placed securely around the bowl with large rubber bands.  A custom built plastic 
holder for the bowl was constructed such that the bowl could be suspended from a square post.  
The bowl was filled with degassed water for ultrasonic transmission (see Figure 5.1).  The water 
was heated to approximately 35 oC using a proportional temperature controller (Yellow Springs 
Instrument Co./Cole Parmer Instrument and Equipment Co. Model 72).  Mineral oil was then 
used as a coupling agent at the point of contact (between skin and Syran® wrap) to ensure an air-
free interface. 
 
Figure 5.1: Experimental Setup 
5.2 Exposimetry 
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5.2.1 Calibration 
 
An automated procedure, based on established standards (AIUM/NEMA 2000, ODS 
1998, NEMA 2009a, 2009b), was used to routinely calibrate the ultrasound fields (Semsprott et 
al. 1999, Zachary et al. 2001).      
All calibrations were performed with calibrated hydrophones [PVDF membrane 
hydrophones (Perceptron Model 804, Plymouth Meeting, PA) and Marconi Model Y-34-6543, 
(Chelmsford, UK)], both before and after experiments were conducted. The Marconi M1 
hydrophone was placed in a custom built tank containing degassed water attached to a 
positioning system.  The transducer was placed perpendicular to the hydrophone in the tank.  
Using the RITEC® power supply, electrical pulses were sent to the transducer. To calibrate, the 
transducer was manually moved until the signal produced on the Agilent scope reached its 
maximal intensity.  Once the transducer was manually centered, the Daedal positioning system 
(Daedal Systems, Inc.) was used to ensure symmetry.   The hydrophone was then placed in the 
lower left corner of the focus, such that the Daedal positioning system could scan through the 
focus to find the pressure output (Sempsrott and O’Brien, 1999; Sempsrott, 2000).  Routine 
calibrations resulted in approximately 10% error in all calibrations.  See block diagram in Figure 
5.2.   
The transducer calibration procedure yielded the following quantities: pulse duration 
(µs), in vitro peak compressional pressure at global maximum (MPa), in vitro peak rarefactional 
pressure at global maximum (MPa), and Mechanical Index (MI).   
While calibrations were performed in degassed water, in situ (at the muscle surface) 
estimation of the US exposure quantities was required to assist in evaluating exposure-effect 
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responses and basic physical mechanisms.  The in situ peak rarefactional pressure was estimated 
from Pr (in situ) = Pr (in vitro) e-Ax, where Pr (in vitro) is the global-maximum water based value.   
 
Figure 5.2: Calibration setup, including a pulser, transducer, hydrophone, amplifier, power 
supply and oscilloscope. 
 “A” is the attenuation coefficient of the skin (A ≈ 2 dB/cm at 1 MHz) (Riederer-Henderson et al. 
1988) overlaying the gracilis muscle, which had a thickness, x, of approximately 1 mm.  
Attenuation of US by intervening tissue is negligible (0.98 of in vitro Pr) and thus the reported Pr 
is that of the in vitro value.  The parameters tested herein include: Pr ranging from 0 to 1.9 MPa, 
PRF = 0 to 40 Hz, ED = 0 to 5 min, DPE = 0 to 6 DPE, and [UCA] = 0 to 10x.  The PD was set 
at 10 µs for all exposures.  The US parameters are stated before the results section of the chapter 
for each experiment. 
5.2.2 Transducer alignment 
 
Before exposures, the transducer’s peak signal was aligned with the marked exposure 
site.  The peak signal was found visually using an attached oscilloscope (500 MS/s, LeCroy 
Model 9354TM Oscilloscope, Chestnut Ridge, NY, USA).  For transducer alignment, a low Pr 
value (50 kPa) was used to ensure minimal US-induced damage.  Parameters used during 
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alignment were a pulse duration (PD) of a 10 cycle sine wave (10 µs), and pulse repetition 
frequency (PRF) of 10 Hz.  
5.3 Animals 
 
 A total of three hundred thirty three female Sprague Dawley rats (Harlan, Indianapolis, 
IN, USA) were used in this study.  Animals ranged in age from 11 to 13 weeks old and weighed 
between 190 and 215 grams.   
 Rats were weighed and anesthetized with ketamine hydrochloride (87 mg/kg) and 
xylazine (13 mg/kg) administered intraperitoneally.  Hind limb hair over the gracilis muscle was 
removed with an electric clipper, followed by a depilatory agent (Nair® Carter-Wallace, Inc., 
New York, NY, USA) to maximize sound transmission.  The rat was then placed in a custom 
built holder.  Bilateral sites on the lateral sides of the left and right gracilis muscle were marked 
with a black dot to denote the US exposure location.  Medial sections of the gracilis muscle 
served as the sham (Pr = 0 MPa) for exposed animals.  The US transducer was visually aligned 
with the black dot using a custom build laser pointer that was spatially registered with the beam 
focus.  For both US-UCA and US-saline infused groups, the 0 DPE rats were euthanized within 
1hr following exposure, and rats assessed at other time points were euthanized on their 
respective recovery day (ie. 3, 5 or 6 DPE).   
The experimental protocol was approved by the Institutional Animal Care and Use 
Committee of the University of Illinois and satisfied all campus and National Institutes of Health 
rules for the humane use of laboratory animals.  Animals were housed in an Association for 
Assessment and Accreditation of Laboratory Animal Care, Rockville, MD-approved animal 
facility and provided food and water ad libitum. 
5.4 Microbubble preparation 
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 The manufacturer’s recommended dosage for infusion was used to establish the 1x 
concentration of Definity® (Bristol-Myers Squibb Medical Imaging, North Billerica, MA) for 
UCA infused groups.   
For 0 DPE animals, 1.5 mL of Definity® solution (containing 0,  0.07, 0.25, or 0.75 mL  
Definity® brought up to volume with saline, for the saline (0x), 1x, 5x, and 10x concentrations, 
respectively) was prepared in a 3 mL syringe.  The 1x UCA concentration [UCA] was 
determined from the package insert (1.3 mL of Definity® in 50 mL saline).   
5.5 Evans blue dye 
 
Evans blue dye (EBD) was discovered in 1917 as a method to estimate blood volume 
(LeVeen et al. 1947).  EBD binds to serum albumin, and is not normally secreted from blood 
vessels; particularly those that do not have large inter-endothelial cell gaps like skeletal muscle.  
Albumin is approximately 70 nm in diameter, whereas the pores in undisturbed skeletal muscle 
are ~ 4 nm.  Therefore leakage of the albumin bound dye indicates capillary disruption.  Since 
1917, EBD has been the choice dye marker for vascular permeability (LeVeen et al. 1947, 
Jackieqicz et al. 1998).  In this study EBD (10 mg/mL) was dissolved in the volume of saline 
prior to addition of UCA.  For the 5 DPE animals, the same procedure was followed, but without 
the addition of EBD due to diffusion to peripheral tissues and potential dye toxicity.  EBD has 
been shown to modify the ultrastructure of regenerating blood vessels in rats (Jackieqicz et al. 
1998). 
5.6 Infusion 
5.6.1 Initial manual injection of UCAs or saline  
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Prior to US exposure, the rat tail vein was manually injected for 30 seconds with 0.5 mL 
of Definity® solution (at 1x, 5x, or 10x [UCA]) such that UCAs were introduced into circulation.  
The saline infusion group received 0.5 mL of saline for 30 seconds prior to US exposure. 
5.6.2 Infusion of UCAs or saline 
 
After manual infusion, 1.0 mL of Definity® solution or saline was infused with an 
infusion pump (model 780100; KD Scientific, Holliston, MA) for 15 minutes into the rat tail 
vein at a rate of 4.0 mL/hr.  The resulting infusion rate was a maximum of 3.3 x 108 
microbubbles/min (at 10x [UCA]).  The following infusion regimes was used: the first of two 
ultrasound-exposed sites was started approximately 5 seconds after the infusion pump was 
started (ie. 5 minutes per exposed site, 3 minutes for realignment with the next site, and 2 sites 
per rat = 13 minutes).  The exposures were completed before the infusion pump was stopped 
such that Definity® solution was present during each exposure.   
The saline infusion groups received the same treatment but without UCA addition. 
The following was used to model the in vivo quantity of Definity as a function of time: 
 
Figure 5.3: Model of the total volume (VT), quantity of Definity® (QD), initial (K1) injection rate 
(0.5 mL in 30 seconds), and infusion rate (K2) (1.0 mL over 15 minutes). 
 
The quantity of Definity®, QD, for the initial injection is the number of microbubbles at time, t 
(minutes), plus the infused amount entering at rate K1.  Such that: 
∆ܳ஽ ൌ ∆ݐܥ ൅ ∆ݐΚଵ (5.1) 
݀ܳ஽
݀ݐ ൌ ܫ ∙ ܥሺݐሻ ൅ Κଵ 
(5.2) 
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ܳ஽ଵሺݐሻ ൌ െΚଵሺ1 െ ݁௧ሻ (5.3) 
where K1= 5 x 109 microbubbles/minute, and t = 0.5 minutes.  To account for the 5 second delay 
between injection and infusion where monoexponential decay (Definity® package insert) occurs: 
ܳ஽ଶሺݐሻ ൌ ܳଵሺ0.5ሻ݁ିఝ௧ (5.4) 
where t = 0.083 minutes and ߮ is the decay constant calculated from the half-life of Definity®.  
The mean lifetime of Definity® in humans is ~ 3 minutes (Definity package insert), but because 
the package insert demonstrated an increase in half-life with changes in respiration, the following 
was noted: 
(1) Normal respiration rate for humans ≈ 12 breaths per minute 
(2) Chronic obstructive pulmonary disease (COPD) (where the respiratory rate is > 36 
breaths per minute) increased Definity’s® half-life by 0.6 minutes (Definity Package 
Insert) 
(3) Rat respiration rate under anesthesia is ~ 3 times greater than humans (assessed while 
sedated) 
(4) COPD is an obstructive disorder which increased the half-life; the rat’s oxygen exchange 
would be normal, but higher than humans.  Thus the half-life should decrease by an 
amount approximately equal to but opposite that of the COPD case, where t1/2 ≈ 0.7 min 
and ߮ = 0.99. 
Then, for the 15 minute infusion, which will include decay: 
ܳ஽ଷሺݐሻ ൌ ൣܳ஽ଶሺ0.083ሻ െ ൫ܭଶሺ1 െ ݁௧ሻ൯൧݁ିఝ௧ (5.5) 
where K2 = 3.3 x 108 microbubbles/minute.  Because Definity® accumulated in the syringe near 
the plunger and the UCA floats, the initial injection was designed such that the initial injection 
72 
 
rate was higher than the infusion rate.  This set of equations assumes that the recirculation rate is 
equal to the collapse (disintegration) of the UCAs.   
 Determining the quantity of microbubbles in vivo was integral for determining the 
volume fraction of Definity®.  The volume fraction of Definity® was calculated using the 
following: 
Γ ൌ ஽ܸ
஻ܸ െ ஽ܸ (5.6) 
஽ܸ ൌ 43 ሺܳ஽ଷሻߨܽ
ଷ (5.7) 
 
where VD is the total volume of gas contained in QD3 bubbles of Definity®, VB is the total 
volume of blood, and a is the bubble radius.  Because the UCA was infused over 15 minutes, 
calculating the volume fraction using only the amount in the syringe is an inaccurate estimator 
for the bubble distribution in vivo.  The Sprague Dawley rat’s cardiac output is approximately 
100 mL/min/100g, so there is ~ 200 mL of blood in a 200g rat (Gotshall et al. 1987).  Because 
QD’ (the steady state quantity) = 3.8 x 108 microbubbles/min, we find that VD = 1.6 x 108 µm3, 
VB = 2 x 1014 µm3 and Γ simplifies to VD / VB because VB >> VD, and Γ = 0.0000008 or 
0.00008%.  To calculate the volume fraction necessary to minimize bubble coalescence a Weber 
number of 0.5 was used to calculate the maximum approach velocity (ݒ௔ ൏ 3.43	 ௠௦ ) using Eq. 
3.52.  This velocity was used to calculate the minimum distance needed for bubbles to not 
coalesce using Eq. 3.51 (݀଴ ൌ 0.021	ߤ݉).  This distance was added to the mean radius of a 
Definity® microbubble to increase the effective diameter of the bubble, and then used to 
calculate ஽ܸᇱ  and Γᇱ, where the prime indicates the effective diameter was used in the estimate 
(Γᇱ ൌ 0.00085%).  Therefore, a single bubble approximation is appropriate for theoretical 
estimates. 
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The saline infusion groups received the same treatment but without UCA addition. The 
volume fraction of Definity as a function of time is shown in Figure 5.4: 
 
Figure 5.4: The volume fraction (%) of Definity® as a function of time at 1, 5, and 10x [UCA] 
showing relative consistency over 15 minutes. 
 
5.7 Photographic log of leakage 
 
 Once the diameter of leakage was measured, the animal was mounted on a custom built 
stage.  Using a Canon PowerShot SD 880 iS camera; digital pictures were taken of the exposed 
sites.  A ruler was placed on the animal when the pictures were taken for size estimations. 
5.8 Post euthanization tissue preparation and processing 
 
 A 6 mm biopsy punch (IntegraTM Miltex® Plainsboro, New Jersey) was used to extract 
the exposed region from the gracilis muscle.  Because the transducer’s beamwidth was 
sufficiently large (~ 5 mm), one-half of each exposed location was either preserved in RNAlater 
(Quiagen, Valencia, CA) (for the 5 DPE animals) or soaked in formamide for 24 hours (for the 0 
DPE animals).  The other half was formalin-fixed in 10% PBS formalin (Fischer Scientific, 
USA) for a maximum of 24 hours.  See Figure 5.5.  The formalin-fixed tissues were then paraffin 
embedded (Thermo Fisher Scientific, USA).  Three-micrometer-thick sections were stained with: 
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hematoxylin and eosin (H&E) for whole tissue examination, and CD-31 antibody (CD-31, Cell 
Marque #1A10, Rocklin, CA) for capillary density counts. 
 
Figure 5.5: Schematic of sample tissue preparation 
 5.8.1 Histology 
 
 The hematoxylin and eosin stain is one of the most widely used stains in histology.  
These two stains are used in conjunction to visually separate nucleus and cytoplasm.  It is a basic 
stain and counterstain combination used to view a tissue’s morphology.  H&E stain identifies 
abnormal features such as hypertrophy, hyperplasia, atrophy, necrosis and apoptosis (provided 
adequate timing).  In addition, accumulation of specific proteins, pigment, and overall structure 
can be assessed.   
There are several stages involved in the H&E tissue staining.  The slides were first 
removed from the heating oven and then placed in xylene three times for two minutes each.  Ten 
dips in 100% ethanol, ten dips in 95% ethanol (twice) follow.  The slides were then rinsed with 
tap water until the water ran off evenly.  Hematoxylin was added to the slides for 15 minutes, 
and then the slides were rinsed.  Ammonia water (0.25%) was used to treat the slides prior to ten 
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tap water dips to allow the hematoxylin to set.  Finally, eosin was added to the slides (15 dips), 
and the slide was then dipped ten times with two changes of 95% ethanol, three changes of 100% 
ethanol, and three changes of xylene.  Cover slips were applied at the end.  
In order to look for particular structures however, immunohistochemical (IHC) 
techniques are employed to specifically stain for capillaries.   
For IHC, CD-31 was used.  CD-31 is also known as platelet endothelial cell adhesion 
molecule.  Part of its role is to provide a signal medium for the digestion of aging neutrophils via 
macrophage uptake.  CD31, as a result, is normally found on cells that are involved in 
inflammation or inflammation resolution, such as: endothelial cells, platelets, macrophages, T / 
NK cells, and neutrophils.  
Several stages of slide preparation were involved in the IHC tissue staining.  The slides 
were removed from the drying oven.  Then the slides were incubated 3 times in xylene for 10 
minutes, twice in 100% ethanol for 2 minutes, and hydrated by placing in 95%, 70%, 50%, 30% 
ethanol for 2 minutes each.  The slides were then placed in buffer for 5 minutes. Buffer: 0.25 M 
Tris-HCl at pH 7.5.  Slides were blocked with CD-31 primary antibody (CD-31, Cell Marque 
#1A10, Rocklin, CA), incubated for 20 minutes at room temperature in a humidified chamber, 
and washed in buffer for 5 minutes.   Then slides were placed into buffer containing 0.5% BSA 
and 2% Fetal Calf Serum for five minutes.  Once again the slides were incubated in a humidified 
chamber overnight with secondary antibody (iVIEWTM DAB Detection Kit mouse IgG, IgM and 
rabbig IgG, Ventana Tuscon, AZ), and the secondary antibody was diluted in the Tris with 
protein solution above.  The antibody was diluted from 1:20.  The slides were then rinsed with 
buffer solution and fitted with cover slips.  
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For each exposed site the following slides were created: H&E, CD-31, and CD-31 
negative control.  A CD-31 positive control was made for a batch of slides. H&E was used to 
observe whole tissue effects. CD-31 slides were used for capillary density counting according to 
techniques detailed in previously published literature (Johnson et al. 2010).  Briefly, each CD-31 
slide was divided into 15 random high power fields (HPFs) within the region of interest (the US 
exposed area) for capillary assessment.  Only full lumen capillaries were counted.  The Carl 
Zeiss® Axioscope 2 upright light microscope (Carl Zeiss Microscopy, Thornwood, NY) had a 
HPF diameter of 0.45 mm in diameter at 40x magnification.  Fifteen HPFs were averaged and 
reported as capillaries/mm2 ± standard error of the mean (SEM). 
 5.8.2 Vascular endothelial growth factor (VEGF) 
 
 The RNAlater section was used for VEGF analysis; RNAlater preserved the RNA in the 
tissue.  First, total RNA was isolated using the Quiagen® RNeasy kit (Quiagen, Valencia, CA).  
The procedure used was a standard protocol (RNeasy Mini Handbook 2006).  Then the optical 
density of the solution was read using the Nanodrop® 2000 Spectrophotometer (Thermo 
Scientific, Wilmington, DE).  The RNA was labeled and stored at -80oC.  After isolation, the 
RNA was reverse transcribed to cDNA.  
The real-time PCR was run on the cDNA (Platinum Q PCR Package Insert) with the ABI 
Prism 7500 (ABI, Applied Biosytems, Foster City, CA) using a TaqMan One-Step RT-PCR 
Master Mix Reagents Kit (ABI) according to the manufacturer's recommendation. Real-time 
reactions were carried out using pooled RNA samples for both 18S RNA and vascular 
endothelial growth factor-A (VEGF) RNA.   The VEGF primer was designed with the forward 
sequence: CCACTTCATGGGCTTTCTGCT, and reverse sequence: 
CACTTGTACCTCCACCATGCCAAG. 
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The cDNA was loaded into a 96 well plate with the primers (25 µL total) and run on the 
ABI 7500.  Three stages were set in the thermal profile (Stage 1: 1 repetition of 950C for 10 
minutes, Stage 2: 40 repetitions of step 1: 950C for 15 seconds and step 2: 600C for 1 minute, 
Stage 3:1 repetition of 950C for 15 seconds, step 2: 600C for 1 minute, step 3: 950C for 15 
seconds) provided fold changes (relative to 18S RNA and control samples). Values for VEGF 
were normalized to values obtained for 18S RNA in each sample and data were expressed 
relative to normalized values for controls.   
 5.8.3 Evans blue dye assessment for permeability 
 
 To assess the quantity of extravasated EBD, following experiment, half of the exposed 
site was removed via biopsy punch, placed on a paper towel for a few minutes to remove excess 
moisture, weighed and then placed in 100% formamide for 24 hours at 60oC.  This allowed the 
dye to come to equilibrium with the solution.  After soaking in formalin for 24 hours, the 
supernatant’s absorption was measured using the Nanodrop® 2000 spectrophotometer (Thermo 
Scientific, Wimington, DE) at 620 nm (Jancar et al. 1991).  The weight was recorded such that 
extravasated EBD could be expressed as normalized to the weight of the extracted tissue (µg of 
EBD leaked per gram of tissue). 
5.9 Statistical analysis 
 
For the studies detailed herein, one-way, two-way, or N-way analysis of variance 
(ANOVA) in Matlab® was used to determine significance for the main effects and interactions.  
One-way, two-way and N-way ANOVA are special cases of the general linear model: y = xb + ε, 
where y is a matrix of the observations, x is a design matrix to indicate the independent variables 
that describe observations in terms of known variables b is a matrix containing estimated 
parameters, and ε is a matrix containing errors (random disturbances).   
78 
 
ANOVA was chosen because multiple settings were examined in each chapter (ie. 
acoustic pressure, DPE, [UCA]), where the overall question was: ‘Are the fixed effects, 
parameter x, y, or z, significant for the response? (within the tested range)’;  ANOVA is a robust 
test for statistical difference between two or more groups under the assumption that the sampled 
populations are normally distributed.  ANOVA is useful for comparing two or more means 
without increasing the type I error (false positive).  For all teststhe level of significance was set at 
α = 0.05.   
5.9.1 One-way ANOVA 
One-way ANOVA is generally represented by: 
ݕ௜௝ ൌ ߙ௝ ൅ ߝ௜௝ (5.8) 
where yij is a matrix of the observations that are the sum of  αj, a matrix of the group means, and  
εij, a matrix of random disturbances.  One-way ANOVA was used for EBD (at 0 DPE) and 
VEGF (at 5 DPE only) observations (assessments).  For these assessments, only one variable, αj: 
αEBD or αVEGF, was being tested for significance. 
 5.9.2 Two-way ANOVA 
Two-way ANOVA is generally represented by: 
ݕ௜௝௞ ൌ ߤ ൅ ߙ௝ ൅ ߚ௜ ൅ ߛ௜௝ ൅ ߝ௜௝௞ (5.9) 
where yijk is a matrix of the observations with row i, column j, and repetition index k, µ is a 
constant matrix of the overall mean, αj is a matrix where the columns are the deviations of the 
observations attributable to a specific parameter, βi is a matrix whose rows are the deviation of 
each observation attributable to a second specific parameter, γij is a matrix of interactions, and 
εijk, a matrix of random disturbances.  Two-way ANOVA was used for the capillary density 
assessments, where αj was DPE (0 or 5 DPE), and βi was Pr, [UCA], ED, or PRF. 
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 5.9.3 N-way ANOVA 
 The special case of N-way ANOVA was used only in Chapter 6 where a factorial design 
study was conducted. Three main effects were varied: DPE (αj), [UCA] (βi) , and Pr (γk) , and 
three assessments were made: capillary density (y1,ijk), inflammation (y2,ijk) and VEGF (y3,ijk).  N-
way ANOVA, in this case was represented by:  
ݕ௜௝௞௟ ൌ ߤ ൅	ߙ௝ ൅ ߚ௜ ൅	ߛ௞ ൅ ሺߙߚሻ௜௝ ൅ ሺߙߛሻ௜௞ ൅ ሺߚߛሻ௝௞ ൅ ሺߙߚߛሻ௜௞௝ ൅	ߝ௜௝௞௟ (5.10) 
where ሺߙߚሻ௜௝, 	ሺߙߛሻ௜௞	and 	ሺߚߛሻ௝௞	are two-way interaction terms and ሺߙߚߛሻ௜௞௝ is a three-way 
interaction term. Initially when the data is tested the full model is fit (ie. all terms and 
interactions are tested for significance).  When higher order terms did not reach significance they 
were removed from the model, such that the most prudent representation could be used to 
explain the output variable y.  
5.9.4 Follow-up tests 
Because the results of ANOVA only determines if there is significance for a particular 
parameter or combinations of parameters (interactions), it is typically followed with additional 
tests to determine which groups are different from each other.  For example, if parameter ‘αj’ is 
found to be significant, it remains unknown whether α1 is statistically different from α2, α 3, … α 
n or if all αj statistically differ from one another.  Multiple comparisons (ie. follow-up tests) were 
made with Tukey’s honestly significant difference (Tukey-HSD) criterion.  Tukey-HSD 
simultaneously tests pairwise comparisons for all αj and identifies where the difference is 
significant. This test assumes normality, independence and equal variation.  The test uses the q-
statistic (based on the studentized range distribution), which is similar to the t-statistic, but 
accounts for experiment-wise type I error increases that occur with multiple testing.  The q-
statistic, qs, is defined as: 
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ݍ௦ ൌ ஺ܻ െ ஻ܻܵܧ  (5.11) 
where YA is the larger of the two means being compared, and YB is the smaller of the two, SE is 
the standard error of the data.  The value of qs is then compared to a q-value from the studentized 
range distribution, and when qs > qcritical, the means are significantly different. 
For the factorial study presented in this thesis, in addition to Tukey-HSD, compound 
comparisons were made.  In the case where main effects did not reach significance with 
ANOVA, two sets of groups, where one set had two or more groups were compared (e.g., 
compare average group means of 3 and 6 DPE with 0 DPE, or grouping Pr values into “low” and 
“high” and comparing low and high).  Combining the data in this way minimized the number of 
test performed and reduced the number of terms in ANOVA. 
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CHAPTER 6: ULTRASOUND CONTRAST AGENTS AFFECT THE 
ANGIOGENIC RESPONSE 
 
Microbubbles have been explored as a means of drug delivery in an effort to treat 
ischemia (Korpanty et al. 2005, Zen et al. 2006, Song et al. 2006).  Studies have shown that US 
and UCAs induce neovascularization (Chappell et al. 2006, Miyake et al. 2007), arteriogenesis 
(Song et al. 2004, Chappell et al. 2008), and improve cardiac function (Song et al. 2008) in 
ischemic models.  However, an equal amount of literature details the ability of US and UCAs to 
create damaging bioeffects to various tissues.  US and UCAs have been documented to create 
undesired bioeffects including: premature ventricular contractions (MacRobbie et al. 1997), 
hemorrhage (Miller et al. 1998), capillary disruptions (Skyba et al. 1998), and lesions (Zachary et 
al. 2006) in normal animal models.  Generally, bioeffects studies focus on 0-day effects in 
normal models, while methods to induce angiogenesis focus on 3-28 days after US exposure, 
typically with ischemic models.  Acute (0-day) and effect days are rarely addressed in the same 
study.  As such, little is known about the mechanism of US-UCA-induced angiogenesis.  
One of the reasons for the disconnect between US’s potential adverse biological effects 
and therapy is that there is a lack of understanding regarding mechanisms initiating the 
angiogenic response.  As such, a wide range of US peak rarefactional pressures (Prs) has been 
used (Song et al. 2004, Barzelai et al. 2005, Leong-Poi et al. 2007, Song et al. 2008, Fuji et al. 
2009) with no dose-effect examination of the therapy.  A relatively low Pr (0.25 MPa) was 
demonstrated to induce an angiogenic response (Zen et al. 2006), but Fuji et al. (2009) found a 
much higher Pr (4.5 MPa) to be beneficial.  When UCAs are used, Pr is the exposure quantity of 
particular importance because it affects the behavior of the UCA.  As incident Pr increases, the 
UCA’s behavior progresses from oscillation to eventual collapse (Marmottant et al. 2005, Ammi 
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et al. 2006b, King et al. 2010).  The UCAs behavior may affect the vasculature and initiate a 
biological response (Nyborg et al. 1958, Elder et al. 1959).   
Therefore, in an effort to connect the 0-day (day of exposure) bioeffects with subsequent 
therapeutic responses, this study sought to examine the role of the UCAs, and provide insight to 
the physical mechanism by which US-UCA interaction induces angiogenesis, via a dose-effect 
study on Pr.  This study used either saline or a UCA concentration ([UCA]) of 5x, where 25% 
Definity® by volume was infused during bilateral exposures for infusion (see Chapter 5).  
Capillary density, inflammation and vascular endothelial growth factor (VEGF) were used to 
assess bioeffects and the subsequent angiogenic response at 0, 3 and 6 days post exposure (DPE).  
One hundred fifty female Sprague Dawley rats were used in this 3 x 4 x 2 factorial study 
examining DPE, Pr and infusion media.  Six rats served as cage controls where no treatment was 
given; the remaining 144 rats were randomly assigned to one of 24 (3 x 4 x 2) groups with six 
rats per group.  US exposure parameters were: Pr = 0.25, 0.83, 1.4, and 2.0 MPa, PRF = 10 Hz, 
PD = 10 µs, ED = 5 min. 
6.1 Results 
 
Capillary density (CD-31) 
Normalized capillary density was determined with US exposures of 0.25, 0.83, 1.4 and 
2.0 MPa at 0, 3 and 6 DPE for saline and UCA infusion, respectively (Figure 6.1).  Statistical 
significance was not found with DPE or Pr for capillary density using N-way ANOVA.  The 
general trends of the saline and UCA infused groups were similar; therefore as a further 
examination of capillary density, the data were grouped into low (0.25 and 0.83 MPa for both 
saline and UCA infusion) and high (1.4 and 2.0 MPa for both saline and UCA infusion) pressure 
groups (Figure 6.2).  While two-way ANOVA determined that there was no significant 
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difference for the pressure groups, DPE was a significant parameter.  Multiple comparisons 
showed that the low pressures’ acute capillary density was not significantly different from the 3 
and 6 DPE capillary density.  However, significance is reached when comparing the high 
pressures’ acute capillary density to the combined 3 and 6 DPE capillary densities (p < 0.05). 
 
Figure 6.1: Normalized capillary density for exposures, saline (left) and UCA (right).  The color 
darkens as DPE increases, with saline infusion in stripes, and UCA infusion in solids (Johnson et 
al. 2011) 
 
Figure 6.2: Grouped capillary density at low (025 and 0.83 MPa) and high (1.4 and 2.0 MPa) 
pressures, combining saline and UCA infused groups. * p < 0.05 with respect to HIGH 0 DPE. 
 
Inflammation 
The IHC slides were digitized and a program to analyze the presence of CD-31 from the 
images was generated in Matlab®.  This program was designed to quantify the presence of the 
brown stain indicative of inflammation marked by CD-31 (Figure 6.3).  The results were 
normalized to the cage control rats after raw percentages of inflammatory cells were gathered.  
The program was constructed to read in an image, and using RGB threshold values, highlight 
*
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only the pixels of interest.  Visual examination of each image confirmed the approximate 
correctness of the program.  The program then returned a percentage (of total pixels in the image, 
pixel size: 0.5 μm) of inflammatory cells with respect to the total image.  This number was used 
to quantify the extent to which inflammation was occurring.   
 
Figure 6.3: CD-31 quantification for inflammation analysis (Johnson et al. 2010). 
Figure 6.4 shows the normalized inflammation at 0, 3 and 6 DPE for both saline and 
UCA-infused groups. Representative IHC images of inflammation are shown in Figures 6.5 and 
6.6.  In Figure 6.5 and 6.6, acute inflammation (0 DPE) images representing 0.25 to 2.0 MPa 
show minimal variation for saline and for UCA infusion. 
  
Figure 6.4: Normalized inflammation, saline (left) and UCA (right).  The color darkens as DPE 
increases, with saline infusion in stripes, and UCA infusion in solids (Johnson et al. 2011). 
 
US exposure caused an increase in inflammation with respect to the control.  The 
inflammation did not demonstrate a trend across Pr for neither UCA nor saline-infused groups 
(Figure 6.3) using N-way ANOVA.  DPE was found to be a significant parameter for the saline-
infused group only.   
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Multiple comparisons showed the 3 DPE inflammation to be significantly higher than 0 DPE (p 
< 0.02); however the 3 and 6 DPE groups did not differ. 
 
Figure 6.5:  Representative images of exposed CD31 stained slides, saline. (Left) 0 DPE, (right) 
6 DPE.  Top to bottom for each column:  0.25, 0.83, 1.4 and 2.0 MPa, respectively. Bar = 100 
μm (Johnson et al. 2011). 
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Figure 6.6: Representative images of exposed CD31 stained slides, UCA. (Left) 0 DPE, (right) 6 
DPE.  Top to bottom for each column:  0.25, 0.83, 1.4 and 2.0 MPa, respectively. Bar = 100 μm 
(Johnson et al. 2011). 
 
Vascular endothelial growth factor-A (VEGF) 
87 
 
 VEGF expression is shown in Figure 6.7 in terms of fold change.  Using N-way ANOVA 
for the saline-infused animals, DPE was significant for VEGF (p < 0.001).  The 0 DPE mean 
value of VEGF increases with pressure, but neither 3 nor 6 DPE were significantly different from 
the control. 
N-way ANOVA determined that both Pr and DPE were significant for VEGF when 
UCAs are used (p < 0.01 and p < 0.001, respectively).  Multiple comparisons determined that the 
Pr of 2.0 MPa at 0 DPE was significantly different from the control and other pressure settings, 
indicating a pressure dependency (p < 0.05).  0 DPE was not significantly different from 3 DPE; 
however 6 DPE was significantly lower than 0 or 3 DPE (p < 0.05). 
  
Figure 6.7: Relative VEGF expression for exposures, saline (left) and UCA (right).  The color 
darkens as DPE increases, with saline infusion in stripes, and UCA infusion in solids (Johnson et 
al. 2011). 
 
Figure 6.8: Grouped VEGF expression at low (025 and 0.83 MPa) and high (1.4 and 2.0 MPa) 
pressures, combining saline and UCA infused groups.* p < 0.05 with respect to HIGH 0 DPE. 
*
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Because both saline and UCA infused groups demonstrated a general trend of acute 
increase in VEGF expression followed by a decrease at 3 and 6 DPE, the data were grouped for a 
macroscopic view of the Pr effect of US exposure (Figure 6.8). Like capillary density, the high 
pressures’ acute capillary density was significantly different from the combined 3 and 6 DPE 
capillary densities (p < 0.05). 
6.2 Discussion 
 
The intent herein was to ensure that excessive damage did not occur acutely, but also to 
elicit an angiogenic response such that the mechanism could be explored.  With information 
concerning the mechanism of ultrasound-induced angiogenesis, current treatments can be 
improved, optimized, or assessed for use in a particular situation.   
This study used a range of pressures and three measurements (capillary density, 
inflammation and VEGF) to explore if US and/or US-UCA interactions could be used to induce 
an angiogenic effect. The results showed that the angiogenic response was dependent upon 
infusion media, incident Pr and DPE.  The data also suggested that collapse of UCAs resulted in 
higher acute VEGF expression. 
It was expected that as Pr increased the acute capillary density, inflammation and VEGF 
would decrease, and there would be a subsequent rebound as DPE increased as seen in previous 
findings (Johnson et al. 2010).  Literature supports that there is possibly a range of Prs that may 
result in beneficial therapy.  US pressures ranging from 40kPa to 5 MPa (at a US frequency of 1 
MHz) have been used to stimulate healing in varicose ulcers, induce angiogenesis, and treat 
ischemia both with and without the use of UCAs (Dyson et al. 1976, Hogan et al. 1982, 
Korpanty et al. 2005, Barzelai et al. 2005, Chappell et al. 2006, Chappell et al. 2008, Fuji et al. 
2009).   
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Ultrasound bioeffects 
It is generally assumed that the therapeutic benefits of ultrasound are initiated by 
damage—as a result of inertial cavitation or cellular changes via mechanical perturbation 
(Gormley et al. 1998, Leong-Poi et al. 2007, Chappell et al. 2008, Johnson et al. 2010).  These 
effects may or may not result in tissue level damage.  Research shows that ultrasound can induce 
petechiae in vivo without tissue destruction (Miller et al. 1998).  For this study, to assess US 
bioeffects the saline infused group was used.  For this group, a rise in VEGF and inflammation 
was expected to occur prior to any increase in capillary density as seen in the literature (Bates et 
al. 2003, Chappell et al. 2006, Mariotti et al. 2006).  Analysis of this study agreed with VEGF 
appearing with exposure to US, and inflammation increasing above the control.  The acute 
VEGF increase suggests that US exposure activated the expression of VEGF to initiate an 
angiogenic response by increasing vascular permeability (as discussed in Chapter 2).  US caused 
inflammation that demonstrated an onset peaking at 3 DPE.  The 3 DPE peak of inflammation 
was not unexpected as angiogenesis is known to involve both early and late stage inflammation 
(Bates et al. 2003).   
Ultrasound contrast agents 
UCAs increase the potential for damage by introducing cavitational bodies 
intravascularly.  While the general progression of angiogenic response elicited from US-UCA 
was similar to US-saline, the UCA group demonstrated acute inflammation that possibly occurs 
due to the increased level of vascular perturbation.  For therapeutic applications, typically, UCA 
concentrations have exceeded the standard recommendations for imaging (Chappell et al. 2006, 
Chappell et al. 2008, Fuji et al. 2009).  For bioeffect and therapy, however, [UCA]s range from 0 
to 60% UCA by volume.  With greater [UCA] the likelihood for damage is presumably 
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increased, due to the presence of clouds of bubbles undergoing a range of dynamic behavior.  To 
minimize damaging effects, this study used a relatively low concentration of UCAs (~ 25% 
Definity® by volume).   
Interestingly, when UCAs are used, Pr is one of the most relevant parameters for 
determining bubble dynamics.  UCAs progress from oscillation to collapse with increasing Pr.  
In separate in vitro experiments, this lab determined that the 5% collapse pressure threshold of 
Definity® occurs at approximately 0.2 MPa (King et al. 2010).  The occurrence rises to 50% at 
approximately 0.5 MPa, and 100% of bubbles exposed to US collapse at about 1.0 MPa with 
oscillation co-occurrence (King et al. 2010).  Thus the range of Prs chosen for this experiment 
was from 5% to 100% collapse occurrence with exposure to US.   
 In this study, 0.25 MPa represents a predominantly oscillation inducing pressure.  As Pr 
increases, UCAs slowly expand and rapidly contract resulting in collapse and shell fragmentation 
(Pr = 0.83, 1.4 and 2.0 MPa). This collapse potentially damages the vascular endothelium and 
surrounding tissue.  In this study, there was no decrease in acute capillary density as seen 
previously (Johnson et al. 2010) signifying that the vascular endothelium was not ruptured.  
These data show that oscillation (at 0.25 MPa) causes a change in the VEGF expression possibly 
due to continual local hemodynamic disturbance (Figure 6.7).   As Pr increases, collapse 
eliminates the constant oscillatory disturbance in the US beam focus, but infusion replenishes the 
UCAs.  While locally circulating red blood cells may be damaged the vessel lumen remains 
intact as determined by acute capillary density (Figure 6.1 and 6.2).  Because capillary density 
does not decrease acutely with exposure to US and UCA, the increased VEGF expression seems 
to be mechanical, not damage induced.  Inflammation did appear acutely for Prs above 0.25 
MPa, which suggests some level of perturbation to the vascular endothelium and/or exposed 
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muscle, further indicating that the angiogenic response is, in part, influenced by collapse of 
UCAs.  
US-UCA-induced angiogenesis 
The expression of VEGF was demonstrated to occur in vitro (Reher et al. 1999) and in 
vivo (Barzelai et al. 2005) after exposure to US which agrees with the findings in this study.     
One of the proposed mechanisms underlying US exposure and vascular growth relates to the 
induction of local hypoxia and inducing VEGF expression (Barzelai et al. 2005).  This reinforces 
the possibility of the mechanical effect inducing VEGF.  US and UCAs seem to disturb the 
normal state, and this disturbance caused an increase in VEGF expression both in this study and 
others (Barzelai et al. 2005, Chappell et al. 2006). This study displayed higher fold changes in 
VEGF for all pressures explored when compared to previous findings in an ischemic model 
(Barzelai et al. 2005).   
Heating as a possible mechanism 
Ultrasound induced heating has also been documented to provide some therapeutic 
benefit (Draper et al. 2010).  The maximum change in temperature can be approximated with 
ΔTmax =  (QΔt)/Cv, where t  is the exposure duration (for a single pulse, ED is 10 µs), Cv is the 
medium’s heat capacity per unit volume (4.18 J/cm3-˚C for biological tissue) and Q  is the rate of 
heat generation per unit volume (Fry et al. 1953, Cavicchi et al. 1984, O’Brien et al. 2007).  For 
this study, ΔTmax was calculated to be 0.950C, for the 2.0 MPa exposure.  This approximation 
assumes no heat removal, which is not necessarily the case for a 5 minute exposure.  Further, 
thermal therapy frequently requires repeated exposures of continuous ultrasound (Usuba et al. 
2006, Draper et al. 2010), whereas one-time pulsed US was used herein. Thus, it is reasonable to 
assume that heating is not a significant biophysical mechanism for the results noted herein. 
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Previously published work conducted in this lab used the same [UCA], but a pressure that 
was approximately double the maximum Pr used in this study (Johnson et al. 2010).  Unlike the 
damage seen in previous work, this study supports that a mechanical effect elicits the angiogenic 
response and with the introduction of UCAs there is more variation in such effects.  It should be 
noted that the literature has, to date, reported only effects seen days after treatment, with no 
investigation of connections between exposure and angiogenesis.  If we remove 0 and 3 DPE 
from this dataset, we find that capillary density and inflammation are statistically different from 
the control for all measured endpoints.  The results of this study raises mechanistic questions for 
other US-UCA induced angiogenesis studies.   
This chapter took a large-scale study to determine if trends could be discerned based 
upon Pr, DPE, and infusion media.  UCAs were determined to affect the induction of the 
angiogenic response with US exposure, with increased capillary density (combined 3&6 DPE 
data), acute inflammation and VEGF expression.  Because a large amount of comparisons were 
made for this factorial study, subtle effects did not reach significance.  However, based upon 
inflammation, and macroscopic examination of VEGF expression and capillary density, there 
exists a relationship between Pr, the biological effect and the angiogenic response.  Acute 
inflammation increases for the UCA group suggests that the presence of UCAs play a role in US-
UCA induced bioeffects and therapy but the extent to which UCAs affect the response is unclear 
from this study.  The next chapter uses a smaller scale study to examine the [UCA] in an effort to 
better understand the role of UCAs. 
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CHAPTER 7: THE ANGIOGENIC RESPONSE IS DEPENDENT ON 
ULTRASOUND CONTRAST AGENT CONCENTRATION 
 
There are presently three scenarios for which proangiogenic therapies are used clinically: 
chronic wounds, peripheral arterial disease and ischemic heart disease (Li et al. 2004, Li et al. 
2005), where the goal is to create neovascularization to promote healing.  The main drawbacks 
for current drug, surgical, and cell-based therapies are the diffuse spread of growth factors, 
invasiveness, or the inability to provide spatially specific treatment.  US and UCAs have been 
shown to provide noninvasive and spatially specific treatment, resulting in an angiogenic 
response to exposure (Johnson et al. 2010). 
Several studies report a reparative response to US and UCA exposure (Chappell et al. 
2005, Hwang et al. 2005, Korpanty et al. 2005, Miyake et al. 2007, Song et al. 2008, Bohmer et 
al. 2010).  While there is a body of literature that seems to show efficacy, there is a great deal of 
conflicting results, perhaps because there is a lack of mechanistic exploration.  The previous 
chapter detailed how UCAs affect the angiogenic response by increasing expressed vascular 
endothelial growth factor (VEGF), inflammation and capillary density at higher Prs.  In that 
study, however, the difference between the controls and exposed groups were significant, but 
subtle, possibly due to the relatively low UCA concentration ([UCA]).  Current diagnostic 
recommendations for imaging are up to twenty times lower than concentrations used in 
therapeutic studies, with a wide range of [UCA]s represented in the literature (Johnson et al. 
2011, Zen et al. 2006, Chappell et al. 2008, Miller et al. 2009).   
Therefore, to further understand the US and UCA therapy to induce angiogenesis, [UCA] 
has been explored.  [UCA] is of particular interest because, as alluded to previously, increasing 
the [UCA] increases the number of potential cavitating bodies and the opportunity for bubble-
bubble and bubble-vascular interaction.  It is, presumably, these interactions that facilitate US 
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and UCA’s therapeutic effects.  A major impediment for progress to clinical applicability is the 
lack of understanding of the mechanisms that connect US and UCA to the angiogenesis 
response, and bioeffects to subsequent angiogenesis.  Therefore, in an effort to understand the 
mechanism and characterize the angiogenic response, [UCA] was explored in this study both at 0 
days post exposure (DPE) and at 5 DPE.  This chapter explores the acute effects (0 DPE) in 
terms of capillary density and Evans blue dye (EBD) as a marker for vascular permeability (as 
opposed to acute VEGF expression that was used in Chapter 6).  EBD was used because it can be 
instantaneously visualized and VEGF expression for increased permeability is not well 
documented with this procedure.  In addition, this study does not assess inflammation.  Though 
inflammation reached statistical significance in the previous chapter, a 2% increase from the 
control is not readily extrapolated to biological significance.  Instead H&E was used to 
determine if inflammation had occurred via the presence of inflammatory infiltrates.  Damage 
was also assessed via hemorrhage necrosis and changes in capillary density.  For the 5 DPE 
angiogenic responses, both capillary density and VEGF expression were explored. 
Using twenty-eight rats four separate [UCA]s were explored: 0x, 1x, 5x, and 10x [UCA] 
for both 0 and 5 DPE.  At 0 DPE there was an n = 4 per [UCA]; at 5 DPE there was an n = 3 per 
[UCA].  The 1.5 mL infused solution contained 0, 0.07, 0.25 and 0.75 mL of Definity® for 0x, 
1x, 5x, and 10x [UCA] respectively.  US exposure parameters were: Pr = 0.7 MPa, f = 1 MHz, 
PD = 10 µs, PRF = 10 Hz, and ED = 5 min.  EBD was used only for acute exposures as it has 
been documented to interfere with regenerating vasculature (Jackieqciz et al. 1998).  Bilateral 
sites on the lateral sides of the left and right gracilis muscles were exposed and the medial site 
served as the control. 
7.1 Results 
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Capillary density (CD-31) 
 Capillary density was normalized to the medial-site control value.  Two-way ANOVA 
determined that DPE was not a significant parameter for capillary density (p > 0.05), however, 
significance was found for [UCA] (p < 0.05); suggesting a change in capillary density with 
increased [UCA] (Figure 7.1).  The interaction term, DPE* [UCA] was not significant (p > 0.05).  
Multiple comparisons between 0 DPE and 5 DPE found, the capillary density to be significantly 
different at 10x [UCA] (p < 0.05).   
 
Figure 7.1: Normalized capillary density at various [UCA]s.* p < 0.05 with respect to 0 DPE at 
10x [UCA] 
Histological assessment (H&E and CD-31) 
 Tissue-level effects for 0 DPE demonstrated signs of capillary engorgement at 10x 
[UCA].  No tissue damage, inflammatory infiltrate or necrosis was observed at any of the UCA 
concentrations (Figure 7.2). 
Evans blue dye (vascular permeability) 
EBD leakage as a measurement of vascular permeability was also normalized to the 
medial-site control.  One-way ANOVA was used to determine that [UCA] was a significant 
parameter for EBD leakage (p < 0.001) (Figure 7.3).  The medial-site control samples were not 
significantly different from the saline-infused (0x [UCA]) rats (p > 0.05).  EBD leakage 
demonstrated an increasing trend of permeability as the [UCA] increased, with 1x [UCA] and 5x  
96 
 
 
 
Figure 7.2: Acute histology, H&E (left) and CD31 (right) demonstrating the lack of tissue level 
effects associated with US-UCA exposure for various [UCA] at 40x magnification.  Top to 
bottom: medial-site control, saline (0x [UCA]), 1x, 5x, and 10x [UCA].  Bar = 50 µm. 
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[UCA] being near the control value for the assessment (Figure 7.3).  Multiple comparisons 
between UCA concentrations determined that 1x, 5x and 10x [UCA] were significantly different 
from 0x [UCA] (p < 0.05).  10x [UCA] was significantly different from 1x and 5x [UCA] (p < 
0.05). 
 
Figure 7.3: Normalized EBD leakage indicating vascular permeability at varying [UCA].  *p < 
0.05 with respect to the control and 0x, + p < 0.05 with respect to 1x.  The medial-site control 
EBD leakage was 8.8 µg/g. 
 
Vascular endothelial growth factor-A (VEGF) 
 To supplement capillary density, VEGF expression was measured to assess the 
angiogenic response.  One-way ANOVA was used to determine if [UCA] was a significant 
parameter for VEGF expression (p < 0.001).  Lower [UCA]s showed less than half the VEGF 
expression seen at 10x [UCA] (Figure 7.4).  Multiple comparisons between [UCA]s indicated 
that 1x, 5x and 10x [UCA] were significantly different from 0x [UCA] (p < 0.05). 10x [UCA] 
was also significantly different from 1x and 5x [UCA] (p < 0.05). 
7.2 Discussion 
 
The objective of this study was to determine the effect, if any, of [UCA] on the 
angiogenic response induced by US and UCA.  Further, this study examined the acute bioeffects  
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Figure 7.4: Relative VEGF expression (in fold change) at various [UCA]s.  * p < 0.05 with 
respect to 0x [UCA], + p < 0.05 with respect to 1x, 5x [UCA]. 
in an effort to provide biological mechanistic clues leading to the angiogenic response.  US 
exposure parameters were chosen to reduce the thermal effects, with an estimated maximal 
temperature increase of 0.5oC (Fry et al. 1953), assuming no heat removal, which is not 
necessarily the case for a 5 minute exposure duration.  The previous chapter demonstrated that at 
5x [UCA] only subtle significant differences existed with respect to the saline control with 
VEGF expression assessment and up to a 2% increase in inflammation, without inflammatory 
infiltrate.  This study demonstrated that [UCA] is an important determinant of not only 
bioeffects, but also angiogenic responses. 
Understanding the role of [UCA] is important for understanding the mechanism of  US 
and UCA therapeutic applications.  In US-induced angiogenic therapy, typically, [UCA]s have 
exceeded the standard recommendations for imaging (Chappell et al. 2006, 2008, Fuji et al. 
2009).  US and UCA therapy in the literature use [UCA]s ranging from 0 to 60% UCA by 
volume of solution (0 to 16x [UCA]) (Chappell et al. 2006, 2008, Bohmer et al. 2010, Zen et al. 
2006, Miller et al. 2009).  Variability in the dosages (some [UCA]s are not reported) and 
differing delivery methods (ie. bolus or infusion) make it difficult to extrapolate the results to 
new applications (Hwang et al. 2005, Bohmer et al. 2010, Zen et al. 2006 Miller et al. 2007).  
The [UCA] range chosen was scaled to ensure animal survival.  Chappell et al. (2006) found that 
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animal death occurred once the infusion concentration reached 2.5 x 107 microbubbles/min in 
mice (estimated to be 3.3 x 109 in rats); this information was used to determine the upper [UCA] 
limit.  
One must note that increasing [UCA] to significantly high doses may also cause excess 
bioeffects to occur.  ‘Excess bioeffects’ is defined here as a reduction in acute (0 DPE) capillary 
density or tissue-level changes.  One study showed that an estimated dosage of 3.2 x 1010 
microbubbles/min (an equivalent of 16x [UCA] with the parameters used in this study) injured 
rat cardiomyocytes but recovery from injury was not explored (Miller et al. 2005).  Another 
study demonstrated that after a ‘sufficiently’ high dose of UCAs was used in mice, increasing 
that dose did not change the response (Chappell et al. 2006).   
To study the bioeffects of US, EBD is frequently used.  Research has shown that US and 
UCAs cause vessel leakage (Bohmer et al. 2010, Miller et al. 2000, 2007, Zachary et al. 2006, 
Shang et al. 2011).  Microvascular effects have been shown to increase with increasing UCA 
dosage (Miller et al. 2007), which agrees with the findings herein (Figure 7.3).  It has been 
speculated that US and UCAs increase vascular permeability by destabilizing the tight junctions 
associated with blood vessels, showing increased permeability up to 9 hours after exposure 
(Shang et al. 2011).  Focused US, along with lipid shelled UCAs has been shown to increase 
EBD extravasation in muscle with as much as 8% of the total injected dose leaking at the 
exposed site (Bohmer et al. 2010).  It was also noted that microvascular leakage may be 
reversible (Miller et al. 2007).  As such, the role of [UCA] in inducing this acute bioeffect was 
assessed as a potential motivating factor for an angiogenic response. 
VEGF, like US application, is known to play a role in increasing vascular permeability.  
However, at 10x [UCA], EBD leakage was observed under 1 min after the start of the exposure, 
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which is insufficient time for increases in VEGF expression (Bates et al. 2003).  Typically VEGF 
peaks 3 to 7 days after injury in wound healing (Bates et al. 2003), though minimal increases 
may be captured in as little as 10 hours as seen in Chapter 6.  US-UCA could acutely increase 
VEGF through shear stress inducible pathways (via biological signal transduction) and this 
increase in VEGF could be responsible for increased permeability, it could be purely mechanical 
(physical effect of UCA motion), or both.   
Several studies suggest that therapy is bioeffect driven—as a result of high Prs inducing 
thermal or mechanical (UCA destruction) perturbations to the vasculature (Gormley et al. 1998, 
Leong-Poi et al. 2007, Chappell et al. 2008).  The angiogenic response did not result from tissue 
level changes in this study, however.  Although UCAs increase the potential for bioeffects by 
introducing cavitation bodies intravascularly, the Pr used herein was chosen to reduce the 
incidence of UCA collapse such that excess bioeffects were not caused.  The 0 DPE capillary 
density did not significantly change with [UCA] (Figure 7.1), nor were there any biologically 
significant signs of hemorrhage, inflammation, or necrosis after exposure (Figure 7.2).  The lack 
of acute effects suggest that the increased vascular permeability was the result of US-UCA 
mechanical interactions with the vascular ECs which lead to either increased porosity or 
increased size of pores between ECs.   
The assumption is that US-UCA exposure leads to increased microvascular permeability 
which induces vascular remodeling (Chappell et al. 2006, Bohmer et al. 2010).  While locally 
circulating cells may be damaged, the vessel lumen remains intact as demonstrated by capillary 
density assessments at 0 DPE (Figure 7.1).  Because this study sought to understand the role of 
[UCA] in the context of angiogenesis, recovery from the perturbed state with signs of benefit 
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was of importance.  Capillary density (at 5 DPE) and VEGF expression were used to assess 
recovery in the context of an angiogenic response. 
Capillary density assessed at 5 DPE showed a significant difference with respect to 0 
DPE for the 10x [UCA] (Figure 7.1), supporting the notion that sufficient increases in 
permeability could motivate an angiogenic response.  In agreement with this study, when gene 
transfer was used with US and UCA exposure, the therapy caused an increase in capillary density 
(Taniyama et al. 2002).  Others have measured significant increases in angiogenic related events 
such as: vascular density, arteriogenesis, or tissue perfusion (Chappell et al. 2006, 2008, Miyake 
et al. 2007, Song et al. 2004). 
VEGF is known to have a vital role in angiogenesis, thus was measured in this study 
(Bates et al. 2003, Mariotti et al. 2006, Medinger et al. 2010).  There has been very limited 
research on the induction of VEGF with US and UCAs; the expression of VEGF was 
demonstrated to occur in vitro (Reher et al. 1999, Doan et al. 1999) and in vivo (Barzelai et al. 
2006) after exposure to US which agrees with the findings in this study.  This reinforces the 
possibility of the acute mechanical effect inducing VEGF and causing an increase in the 
angiogenic response seen in Figures 7.1 and 7.4.  In normal wound healing associated 
angiogenesis, changes in vascular permeability occur prior to increased VEGF expression (Song 
et al. 2004, Mariotti et al. 2006).  Under normal conditions, blood vessels are at steady state, 
where vascular endothelial cell proliferation equals that of cell death and VEGF levels remain 
nominal (Cherwek et al. 2000).  This study demonstrates an offset of that balance owing to 
increased VEGF and, as mentioned earlier, a higher capillary densities for 10x [UCA] at 5 DPE 
(Figures 7.1 and 7.4).  This further suggests a mechanical dependence of VEGF stimulation 
through permeability perturbation, not by tissue damage (Figure 7.2).   
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Chapter 6 used a 5x [UCA] to study the angiogenic effect and that study supported that a 
mechanical effect elicits the angiogenic response and that the introduction of UCAs disturbs the 
effects.  Using the same experimental setup, this study extended previous work by examining the 
concentration. The findings in this chapter at 5x [UCA] are in agreement with those seen in the 
previous chapter.  In Chapter 6, VEGF acutely peaked, which was indicative of increased 
vascular permeability.  This chapter also found increases in vascular permeability at 5x [UCA].  
Both studies showed no change in capillary density at 0 DPE or 5 DPE, but this chapter 
demonstrated that [UCA] may have been the reason why significance was not reached in Chapter 
6.  VEGF levels peaked at 5 DPE for this study which agrees with the progression for wound 
healing.  So, [UCA] determines the angiogenic pathway utilized—where no or low [UCA]s 
stimulates VEGF acutely and high [UCA] causes it to peak later (at 5 DPE).  This peak at 5 DPE 
is possibly because it uses shear stress factor activation to increase VEGF expression as shown in 
Figure 4.1.  Also this study found VEGF expression to be about the same as in Figure 6.8 for the 
low Pr group at the angiogenic response day of assessment. 
This chapter demonstrated that [UCA] has a significant effect not only in the acute 
bioeffects, but also in the subsequent angiogenic response.  The response for both acute 
bioeffects and angiogenic response are positively correlated with the infused [UCA]. Beginning 
with a suggested mechanically induced increase in permeability, up to a 20% increase in 
capillary density and a 3 fold change in VEGF expression was found.  Because the [UCA] was 
strongly correlated with the acute bioeffects and the angiogenic response, and [UCA]s less than 
10x [UCA] demonstrated only subtle effects with respect to the control, Pr should be 
reinvestigated at higher [UCA].   
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Mechanistically, the data from Chapter 6 and this study suggest that UCAs enhance 
bioeffects and that increasing the [UCA] enhances the angiogenic response.  Because Chapter 6 
demonstrated an increase in capillary density (5 DPE) and VEGF expression with higher Prs at 
relatively low [UCA], and this chapter showed that at relatively low Pr, higher [UCA] yielded 
increases in capillary density (5 DPE) and VEGF expression, there appears to be a trade off with 
respect to US-UCA induced angiogenesis. The next chapter details the reinvestigation of Pr at 
10x [UCA] and comments on the differences between 1x, 5x, and 10x [UCA] for a Pr range 
representative of linear oscillation, nonlinear oscillation and collapse.  
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CHAPTER 8: THE ULTRASOUND AND ULTRASOUND CONTRAST 
AGENT CONCENTRATION’S INDUCED ANGIOGENIC RESPONSE IS 
PRESSURE DEPENDENT 
 
 Though the concept of US and UCA induced wound-healing has existed for over three 
decades (Dyson et al. 1968, Hogan et al. 1982), there has been no established protocol for the 
usage of US-UCA induced angiogenesis.  
 Chapters 6 and 7 showed that UCAs affect the angiogenic response, and that UCA 
concentration ([UCA]) influence both the bioeffects and subsequent therapy associated with US-
UCA induced angiogenesis, which agrees with other literature (Miller et al. 1998c, 2007, 
Chappell et al. 2006, Johnson et al. 2011, in press (Chapter 6), Johnson et al. 2011, submitted 
(Chapter 7)).  In addition, Pr seems to be related to the angiogenic response from the range of 
pressures used and the consequent variation in effects.   US Prs have ranged from 0.18 to 4.5 
MPa in the effort to treat ischemia with UCAs (Zen et al. 2006, Chappell et al. 2006, Fuji et al. 
2009, Johnson et al. 2010).   
Because UCAs behavior varies with the applied Pr, understanding how the microbubbles 
interact with US (and the vasculature) to produce an effect is of particular interest.  While Pr was 
varied in previous studies (Dalecki et al. 2000, Song et al. 2002, Johnson et al. 2011, in press 
(Chapter 6)), this study seeks to revisit the angiogenic response with Prs that range from 
atmospheric pressure (ie. 100 kPa) to a Pr that fits within the FDA-regulated mechanical index of 
1.9 (AIUM/NEMA 1998, ODS 1998, NEMA 2009a, 2009b).  In addition, since previous 
findings demonstrated that low [UCA] produces an angiogenic response within the noise range 
of detection, this study sought to reinvestigate Pr using a higher [UCA].  After 10x [UCA] was 
explored, the [UCA] was reduced to 1x and 5x, and Pr reassessed for the angiogenic responses at 
5 DPE. 
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Using forty female Sprague Dawley rats, Pr was explored at 10x [UCA].  For both 0 and 
5 DPE there was an n = 4 rats per Pr.  The infused solution contained 0.75 mL Definity® brought 
up to 1.5 mL with saline.  US parameters included Pr = 0.1, 0.7, 1.3 and 1.9 MPa, f = 1 MHz, 
PRF = 10 Hz, PD = 10 µs, and ED = 5 min.  Following the 10 x [UCA] study, 1x and 5x [UCA] 
was investigated for the angiogenic response to determine the significance of the interaction term 
Pr X [UCA].  This follow up study used nineteen rats to assess 0.7, 1.3 and 1.9 MPa for VEGF 
expression and capillary density at 5 DPE.  For both studies bilateral sites on the lateral side of 
the left and right gracilis muscles was exposed and the medial site served as the control. 
8.1 Results 
 
Capillary density 
 Capillary density was measured as capillaries per square millimeter; the values were 
normalized and results are presented in Figure 8.1.  Two-way ANOVA determined that DPE, Pr 
and DPR*Pr were significant parameters for capillary density (p < 0.01) (Figure 8.1).   Multiple 
comparisons showed that 0.1 MPa was not significantly different from the control (p < 0.001), 
but 0.7, 1.3, and 1.9 MPa were significantly different from 0.1 MPa (p < 0.001) at 5 DPE.   
 A trend was noticed at 10x [UCA] with Pr at 5 DPE, therefore the [UCA] was lowered to 
1x and 5x [UCA] to further explore the relationship between Pr, [UCA] and the angiogenic 
response (Table 8.1).  Because no effect was seen at 0.1 MPa for the highest concentration (10x 
[UCA]), this Pr was excluded from the assessment. 
 Table 8.1 shows the 5 DPE normalized capillary density + SEM.  The table shows that 
the 5 DPE capillary density tends to increase with increasing pressure at 1x [UCA], however, as 
the [UCA] increases the capillary density first increases with respect to the control, but then 
decreases at high Pr.  Multiple comparisons showed that at 5x [UCA] capillary density was not 
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significant across Pr.  When Pr is low, an increase in capillary density with increasing [UCA] is 
noted, however increasing Pr to 1.3 MPa does not impact the capillary density with varying 
[UCA].  At the highest Pr setting, there is a distinct separation in capillary density with [UCA].   
 
Figure 8.1: Normalized capillary density at 0 DPE (blue) and 5 DPE (red) across Pr.  *p < 0.001 
with respect to 0.1 MPa at 5 DPE. 
 
 
Also of note is that as [UCA] increases, so does SEM of the capillary density 
measurement, which was also seen in a [UCA] bioeffect studies completed by Miller et al. (1998, 
2007, 2008). N-way ANOVA determined that the interaction of Pr and [UCA] was significant 
for 5 DPE capillary density with p < 0.05. 
Evans blue dye (vascular permeability) 
 One-way ANOVA was used to determine that Pr was a significant parameter for vascular 
permeability (p < 0.001).   EBD leakage demonstrated an increasing trend of permeability as the 
Pr increased (Figure 8.2 and 8.3).  Multiple comparisons showed that the 0.1 MPa group was not 
significantly different from the control, but 0.7, 1.3, and 1.9 MPa was significantly different from 
Table 8.1: 5 DPE Normalized capillary density for Pr X [UCA] 
Pressure (MPa) 1x 5x 10x 
0.1 -- -- 0.8 ± 0.1 
0.7 1.0 ± 0.1 1.2 ± 0.1 1.4 ± 0.3 
1.3 1.1 ± 0.2 1.2 ± 0.3 1.3 ± 0.3 
1.9 1.6  ± 0.2 0.9 ± 0.1 1.3 ± 0.2 
* * * 
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0.1 MPa (p < 0.001). Further, vascular permeability at Prs > 0.1 MPa was significantly different 
from the lower pressure groups (p < 0.001) (ie. 0.7 MPa < 1.3 MPa < 1.9 MPa). 
 
Figure 8.2: Photographic log of Evans blue dye leakage.  Left photo is skin, right is muscle.  Top 
to Bottom: 0.1 MPa, 0.7 MPa, 1.3 MPa, 1.9 MPa exposures. 
 
Vascular endothelial growth factor-A (VEGF) 
 VEGF expression was significant across Pr (p < 0.001) with one-way ANOVA.  The 0.7 
MPa pressure displayed the greatest amount of VEGF expression, whereas the lowest and 
highest Prs demonstrated relatively low VEGF expression (Figure 8.3). 
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Figure 8.3: Normalized EBD as a marker for permeability at 0 DPE across Pr.  *p < 0.001 with 
respect to 0.1 MPa, +p < 0.001 with respect to 0.7 MPa, and #p < 0.001 with respect to 1.3 MPa. 
Multiple comparisons between Prs showed that 0.7 MPa and 1.3 MPa were significantly 
different from 0.1 and 1.9 MPa (p < 0.001).  
 
Figure 8.4: Relative VEGF expression at 5 DPE across Pr.  *p < 0.001 with respect to 0.1 MPa. 
Similar to capillary density at 5 DPE, VEGF expression demonstrated a trend with Pr at 
10x [UCA].  To support capillary density and explore the angiogenic response with respect to Pr 
and [UCA], the [UCA] was reduced and VEGF expression quantified.  The analysis neglected 
0.1 MPa due to the lack of effect at 10x [UCA] (Table 8.2). 
 
Table 8.2: 5 DPE VEGF expression (in fold change) for Pr X [UCA] 
Pressure (MPa) 1x 5x 10x 
0.1 -- -- 0.5 ± 0.2 
0.7 1.5 ± 0.3 1.3 ± 0.1 3.1 ± 0.3 
1.3 1.9 ± 0.3 1.3 ± 0.2 2.1 ± 0.3 
1.9 1.2 ± 0.6 2.0 ± 0.1 0.7 ± 0.1 
 
* 
+ 
#
* 
+ 
* 
*
*
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Table 8.2 shows the relative VEGF expression (in fold change) + SEM at 5 DPE. VEGF 
expression tends to decrease with 5x [UCA] except in the 1.9 MPa case.  There appears to be an 
optimal Pr window of VEGF expression that varies with [UCA].  Lower concentrations require 
higher Pr to create larger increases in VEGF.  N-way ANOVA determined that the interaction of 
Pr and [UCA] was significant for VEGF with p < 0.01. 
8.2 Discussion 
 
 Previous work conducted in this lab sought to reduce the amount of acute damage to 
vasculature and surrounding tissue by keeping the [UCA] relatively low (Johnson et al. 2011, in 
press (Chapter 6)).  However, subsequent work suggested that the angiogenic response is highly 
dependent upon [UCA], and that using a comparatively high [UCA] affords more of a response 
as measured by VEGF and changes in capillary density (Chappell et al. 2006, Johnson et al. 
2011, submitted).  “High [UCA]” is with respect to imaging concentrations because standards for 
therapeutic applications have not been assessed.  Therefore it does not make sense to apply 
therapeutic limitations based upon established (imaging) standards—especially if angiogenesis 
is, in fact, damage induced.  Using EBD, capillary density and VEGF, this study sought to 
address angiogenesis across a functional range of Pr with a high [UCA] at both 0 DPE and 5 
DPE, such that mechanistic motivation could be elucidated.  
 This study supported the original finding that UCAs affect the angiogenic response and 
that [UCA] is an important parameter for determining this response. Again, no acute changes in 
capillary density occurred (Figure 8.1), which is in agreement with previously reported findings 
(Chappell et al. 2006, Korpisalo et al. 2010, Johnson et al. 2011, in press (Chapter 6)).  No 
tissue-level damage was seen in histological section acutely, either.  It should be noted that the 
initial signs of tissue damage do not appear until approximately 8 hours after damage (Robbins 
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& Kotran, Tiidus et al. 2008).  Korpisalo et al.  (2010) suggests that capillary enlargement 
precedes angiogenesis for therapy driven applications.  The capillaries could either be dilating or 
there could be a physical stretching of capillaries from the US and UCA exposure that leads to 
increased pore size between endothelial cells.  This increased pore size would allow EBD to 
leak.  In accordance, acute measurements of EBD were shown to increase with increasing Pr 
(Figure 8.2 & 8.3). Bioeffects studies using EBD support that permeability increases with 
increasing Pr (Miller et al. 2007, Miller et al. 2009, Shang et al. 2010, Bohmer et al. 2010), but 
this is the first time it has been explored as a mechanism to potentiate the angiogenic response. 
Capillary density at 5 DPE did change across Pr (Figure 8.1).  A change in capillary (or 
vessel) density agrees with other US-induced angiogenesis studies (Barzelai et al. 2006, Chappell 
et al. 2006, Song et al. 2008, Bohmer et al. 2010).  Also VEGF expression changes have been 
measured in ischemic studies conducted on skeletal and cardiac muscle (Reher et al. 1999, Wang 
et al. 2004, Nakajima et al. 2004, Barzelai et al. 2005). The co-occurrence of increased VEGF 
expression and increased capillary density was found at 0.7 MPa in this study, which disagrees 
with the notion put forth by Barzelai et al. (2005) that very low intensity US can be used to 
induce an angiogenic response.  The data herein shows strong agreement with different studies 
that used Pr ≈ 0.8 MPa, and showed increases in capillary density, however (Song et al. 2004, 
Chappell et al. 2006, 2008).   
As Pr increases UCAs undergo a dynamic range of events ranging from oscillation to 
collapse (Holland et al. 1996).  Oscillation and collapse produce secondary effects including 
microstreaming, hemodynamic disturbances, and brief duration high temperatures and pressures 
in the surrounding media (Didenko et al. 1999, Suslick et al. 2001).  The range of Prs was chosen 
because it encompasses the entire range of microbubble effects.  Also, it includes only Pr 
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quantities that are FDA regulated (mechanical index = 1.9) (ODS 1998, Holland & Apfel 1989, 
Apfel & Holland 1991, NEMA 2009).  With US exposure to low Pr, UCAs oscillate, therefore 
with Pr = 0.1 MPa, virtually no bubbles undergo collapse.  By 0.7 MPa, however, approximately 
60% of exposed UCAs undergo collapse with oscillation co-occurrence; this percentage rises to 
100% by 1.9 MPa (King et al. 2010, Figure 3.6).  Because this study demonstrated an angiogenic 
response onset at 0.7 MPa, it suggests that UCA collapse is necessary for an angiogenic 
response.  Chapter 6 and 7 show agreement with the findings in this chapter showing increased 
bioeffect and angiogenic responses when collapse occurs and increased VEGF expression at 10x 
[UCA] when 0.7 MPa is used, respectively. 
 This study and Chapter 6 determined Pr was significant at 10x and 5x [UCA] 
respectively.  Chapter 7 assessed [UCA] and found significance at a set Pr.  Pr X [UCA] was 
expanded in terms of the angiogenic response (5 DPE) to determine if the interaction term was 
significant (Table 8.1 and 8.2).  Not only was significance found, but higher VEGF expression 
also corresponded relatively well to higher capillary density, particularly in the 10x [UCA] case. 
Thus far, Pr, [UCA], and Pr X [UCA] have been explored with respect to the induction of 
bioeffects that lead to an angiogenic response.  These studies found that the presence of UCAs 
increases both acute and 5 DPE responses, Pr was significant for determining the extent of the 
responses, and that there was an interaction between Pr and [UCA] to elicit the responses.  These 
findings suggest that collapse, or inertial cavitation is necessary for the optimal response because 
the oscillation regime (at 0.1 MPa) did not show significance for biological effects nor the 
angiogenic response when compared to the control.  The biophysics of the UCA is further 
explored with respect to bioeffects and the angiogenic response in the next chapter by narrowing 
the Pr range to observe responses and discuss UCA radial expansion and collapse trends. 
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CHAPTER 9: ULTRASOUND CONTRAST AGENT COLLAPSE 
POTENTIATES ANGIOGENIC RESPONSE 
 
The findings from the previous studies include both a [UCA] and Pr dependency of the 
angiogenic response, which agrees with results from other literature that use a range of [UCAs] 
and Prs in ischemia related US-UCA therapy.  Concentrations ranging from no UCAs to bolus, 
and Prs ranging from 40 kPa to 4.5 MPa have all been used and demonstrated some effectiveness 
(Song et al. 2002, Barzelai et al. 2005, Chappell et al. 2006, Chappell et al. 2008, Zen et al. 2006, 
Song et al. 2004, Korpanty et al. 2005, Fuji et al. 2009, Johnson et al. 2010, Bohmer et al. 2010, 
Johnson et al. 2011, in press).  Numerous researchers have documented Pr’s effect on UCAs 
(Atchley et al. 1988, Stride et al. 2003, Sboros et al. 2008, Santin et al. 2010), which makes 
broad ranges of Pr and [UCA] curious.  There is a well-established body of literature detailing 
the progression of UCAs from oscillation (stable cavitation) to collapse (inertial cavitation) with 
increasing Pr and the effects that this perturbation has on the surrounding media (Wu et al. 1997, 
Stride et al. 2003, Marmottant et al. 2005, Sboros et al. 2008, King et al. 2010).  Both oscillation 
and collapse have been observed with in vitro single bubble experiments in this lab (Ammi et al. 
2006b, Haak et al. 2007, King et al. 2010) and theoretically modeled (Lauterborn et al. 1976, 
Marmottant et al. 2005, King et al. 2010, 2011).  More sophisticated models have been attempted 
to address the complexity of in vivo models, but in vivo variability slows the adaptation of a 
model robust enough to be applicable in all scenarios (Qin et al. 2010).   
Bioeffect studies have attempted to address the effects of US-UCA from a biological 
standpoint.  Hemorrhage, premature ventricular contractions, lesions, and microvascular 
disruptions have all been noted to occur with US-UCA exposure (Skyba et al. 1999, Dalecki et 
al. 1995, Chappell et al. 2006, Zachary et al. 2006, Miller et al. 2008).  However, the correlation 
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to bubble dynamics is rarely, if at all, studied with respect to bioeffects or therapy.  Therefore, 
the question that plagues most bioeffect and therapeutic studies is: “Is collapse necessary for a 
response, and if so, is there a particular level of collapse that will optimize this response?”  The 
intent herein is to address this question for the specific case of US-UCA-induced angiogenesis. 
Because the collapse incidence of the UCA used in this study, Definity®, has been 
extensively examined in vitro in this lab (Ammi et al. 2006b, Haak et al. 2007, King et al. 2010), 
of particular interest is to understand how the bubble dynamics related to both acute bioeffects 
and subsequent angiogenesis.  Therefore, a narrow range of Pr was used to assess the acute 
bioeffects and subsequent angiogenic response via a theoretical correlation of bubble dynamics 
to in vivo experiments.  Using thirty-six rats 5 different Pr were explored: 0.1, 0.3, 0.5, 0.7, and 
0.9 MPa.  There were 3 control rats and an n = 3 for each Pr.  US exposure settings were: f = 1 
MHz, PRF = 10 Hz, PD = 10 µs, ED = 5 min, and a 10x [UCA].  Capillary density, vascular 
permeability and VEGF expression were used to assess bioeffects and the angiogenic response.  
All assessments were normalized to the control.  Bilateral exposures on lateral sites were 
exposed and the medial site served as the control. 
9.1 Results 
 
Capillary density 
 Two-way ANOVA demonstrated that DPE and Pr, but not DPE*Pr were significant for 
capillary density (p < 0.05, p < 0.001 and p > 0.05, respectively) (Figures 9.1).  Multiple 
comparisons showed that 0.1 MPa was not significantly different from the control (p > 0.05), but 
0.7 MPa was significantly different from the control and 0.1 MPa (p < 0.001), and 0.9 MPa was 
significantly different from 0.1 MPa at 5 DPE.   
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Figure 9.1: Normalized capillary density at 0 DPE (light grey) and 5 DPE (dark grey) across Pr.  
*p < 0.001 with respect to 0.1 MPa. 
 
Evans blue dye (vascular permeability) 
 One-way ANOVA showed that EBD leakage was significant with Pr (p < 0.001).   EBD 
leakage demonstrated an increasing trend of permeability as the Pr increased (Figure 9.2).   
Multiple comparisons showed that the control was not significantly different from the 0.1 MPa 
group, but 0.3, 0.5, and 0.7 MPa were significantly different from the control and 0.1 MPa (p < 
0.001). Further, 0.7 MPa was significantly different from 0.3 MPa (p < 0.01), and 0.9 was 
significantly greater than the other pressure groups (p < 0.001). 
 
Figure 9.2: Normalized Evans blue dye as a marker for permeability at 0 DPE across Pr.  *p < 
0.001 with respect to the control, +p < 0.001 with respect to 0.1 MPa, #p < 0.001 with respect to 
0.3 MPa, and ^p < 0.001 with respect to 0.5 MPa, ~p < 0.001 with respect to 0.7 MPa. 
 
Maximal radial expansion (MRE) 
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 The maximal radial expansion (MRE) was calculated using the Marmottant equation (Eq. 
3.35), (Figure 9.3) with the parameters listed in Table 9.1.  According to the Marmottant theory, 
bubbles collapse when R/Ro reaches approximately 1.5 (or less) (Marmottant et al. 2005, King et 
al. 2010, 2011).  At Pr = 0.9 MPa the MRE ~ 9, suggesting that a large percentage of these 
UCAs undergo collapse. 
Table 9.1: Summary of values used in the Marmottant equation simulation. 
F 0.93 MHz ρblood 1060 kg/m3 
Ro 1 µm Po 101.3 x 10
3 Pa 
Pr 0.1, 0.3, 0.5, 0.7, 0.9 MPa σbubble 0 N/m 
No. of cycles 10 σblood 0.046 N/m 
c 1500 m/s χ 0.38 N/m 
κ 1.06 Rbuckling 0.99Ro 
µblood 0.005 Pa*s Rbreakup 1.5Ro 
ks 0.5 x 10-9 N Rrupture 1.08Ro 
 
 
Figure 9.3: Maximal radial expansion of UCAs at varied Pr. 
 
 According to King et al. 2010, Definity® exhibits increasing percentage collapse with 
increasing Pr, where at 0.9 MPa approximately 85% of UCAs collapse at f  = 1 MHz.  If the 
percent collapse is compared to the EBD leakage, we see that the trends are  similar (Figure 9.4). 
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Figure 9.4: A trend comparison of relevant portion of percent collapse (left, King et al. 2010) and 
normalized vascular permeability (right).  An overlay of percent collapse and absolute vascular 
permeability (bottom, also in Figure 9.2) the collapse curve was shifted. 
 
Vascular endothelial growth factor-A (VEGF) 
 Pr was a significant parameter for VEGF expression (p < 0.01) as determined by one-way 
ANOVA.  The greatest level of VEGF expression occurred at 0.7 MPa, rising to significance 
when compared to 0.1, 0.3 and 0.5 MPa (p < 0.01).  The VEGF expression decreased at 0.9 MPa.  
Where there is oscillation only, 0.1 MPa, demonstrated the lowest amount of VEGF expression. 
(Figure 9.5). 
9.2 Discussion 
 
 This study found that an increase in vascular permeability (EBD leakage, Figure 9.2) 
coincides with the occurrence of increased VEGF expression and capillary density at 0.7 MPa 
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(Figures 9.1 and 9.5) which agrees with the findings in Chapter 8.  Previous in vitro experiments 
concluded that Definity®’s collapse threshold (5% occurrence rate) was approximately ~ 0.2 
MPa—Definity® reaches 100% collapse by ~ 1.0 MPa (King et al. 2010).   Therefore collapse 
co-occurs with US-UCA induced angiogenesis.    
 
 
Figure 9.5: Relative VEGF expression at 5 DPE across Pr.  *p < 0.01 with respect to 0.1 MPa, 
+p < 0.01 with respect to 0.3 MPa, #p < 0.01 with respect to 0.5 MPa, ^p < 0.01 with respect to 
0.9 MPa. 
 
UCAs have a resonant frequency at which they oscillate most efficiently that is 
dependent on bubble size.  An activated vial of Definity has a range of bubble sizes with the 
following descriptors for its profile: a mean diameter range of 1.1 to 3.3 µm, 98% of bubbles are 
less than 10 µm, but the maximum diameter is 20 µm (Definity package insert).  Because of the 
presence of larger bubbles, the resonant frequency of Definity® is on the order of fo = 1 MHz, 
which is comparable to the frequency used in this study (and other therapeutic applications).  
Therefore, when sonicating at the approximate resonant frequency of the UCA, we can assume 
that there is a predictable pattern of behavior for the oscillation regime (0.1 MPa, in this study). 
Chapter 3 discussed the fitting of theoretical equations to single bubble experiments.  
Further, Chapter 5 estimated a volume fraction that suggested that the theoretical constructs 
could be used as an approximation.  With this trail of evidence, we can link the theory to the 
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bioeffects noted in this study.  Changes in vascular permeability did not occur until the 5% 
collapse threshold, determined by in vitro experiments, was exceeded, signifying that collapse is 
required to elicit the acute bioeffect.   As in previous chapters, capillary density at 0 DPE 
remained constant.  
The literature proposes that collapse is necessary for angiogenesis to occur.  However, 
reports that microbubble destruction leads to an angiogenic response was not supported by 
bubble characterization or theoretical simulations (Chappell et al. 2006, Chappell et al. 2008, 
Song et al. 2008, Geis et al. 2009).  Herein we saw that the angiogenic response is not initiated 
(ie. does not reach significance) until after Definity reaches an approximate 60% collapse 
occurrence.  Figure 9.1 and 9.5 demonstrated increases in both 5 DPE capillary density and 
VEGF expression.  Thus the notion of collapse being required for both the bioeffect and the 
subsequent angiogenic response is supported.  In general, the work herein shows agreement with 
theoretical models demonstrated by Miao et al. (2008) with vessel perturbation (where wall 
stress exceeds the capillary strength) being analogous to increased permeability eventually 
leading to probably rupture at Pr  = 0.2 MPa (see more detail in Chapter 3.4).   
To extend the findings thus far, the Marmottant model can be used to predict the Pr at 
which UCAs collapse.  Up to now, the biological findings for increases in vascular permeability 
have been observed with increasing Pr.  This chapter demonstrated that the in vitro trend for 
UCA collapse is similar to that of the induction of increased vascular permeability up to 0.9 MPa 
even though in vitro experiments used a single bubble setup.  The next chapter examines the 
following: if the Marmottant equation can be used to explain the cause of bioeffects and the 
subsequent angiogenic response for all Prs in Chapters 7 to 9, if the theoretical simulation aligns 
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with the in vitro data from King et al. 2010, and finally if both can be connected to the in vivo 
data presented in this thesis. 
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CHAPTER 10: UCA BIOPHYSICAL EXPLORATION: OSCILLATION OR 
COLLAPSE? 
 
Based upon previous concentration and volume fraction calculations the single bubble 
model is appropriate for describing UCA dynamics in vivo with the [UCA]s used herein.  This 
chapter focuses on the biophysics of the bubbles and their associated biological implications in 
an effort to further explore the cause of acute bioeffects.  Chapter 9 demonstrated a trend 
similarity between the collapse of UCAs and increases in vascular permeability.  This chapter 
will expand upon the findings in Chapter 6 through 9 and discuss what is presumed to be 
occurring to the UCAs in the beam of the transducer during exposures. 
Table 10.1: Summary of values used in simulations. 
f 0.93 MHz ρblood 1060 kg/m3 
Ro 1 µm Po 101.3 x 10
3 Pa 
Pr 0.1, 0.3, 0.5, 0.7, 0.9, 1.3, 1.9 MPa σbubble 
0 N/m 
No. of cycles 10 σblood 0.046 N/m 
c 1500 m/s χ 0.38 N/m 
κ 1.06 Rbuckling 0.99Ro 
µblood 0.005 Pa*s Rbreakup 1.5Ro 
ks 0.5 x 10-9 N Rrupture 1.08Ro 
 
Up to now, a range of Prs have been explored (0.1 to 1.9 MPa).  Table 10.1 lists the 
constants used for the Marmottant equation modeling bubble radius and driving pressure as a 
function of time.  Figure 10.1 shows pressure and radius as a function of time for “low Pr”: 0.1, 
0.3, 0.5 and 0.7 MPa. When the bubble is oscillating, there are low amplitude decreases and 
increases in bubble radius, involving equal contraction than expansion. Even at relatively low Pr 
the bubble expansion may be non-uniform due to the density, surface tension and viscosity of 
blood.  In addition, the value of the surface dilation viscosity slightly alters curve, and has been 
reported to be anywhere from 0.5 x 10-9 to 12 x 10-9 N (Marmottant et al. 2005, Goertz et al. 
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2007, Santin et al. 2010).  From this simulated bubble reaction to US, we note that the UCA 
becomes more susceptible to slow large amplitude expansions followed by rapid contractions as 
Pr increases eventually leading to UCA collapse (Figure 10.1 and 10.2). 
 
Figure 10.1: Radial displacement and driving pressure for low Pr. 
 
Figure 10.2: Radial displacement and driving pressures for high Pr. Note that the initial radius of 
the UCA is 1 x 10-6 m ( or 1 µm); the scale of the radius on the right is of the 10-5 order. 
 Figure 10.3 shows the maximal radial expansion (MRE) of the Definity bubbles at 
various Prs. The MRE ranges from 1.03 at 0.1 MPa to 16.58 at 1.9 MPa. The general acceptance 
for when a bubble will collapse is when R/Ro > 2, though recent studies suggest that collapse 
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occurs at MREs > 1.1 (King et al. 2011).  Thus the MRE from the Marmottant model 
approximates the Pr at which 100% of UCAs collapse.   
 
Figure 10.3: Maximal radial expansion for all experimental Pr, where a value of 1 means that 
maximal expansion is equal to the initial radius, ie. no expansion. 
 
Once the Pr reaches 0.9 MPa there is a much slower and considerably larger expansion 
that is questionably beyond the confines of a lipid-shelled bubble.  This is followed by a rapid 
contraction depicted in Figure 10.2 as an infinite radius slope, therefore the fact that collapse has 
occurred can be derived.  From separate in vitro experiments it was found that the onset of 
collapse is not finite, but rather collapse occurs with greater frequency as Pr increases (King et 
al. 2010).  This is possibly due to the range of bubble sizes present in a vial of Definity®, so 
bubbles respond slightly different depending upon how close to resonance the UCA is.  
Therefore microstreaming co-occurs with collapse at Prs less than about 1.0 MPa, at which point 
100% of UCAs collapse (Figure 3.6) (King et al. 2010).   
 Microstreaming is of particular interest because of its ability to alter the normal shear 
stresses present intravascularly.  As mentioned in Chapter 4, as little as 0.075 Pa is linked to 
increased permeability and enhanced endothelial cell biosynthetic capabilities.  Because shear 
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stress is directly proportional to bubble radius, and radius is proportional to Pr, as Pr increases, 
shear stress increases.  Figure 10.4 shows the shear stress as a function of radius for a Pr up to 
1.9 MPa.  From Eq 3.43 to 3.45 we find that a radius change of + 0.002 nm is where the vascular 
shear stress exceeds 0.075 Pa, which suggests that US induced microstreaming via bubble 
oscillation affects the vascular endothelium at even very low Pr, excluding any US radiation 
force effects.  From the data gathered thus far, though 0.1 MPa can induce changes in shear 
stress, the changes are insufficient to elicit changes in vascular permeability or the angiogenic 
response with one exposure. 
 
Figure 10.4:  Shear stress as a function of radius.  When Pr = 1.9 MPa a range of shear stresses 
are produced as the UCA grows and undergoes IC.   
For a microbubble to produce double the shear stress naturally occurring intravascularly, 
a radial expansion of only 0.01 nm is needed.  In Figure 10.1 the oscillation regime produced 
high enough radial oscillations to locally increase the shear stress experienced by endothelial 
cells.  Shear stresses produced with radial expansions of 0.5µm are on the order of several 
hundred Pa.  Combining the physical effect of microstreaming-induced shear stresses and 
collapse to the acute bioeffects presented in previous chapters, the trend of vascular permeability 
agrees with the trend for collapse as seen in Figure 10.5 and in Chapter 9, Figure 9.4.  For Figure 
10.5, the absolute values for vascular permeability were in µg of dye/g of tissue.  The EBD 
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leakage values were shifted down by 10 µg/g (ie. 10 ug/g was subtracted from the absolute 
permeability value such that the curve intersected (0, 0) and so that the curves could be plotted 
on top of one another.  Noting that the percentage of collapse increases with increasing Pr, it can 
be inferred that the percentage of oscillating bubbles decreases (from the total number of bubbles 
at t = 0) as we increase Pr.  It should be noted that this graph does not show a one-to-one 
correspondence with percentage leakage and percentage collapse, but rather that the trends are 
comparable.  The pressure at which moderate leakage and maximal angiogenesis occurred for the 
studies presented is at Pr = 0.7 MPa—the pressure where approximately 60% of UCAs collapse. 
Further, if we assess the angiogenic responses presented in previous chapters, we find 
that 0.9 MPa is not only the point at which the VEGF expression declines (from the peak VEGF 
expression value at 0.7 MPa), but it is also the approximate onset point of inertial cavitation of 
the UCAs (Figure 10.2).   
 
Figure 10.5: Overlay of experimental Pr-associated changes in vascular permeability with the 
percentage collapse of Definity®. Blue dots represent the average in vitro collapse data and 
fitting of the collapse data with a logistic regression curve (solid green) with a 95% confidence 
interval (dashed green).  Red dots indicate the average absolute vascular permeability from 
Chapter 7 to 9. 
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Ultimately, acute bioeffects should be evaluated with a risk/benefit measurement for 
therapeutic applications.   In an effort to develop an understanding of the path from acute 
bioeffects to the end goal of therapy, examining the tissue at several time points after exposure 
will provide information regarding of the risk of US-UCA therapy.  This investigation will 
specifically further the understanding of not only the connection of biophysical events to tissue-
level effects, but also the nature of the damage that is induced for the therapy.  The next chapter 
explores the tissue-level damage from US-UCA exposure with respect to collapse and the 
induction of angiogenesis.  
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CHAPTER 11: TISSUE EFFECTS OF US-UCA-INDUCED 
ANGIOGENESIS 
 
Inflammation, vascular permeability and capillary density have been assessed at 0 DPE 
for acute damage, where a reduction in capillary density was indicative of lumen disruption.  
This chapter focuses on the tissue effects, which are not seen until a minimum of 8 hours after 
exposure to ultrasound.  Studying the histological progression of the bioeffect leading to the 
angiogenic response adds value to the risk/benefit notion that is implied with therapeutic 
applications.   
In wound healing, the general progression is as follows: homeostasis, inflammation, 
proliferation, and remodeling.  Only minutes pass prior to the formation of platelet aggregates 
once a vessel lumen is disrupted.  This effect may appear as hemorrhage on cross section of the 
muscle.  The first signs of tissue damage are nonuniformity in the Z-lines and A-lines at 
approximately 8 hours after the damage occurs.  Several hours later, signs of coagulative 
necrosis, demonstrated as blurry nuclei and overall lighter pigmentation appear.  There also may 
be silhouettes of cells without definite form that appears with damage. Then, neutrophils and 
macrophages appear at the site to phagocytose debris (inflammatory infiltrate).  These cell types 
release several factors for angiogenesis, including VEGF.  VEGF begins the proliferative phase 
of angiogenesis by approximately 48 hours after injury as discussed in Chapter 2.  After which, 
in wound healing, there is maturation and remodeling phase.   
To examine the effect of US and UCA on the skeletal muscle, a histological assessment 
was completed.  This study used 12 animals to test 4 Prs (Pr = 0.1, 0.7, 1.3 and 1.9 MPa) at 4 
time points 0, 8, 16, and 24 hours post exposure (HPE).  Two sites on each gracilis muscle were 
exposed for a total of 4 exposure sites per animal (N = 3/HPE group).  This tissue effect study 
was carried out to assess whether the cause of the angiogenic response was ‘frank damage’ (as in 
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myocyte damage) or if it was solely a permeability effect (ie. minor vascular endothelial cell 
perturbation).  H&E was used to observe tissue level effects for all time points. 
11.1 Results 
 
The 0 HPE myocytes show no difference from normal skeletal muscle for all Pr groups.  
However, hemorrhage was inconsistently present at higher Prs (Figure 11.1). 
 
Figure 11.1: 0 HPE Histological images.  Top left: 0.1 MPa, Top right: 0.7 MPa, Bottom left: 1.3 
MPa, Bottom right: 1.9 MPa  White bar = 50 µm. 
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The 8 HPE myocytes demonstrated some nucleus internalization and hemorrhage at 1.3 and 1.9 
MPa, but were normal at 0.1 and 0.7 MPa (Figure 11.2).  Because the muscle was sliced to be 3 
µm thick, some artifacts like tissue folds appear in section. 
 
Figure 11.2: 8 HPE Histological images.  Top left: 0.1 MPa, Top right: 0.7 MPa, Bottom left: 1.3 
MPa, Bottom right: 1.9 MPa  Arrow shows nucleus internalization, white star shows 
hemorrhage.  White bar = 50 µm. 
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By 16 HPE, the skeletal muscle began to show signs of coagulative necrosis along with 
hemorrhage, nucleus blurring, and A- and Z-line disruption when exposed to Pr greater or equal 
to 1.3 MPa.  While the myocytes were normal at 0.7 MPa, there is notable capillary engorgement 
and possible arteriogenesis.  The 0.1 MPa group was normal (Figure 11.3). 
 
Figure 11.3: 16 HPE Histological images.  Top left: 0.1 MPa, Top right: 0.7 MPa, Bottom left: 
1.3 MPa, Bottom right 1.9 MPa.  The white star shows hemorrhage, the arrow shows nucleus 
internalization, and the plus sign shows inflammatory infiltrate.  The asterisk shows contraction 
bands.  White bar = 50 µm. 
*
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Figure 11.4: 16 HPE Histological image showing ligher area where coagulative necrosis (inside 
black circle) occurred.  The white star shows hemorrhage. 1.9 MPa  White bar = 200 µm. 
 
The 16 HPE group also demonstrated observable changes in pigmentation indicative of 
coagulative necrosis (Figure 11.4).  The lighter pigmentation is the result of loss of intracellular 
structures and cytoplasm dominance. The necrosis occurs downstream of hemorrhage, 
suggesting that the tissue is no longer receiving oxygen and/or nutrients. 
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At 24 HPE, there were definite signs of coagulative necrosis for all animals exposed at 
1.3 and 1.9 MPa.  No damage was observed at 0.1 or 0.7 MPa (Figure 11.5). 
 
 
Figure 11.5: 24 HPE Histological images.  Top left: 0.1 MPa, Top right: 0.7 MPa, Bottom left: 
1.3 MPa, Bottom right: 1.9 MPa  The white star shows hemorrhage, and black arrows show 
contraction bands. White bar = 50 µm. 
11.2 Discussion 
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This is the first study to assess what happens histologically at various time points 
following US-UCA exposure.  The assumption for the mechanistic motivation of US-UCA-
induced angiogenesis is that it is damage driven.  This study shows that it is not damage, but 
rather an increase in permeability, caused by the dynamic motions of the UCAs, that potentiate 
the increases in VEGF expression (and capillary density) noted in previous chapters.   
This study showed that mere UCA oscillation (0.1 MPa) did not cause any measurable 
amount of damage to the muscle.  Previous chapters also demonstrated that there was no increase 
in EBD leakage acutely and thus no angiogenic response at oscillatory pressures. However, 
measurable differences occur between 0.1 and 0.7 MPa, as shown histologically here, and also in 
Chapter 9.  Along with increases in acute permeability a dramatic increase in VEGF expression 
presented at 0.7 MPa.  Histologically, at 0.7 MPa there is no change to the muscle at 0 and 8 
HPE, but by 16 HPE there are capillaries that are possibly engorged.  This observation supports 
the notion that US-UCA induced angiogenesis is a vascular event—where the vascular 
endothelial cells sense the mechanical disturbance and activate increases in permeability. 
Chapter 9 and 10 expounded upon the regime of collapse, so it is known that about 60% of 
microbubbles exposed to 0.7 MPa undergo inertial cavitation (with oscillation co-occurrence).  
Collapse may very well enhance the mechanical disturbance that US alone provides.  Heating 
(maximal temperature increase) at 0.7 MPa is an estimated 0.47oC, and thus is insufficient to 
explain the difference.  Related studies have assessed US and UCA induced arteriogenesis and 
have noted engorged capillaries (Song et al. 2004, Chappell et al. 2008), which supports the 
histological findings herein. 
Increasing the Pr to 1.3 MPa (where there is 100% collapse) causes a paradigm shift 
toward damage for all time points.  Multiple slides demonstrated nuclei internalization (Figure 
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11.2).  Internalization is a nonspecific finding, but the occurrence of this event was found to 
increase with the Prs greater than 0.7 MPa.  Also, signs of coagulative necrosis with pale 
pigmentation appeared at 1.3 and 1.9 MPa (Figure 11.4).  Chapter 4 briefly discussed the concept 
of a risk/benefit for using US and UCAs to induce angiogenesis under the assumption that the 
therapy was driven by frank damage.  However, what this chapter indicates is when damage 
becomes obvious histologically, the therapy is no longer beneficial.  Previous chapters insinuated 
this by demonstrating high increases in permeability acutely that corresponded to lower VEGF 
expression at 5 DPE.   A further increase to 1.9 MPa displays even more damage markers 
(Figure 11.1, 11.2, 11.3, 11.4, 11.5).  The curious thing is that all of the Prs used in this study fall 
at or below an MI of 1.9 (AIUM/NEMA 1998, ODS 1998, NEMA 2009).  Because a 1 MHz 
transducer was used, mechanical indices of 0.1, 0.7, 1.3 and 1.9 correspond to the 0.1, 0.7, 1.3 
and 1.9 MPa Prs used respectfully.  Therefore, therapeutically speaking, the MI is not necessarily 
a useful parameter—particularly when UCAs are involved.  One study used a Pr above 0.7 MPa 
and confirmed therapeutic effects (Fuji et al. 2009).  However, that study used a higher 
frequency transducer, where the collapse threshold (Pr) was greater (Ammi et al. 2006b, King et 
al. 2010).   
The questions remain, though, if UCA collapse occurs intravascularly, why are effects 
seen in the tissue, and why is there no reduction in capillary density in previous chapters?  Tissue 
level effects are seen due to US and UCA induced ischemia, resulting from damaged vasculature 
(Figure 11.6).  Because homeostasis is the first stage in wound healing, the clotted vessel is no 
longer providing nutrients or oxygen to the surrounding tissue.  Biologically speaking, the 
distance between two capillaries can be no greater than the diffusion area of oxygen for a given 
time frame to prevent hypoxia from developing.  What is shown in this chapter is that the 
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myocytes are displaying damage due to lack of blood supply (Figure 11.4), and possibly high Pr 
and temperature generated by mass concurrent collapsing.  So why is there not a corresponding 
decrease in acute capillary density?   
 
Figure 11.6: Marked hemorrhage at 8 HPE with a 1.9 MPa exposure.  White bar = 50 µm. 
 
Capillaries comprise only a portion of the conduits that carry blood and oxygen to tissues.  
Capillaries were assessed herein because angiogenesis begins from capillary sprouting, by their 
endothelial cells migrating toward regions of hypoxia, and because it is used by other similar 
studies.  The tissue level effects could be due to damage caused to arterioles.  Also, capillary 
density is a 2-D measurement and does not take into account the complex entanglement that is 
found in situ.  In addition, capillary density may vary from one batch of animals to the next, and 
that the 0 DPE groups and 5 DPE groups were comprised of different animals.  These are the 
reasons why VEGF expression was chosen to support angiogenesis elicitation.    
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Up to now, several factors for US-UCA induced angiogenesis have been investigated in 
terms of bioeffects leading to therapy: [UCA] , Pr,  UCA collapse (Johnson et al. 2010, Johnson 
et al. 2011 in press, Chapter 6)), UCA biophysics, and tissue-level manifestations of exposure.  
From these studies it was found that: UCAs enhance US-induced angiogenesis, vascular 
permeability changes precede (possibly potentiate) the angiogenic response, there is a Pr-
dependency, and thus collapse–dependency of the bioeffect and therapy, and that Prs > 1.3 MPa 
cause deleterious effects.   
Even though some insight to mechanisms has been gained, US has several other 
parameters that have been implicated with bioeffects and therapeutic applications, such as PRF 
and ED.  These “non-UCA” US parameters have the potential to influence angiogenesis by 
affecting the acute response.  Therefore, the next few chapters assess PRF, ED, and total number 
of pulse’s (NP) roles in the angiogenic response, including acute bioeffects.  These chapters not 
only add to the understanding of US-UCA induced angiogenesis, but potentially provide 
optimization criteria. 
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CHAPTER 12: THE ANGIOGENIC RESPONSE IS INFLUENCED BY 
PULSE REPETITION FREQUENCY 
 
 While literature states that bioeffects have been negatively correlated to PRF and 
positively correlated to Pr, separate experiments confirmed that UCA collapse, which is Pr 
dependent, is independent of PRF (Ammi et al.  2006b, Haak et al. 2007).  With that stated, a 
few in vitro studies have explored the role that PRF plays in the induction of bioeffects when 
UCAs are used.  Buldakov (2008) reported increased cell lysis, necrosis, apoptosis, and cellular 
death with lower PRFs.  Other detrimental bioeffects have been suggested to occur are 
negatively correlated to PRF (Apfel and Holland 1991, Miller and Thomas 1995; NCRP 2002, 
Yeh et al. 2008).  In addition, studies have found nephron injury, hemolysis, extravasation, and 
cell sonoporation with PRFs ranging from 3.6 to 40 kHz (Skyba et al. 1998, Miller et al. 2001, 
2007, Miller and Quddus 2000, Williams et al. 2007).  While in vitro studies allowed some 
insight to be gleaned about the relationship between PRF and bioeffects, this insight applies only 
to the analogous in vivo case of bolus injection.   
One study used an in vivo model with a bolus injection and gathered similar results to the 
in vivo studies: lower PRFs caused more of a bioeffect (extravastion) (Song et al. 2002).  
Another study using an ex vivo model found PRF to be negatively correlated with cell death and 
subsequent extravasation of red blood cells with UCAs being infused (Samuel et al. 2006, 2009).  
A logical deduction, therefore, is that in vivo bioeffects with infused UCAs will display similar 
PRF dependency.   
The literature postulates that therapeutic applications of ultrasound rely on the induction 
of bioeffects via UCA destruction (Song et al. 2008, Chappell et al. 2008, Fuji et al. 2009).  Thus 
far, this thesis agrees, suggesting that the anigogenic response is contingent upon acute bioeffects 
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and these bioeffects require collapse (Chappell et al. 2006, Johnson et al. 2010, Johnson et al. 
2011 in press (Chapter 6)).  The exploration of PRFs relationship to bioeffects has, for the most 
part, been investigated in vitro or ex vivo.  No work has been done to assess the effect of PRF on 
subsequent therapy, however.  Therefore there remains some uncertainty about the response in 
vivo and if/how it specifically relates to an angiogenic response.  To address this uncertainty, this 
study sought to explore the effect of PRF in US-UCA induced angiogenesis both acutely (0 
DPE) and at 5 DPE.  Using twenty-four rats, four separate PRFs were assessed: 5, 10, 20 and 40 
Hz.  US exposure parameters were: Pr = 0.7 MPa, f = 1 MHz, PRF = 5, 10, 20, 40 Hz, PD = 10 
µs, ED = 5 min, and 10x [UCA].  As before, bilateral sites were exposed and capillary density, 
vascular permeability and VEGF expression were used to characterize the responses. 
12.1 Results 
 
Capillary density 
 Capillary density was normalized to the control and results are displayed in Figure 12.1.  
Two-way ANOVA determined that DPE and DPE*PRF were not significant parameters for 
capillary density.  However, PRF was found to be significantly different for capillary density (p 
< 0.05) (Figure 12.1).  Multiple comparisons demonstrated that the 10 Hz exposure was 
significantly different from 40 Hz at 0 DPE (p < 0.05) and that 40 Hz at 0 DPE was significantly 
different from 40 Hz at 5 DPE (p < 0.05). 
Evans blue dye (vascular permeability) 
 One-way ANOVA was used to test for significance for vascular permeability with PRF.  
EBD leakage was normalized to the control and is shown in Figure 12.2.  PRF was a significant 
parameter for vascular permeability (p < 0.001).   EBD leakage demonstrated a decreasing trend 
of permeability as the PRF increased (Figure 12.2).  Multiple comparisons revealed that the 5 Hz 
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group was significantly different from the 10, 20 or 40 Hz groups, and that 20 Hz was 
significantly greater than 40 Hz (p < 0.001).  
 
Figure 12.1: Normalized capillary density at 0 DPE (light grey) and 5 DPE (dark grey) across 
PRF.  *p < 0.05 with respect to 10 Hz. 
 
 
Figure 12.2: Normalized Evans blue dye as a marker for permeability at 0 DPE across PRF.  *p < 
0.001 with respect to 5 Hz, +p < 0.001 with respect to 20 Hz. 
 
 
Vascular endothelial growth factor-A (VEGF) 
 VEGF expression in fold change was significant across PRF (p < 0.05) as determined by 
one-way ANOVA.  The 10 Hz group had the greatest amount of VEGF expression.  The VEGF 
expression decreased at 20 Hz and remained low at 40 Hz (Figure 12.3). 
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Figure 12.3: Relative VEGF expression at 5 DPE across PRF.  *p < 0.01 with respect to 10 Hz, 
+p < 0.01 with respect to 5 Hz. 
12.2  Discussion 
 
 Damage, as measured by a reduction in capillary density, was expected to occur with 
decreasing PRF, because vasculature refill is allowed at lower PRFs.  The data agree with this 
notion showing that acutely as PRF decreases so does capillary density (Figure 12.1).  The 40 Hz 
demonstrated an acute increase in capillary density, which was unexpected.  EBD leakage 
confirms trends seen in previously published literature with higher extravasation of dye resulting 
from lower PRFs (Figure 12.2) (Miller and Quddus 2000).  Typically, lower PRFs (~ 10 Hz) are 
used when UCAs are infused to allow refill of the vasculature at the site of exposure.  If pulsing 
occurs too often, the [UCA] effectively decreases.  Studies have shown that PRFs < 100 Hz, over 
time does not afford sufficient refill, and thus effects dwindle to noise levels with exposure 
durations in excess of 20 ms (Samuel et al. 2009).   
 Though the 5 DPE capillary densities remained constant across PRF, VEGF displayed a 
trend that suggests there is an optimal PRF window at ~ 10 Hz for angiogenesis induction 
(Figure 12.1 and 12.3).  Capillary density was chosen as a marker for angiogenesis because it has 
repeatedly been used in similar literature and confirmed to be positively correlated with tissue 
perfusion (Korpanty et al. 2005,Chappell et al. 2006, Barzelai et al. 2006, Chappell et al. 2008).  
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However, as previously mentioned, capillaries form complex networks, and histological 
assessment only provides a two-dimensional account, VEGF expression was also used.   
VEGF is a well-known pivotal player in angiogenesis.   VEGF is present throughout the 
process of the angiogenic response, peaking at about 4-7 days in first intention wound healing 
(Bates et al. 2002, Mariotti et al. 2006, Barrientos et al. 2008).  The data herein show that VEGF 
levels did reach significance, which has been shown to occur with exposure to ultrasound (Reher 
et al. 1999, Korpanty et al. 2005, Barzelai et al. 2006).  Because higher levels of VEGF were 
expressed at lower PRF values and lower PRFs are associated with increased bioeffects, this 
supports that therapy is motivated by vascular permeability changes.   
Like PRF, exposure parameters like exposure duration (ED) may also influence the 
response.  In an effort to optimize the therapy and assess the risk/benefit of long vs. short 
exposures, the next chapter examines ED. 
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CHAPTER 13: EXPOSURE DURATION IMPACTS ACUTE 
PERMEABILITY BUT NOT THE ANGIOGENIC RESPONSE 
 
One of the main considerations for therapeutic application of US and UCA is time.  US 
therapy includes two time properties: pulse duration (PD) and exposure duration (ED). It is a 
well-known fact that as PD and ED increase so does the temperature at the site of exposure (Fry 
and Fry 1953, Nyborg et al. 1981, Cavicchi and O’Brien 1984).  As PD is raised, it approaches 
continuous wave US, and could cause burning, ablation, or necrosis of tissue.  Though PD has 
not directly been explored for US-UCA induced angiogenesis, it has been explored via various 
bioeffects studies and has been shown to be positively correlated with pressure in theoretical 
calculations, in vitro assessments and in vivo studies (Vykhodtseva et al. 1994, Kinsler et al. 
2002).  The therapeutic range of PDs therefore is typically on the millisecond or even 
microseconds range when UCAs are used (Song et al. 2004, Chappell et al. 2006).  While PDs 
are relatively consistent, EDs vary significantly ranging from 1 second to 20 minutes (Reher 
1999, Miller 2005, Chappell et al. 2008, Kruse et al. 2008, Vancraeynest et al. 2009).   
ED is of particular interest because not only is the length of exposure correlated to an 
increase in bioeffects and temperature (Vykhodtseva et al. 1994), but therapeutically speaking 
shorter treatments are more favorable for both the patient and provider.  Longer EDs allow for 
more UCA-vessel interaction.  This increased interaction owing to increased time can potentially 
cause more damage after a sufficient amount of time has lapsed.  Miller et al. (2008) reported 
that for increments of ED below 3 minutes, there is no correlation with bioeffects but a positive 
correlation appears as the duration exceeds this value.  Another study suggested that in cardiac 
tissue, EDs of 9 minutes resulted in an approximate 10% mortality of rats and that EDs in excess 
of 30 minutes resulted in an 80% mortality rate (Vancraeynest et al. 2009).  However, 1 second 
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exposures were reported to cause bioeffects in a transgenic mouse model (Kruse et al. 2008), and 
90 seconds was required to induce angiogenesis in a cardiac model (Zen et al. 2006).  
Therapeutic applications typically use EDs < 5 minutes (Chappell et al. 2006, Zen et al. 2006, 
Miyake et al. 2007).  From the mentioned studies, one can observe the discrepancy with the ED 
required for bioeffect induction and therapy. 
Therefore, in an effort to extend the exploration of US and UCA induced angiogenesis, 
this study sought to examine the effect of reducing the ED on both bioeffects and the angiogenic 
response.   Using twenty-four rats, four EDs were explored: 30 seconds, 1, 2, and 4 minutes.  
This range was chosen as to minimize the effects of heating.  Bilateral sites were exposed; 
medial sites served as the control.  Capillary density, EBD and VEGF expression were used to 
quantify the responses.  US exposure parameters were: Pr = 0.7 MPa, PRF = 10 Hz, PD = 10 µs, 
ED = 30s, 1, 2, or 4 min, and 10x [UCA].  The 5 min data from previous studies with the same 
exposure conditions was added to the graphs, but was not included in statistical analyses. 
13.1 Results 
Capillary density 
 Capillary density was normalized to the control and is shown in Figure 13.1.  DPE nor 
ED was found to be significant for capillary density (p = 0.05 and p  > 0.05, respectively) with 
two-way ANOVA (Figures 13.1).   
Evans blue dye (vascular permeability) 
 EBD leakage was normalized to the control value and is shown in Figure 13.2. One-way 
ANOVA determined EBD leakage to be significant across ED (p < 0.01).   EBD demonstrated a 
decreasing trend of vascular permeability as the ED increased up to 2 minutes (Figure 13.2).   
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Figure 13.1: Normalized capillary density at 0 DPE (light grey) and 5 DPE (dark grey) across 
ED. 
Multiple comparisons showed that the 2 min ED was significantly different from the 30 seconds 
or 1 minute group (p < 0.01) for vascular permeability. 
 
 
Figure 13.2: Normalized Evans blue dye as a marker for permeability at 0 DPE across ED.  *p < 
0.01 with respect to 30s and 1 minute. 
 
Vascular endothelial growth factor-A (VEGF) 
 VEGF expression was not significant across ED (p > 0.05) when tested using one-way 
ANOVA (Figure 13.3).   
13.2 Discussion 
 
This study examined four separate EDs to determine if the angiogenic response depended 
on length of exposure.  Of the all of the assessments only vascular permeability was found to be 
significant. 
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Figure 13.3: Relative VEGF expression at 5 DPE across ED. 
The introduction mentioned PD as a significant time factor for US, however numerous 
studies that observe PDs correlation to UCA collapse show no or weak influence (Ammi et al. 
2006b, Haak et al. 2007, Church et al. 2005).  Because collapse is the suggested cause of the 
induction of bioeffects and, by extension, the angiogenic response, PD, by itself presumably has 
no influence on angiogenesis.  In addition, PD is mathematically proportional to the acoustic 
pressure at which exposures occurs by: 
ITA = IPA * τ = p2τ /(2ρc) 
 (13.1) 
τ = PD * PRF 
 (13.2) 
p2= (2ρc)*(PD*PRF)* IPA, 
 (13.3) 
p2 α PD (13.4) 
 
where ITA is the temporal average intensity, IPA is the pulse average intensity, τ is the duty factor, 
p is the acoustic pressure, ρ is the density of the medium and c is the speed of sound in the 
medium, PD is pulse duration, and PRF is pulse repetition frequency.  It has previously been 
determined that pressure and bioeffects and (UCA collapse) are positively correlated quantities 
(Johnson et al. 2011 in press (Chapter 6), Chapters 7-9). 
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 While ED has no direct impact upon UCA collapse thresholds, it does increase the 
amount of time that vasculature and tissue is exposed to collapsing microbubbles, presumably 
allowing more time to induce bioeffects.  US-UCA induced angiogenesis has been linked to both 
UCA collapse and bioeffects.  Therefore, it was hypothesized that ED would be positively 
correlated to bioeffects and that effect would be propagated through to the therapeutic end goal. 
 The 5 min ED from previous studies demonstrates agreement with the findings hereing  
The 4 min ED begins to show an increase in capillary density at 5 DPE (with respect to 0 DPE), 
but it is not significant.  The separation is more apparent at 5 min because this data is averaged 
from all previous experiments, thus has a larger N and smaller standard error.  Likewise the 5 
min ED’s VEGF expression overlaps with the 4 min ED. 
To keep temperature increases from confounding the results, the range of EDs used with 
the other parameters chosen in this study was 0 to 4 minutes.  Previous studies suggest that the 
angiogenic effect is provoked by bioeffects and an increase in permeability (bioeffect) was seen, 
but we do not see this translating to an angiogenic response for 5 DPE capillary density or VEGF 
expression.  The relatively small window of EDs chosen for this study might have been a reason 
for low significance.   
ED has not been investigated with respect to US-UCA induced angiogenesis; therefore it 
is difficult to compare results gathered herein to other studies.  This study does not agree with the 
finding that EDs below 3 minutes do not show correlation to bioeffects, with a 2 min ED 
showing the most EBD leakage.  This study does, however agree with other US-UCA therapeutic 
studies in that the ‘therapeutic range’ falls somewhere between 2 and 5 minutes (Chappell et al. 
2006, Zen et al. 2005) (Figure 13.1 and 13.3).  
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More so than PD or ED, physical parameters like number of pulses (PRF * ED) show 
significance (O’Brien et al. 2005, Song et al. 2002).  But, by varying ED, the number of pulses is 
also varied.  The next chapter provides an assessment of the number of pulses and duty factor to 
determine the effect of the combined terms with US-UCA induced angiogenesis. 
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CHAPTER 14: COMMENTARY ON NUMBER OF PULSES AND DUTY 
FACTOR 
 
Previous chapters discussed the role of UCAs, PRF and ED in the induction of bioeffects 
and subsequent angiogenesis.  Chapter 13 briefly discussed the possibility that combination 
terms such as number of pulses (NP) and duty factor (DF) may also play a role in the response.  
These parameters, while not directly examined, were assessed, by varying the intrinsic 
parameters.  The two equations below describe the intrinsic parameters of NP and DF. 
NP = ED * PRF (14.1) 
DF = PD * PRF (14.2) 
where ED is exposure duration, PRF is pulse repetition frequency and PD is pulse duration.  
Because PRF was varied in Chapter 12 and ED in Chapter 13, this chapter will discuss the 
implications of those results to NP and DF.   
14.1 Number of pulses 
 
 Number of pulses has not been directly explored with respect to US-induced angiogenesis 
and only limited work is available for bioeffects when UCAs are used.  While the NP is a non 
UCA effect, the more pulses generated would likely increase the incidence of bioeffects.  One 
study using EDs ranging from 100 to 10000 ms, and PRFs ranging from 10 to 1000 Hz compared 
only two NPs (100 and 250) in vitro (Samuel et al. 2009).  A NP = 250 created a smaller area of 
extravasation than did NP = 100 (Samuel et al. 2009), when only PRF was decreased, suggesting 
that more pulses causes a lesser effect.  Samuel et al. (2009) states that “the reduced effect at 
high PRF may indicate that there is a required ED (>10 ms but < 100ms) for an effect.   In cross 
comparing studies, one finds that bioeffects such as hemorrhage, cell lysis, and cell death are 
correlated to NP.  One study, assessed the influence of the PRF on extravasation, and found that 
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as PRF decreased from 1 to 0.1 Hz, the extravasation points increased by 2000% at 0.2 Hz (Song 
et al. 2002)!  Another study that used a PRF of 0.25 Hz and reported an increase in vascular 
permeability that was 100% higher than leakage measured in a group without UCAs (Bohmer et 
al. 2010).  Unfortunately, Song et al.(2002) nor Bohmer et al.(2010) provide information about 
the ED; but with the given material there is a notable disagreement in the level of bioeffect 
reported from their studies.   
Chappell et al. (2008) used a NP of 54 (PRF = 0.2 Hz, ED = 4.5 min) and showed 100% 
greater flow and increased arteriogenesis with respect to the study’s control, and Fuji et al. 
(2009) used 2400 pulses (PRF = 2 Hz, ED = 20 min) to demonstrate 150% increases in capillary 
density and a 400% increase in arteriolar density with respect to the experimental control 
associated with US-UCA exposure, but neither study provides information regarding the acute 
effects.   
A decrease in PRF is analogous to decrease in NP, thus this study leads one to the 
conclusion that NP is negatively correlated with bioeffects.   However, when ED was assessed, 
the amount of cardiomyocytes injured increased when increasing ED from 5 min to 20 min 
exposures, as did the number of petechiae (Miller et al. 1998, 2005).  An increase in ED also 
corresponds to an increase in NP and thus, these studies show NP to be positively correlated with 
bioeffects.   
The studies in Chapter 12 and 13 used NP = 300 to 12000.  When combining the data, for 
the acute bioeffect we find that there is no discernable trend across NP for 0 DPE capillary 
density, but EBD leakage (vascular permeability) increases up to 1500 pulses, and then 
decreases, suggesting an optimal number of pulses for increases in permeability (Figure 14.1, 
Figure 14.2, Table 14.1).   
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Figure 14.1: Normalized capillary density at 0 DPE (light grey) and 5 DPE (dark grey) from 
Chapters 12 and 13 across the total number of pulses.  
 
 
Figure 14.2: Normalized Evans blue dye as a marker for permeability at 0 DPE from Chapters 12 and 
13 across the total number of pulses. 
 
Table 14.1: Combination of acutely measured bioeffects seen in Chapter 12 and 13 across the total 
number of pulses: Normalized 0 DPE capillary density and normalized EBD leakage. 
NP Normalized Capillary Density (0 DPE) Normalized EBD leakage (permeability) 
300 1.0 ± 0.1 2.3 ± 0.3 
600 1.5 ± 0.2 2.5 ± 0.3 
1200 1.2 ± 0.2 3.4 ± 0.3 
1500 1.0 ± 0.1 6.2 ± 0.5 
2400 1.0 ± 0.2 2.9 ± 0.3 
3000 0.9 ± 0.1 2.7 ± 0.5 
6000 1.0 ± 0.1 2.2 ± 0.2 
12000 1.3 ± 0.2 1.3 ± 0.3 
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Because bioeffects were not the end goal of this study, but rather determining the potentiator of 
US-UCA-induced angiogenesis, examining how the NP affects the acute effects with respect to 
the response seen at 5 DPE is important. Thus far it has appeared that, to some extent, 
angiogenesis is driven by increases in acute permeability, but it should be noted that this increase 
is not without limitation.  As shown in Chapter 7, when permeability was very high (at 0 DPE) 
the subsequent measure of VEGF expression at 5 DPE was low. 
When observing the therapeutic response, we find that 1500 pulses is not necessarily 
effective for inducing angiogenesis (Table 14.2, Figure 14.3).   
 
Figure 14.3: Relative VEGF expression (in fold change) across the total number of 
pulses. 
 
Table 14.2: Combination of 5 DPE assessments for the angiogenic responses seen in Chapter 12 
and 1 across the total number of pulses: Normalized 5 DPE capillary density and VEGF 
expression in fold change. 
NP Normalized Capillary Density (5 DPE) VEGF (angiogenesis) 
300 1.1 ± 0.1 2.8 ± 0.8 
600 1.1 ± 0.1 2.1 ± 0.6 
1200 1.1 ± 0.1 3.4 ± 0.9 
1500 1.0 ± 0.1 1.4 ± 0.2 
2400 1.1 ± 0.1 3.5 ± 0.6 
3000 1.3 ± 0.1 2.0 ± 0.4 
6000 1.0 ± 0.1 0.9 ± 0.2 
12000 0.8 ± 0.1 0.8 ± 0.2 
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The trend across capillary density remains relatively constant across NP, peaking at 3000 pulses.  
VEGF expression however varies, being generally higher at lower NP.  Thus, there appears to be 
a range of NP for which angiogenesis is optimal, with a preference for lower NP. 
Therefore, the data suggests that NP < 3000 is sufficient for angiogenesis induction, 
which further reinforces the notion that there is an optimal amount of vascular perturbation 
required to elicit an angiogenic response. 
14.2 Duty factor 
 
 This thesis did not directly address PD due to its relationship to output pressure.  An in 
vitro calibration (see Chapter 5) of several power output settings at PD = 1, 5 or 10 µs, and for 
PRF = 1, 10 and 100 Hz was conducted to determine how these parameters affected Pr (Figure 
14.4).  This calibration revealed a trend for Pr with PD.  As PD was increased from 1 to 10 µs, 
regardless of PRF and power setting, the calibrated pressure was higher with higher PD.  The 
trends across the power output remains relatively constant with varying PRF, although at higher 
power settings variation appears with PD = 10 µs. 
 
Figure 14.4: Pulse duration, pulse repetition frequency and calibrated pressure.  The PD = 1 µs 
groups were very similar and overlay one another. 
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Interestingly, if we look at this same data in terms of duty factor (DF), a clear trend with 
duty factor can be seen as well (Figure 14.5).  Literature has shown that the ‘total time on’ or the 
duty factor is related to intensity, power and pressure, and this experiment attributes the 
relationship to PD.  A few studies have directly examined DF in terms of bioeffects.  It is 
expected that a higher DF (ie. more “on” time) would cause an increase in the amount of 
bioeffects reported, because UCAs are perturbed for longer durations with for a fixed ED, as 
seen in the in vitro study (Figure 14.5).   
 
 
Figure 14.5: Duty Factor vs. Calibrated pressure.  Figure 14.4 represented in terms of DF 
(%). 
 
One study showed that the number of petechiae induced by US-UCA exposure increased 
with increasing duty factor (DF = 0.1 to 1%) (Miller and Gies 1998).  However, further increases 
in DF showed no difference from 1% (Miller and Gies 1998).  The more closely spaced pulses 
were speculated to cause significant changes in the bioeffect, because it increases the Pr.  
Another study examined 5, 10 and 15% DF and found counterintuitive results as well.  Higher 
DF caused more cell lysis than a 10% DF, but this effect did not hold true for sonoporation 
(increases in cellular permeability) activity (Ward et al. 1999).  In the same study, however, the 
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5% DF case demonstrated significantly higher percentage of cellular lysis than the 10% DF case 
(Ward et al. 1999).  
 Duty factors ranging from 2 x 10-3 to 0.5% (Chappell et al. 2005, Hwang et al. 2005) 
have been used for bioeffects as well as therapeutic studies.  Vascular endothelial cell effects 
including increased calcium permeability, reactive oxygen species generation, and cytoskeleton 
rearrangements were reported using a DF = 0.2% (Juffermans et al. 2009).  These effects were 
confirmed by a different study in vivo that found extravasation and endothelial cell damage with 
a DF = 0.22% (Hwang et al. 2005).  Other therapeutic studies found increased healing of 
varicose ulcers at DF = 2%, enhanced cardiac function (with increased vascular density) with DF 
= 50%, and increased angiogenesis at DF = 2 x 10-3% (Dyson et al. 1976, Chappell et al. 2005, 
Song et al. 2008). This thesis uses a DF = 1 x 10-2% for most of the studies, varying only in 
Chapter 12 when PRF was assessed (DF = 5 x 10-3% – 4 x 10-2%).  This range was quite small to 
prevent the reported effects of heating (PD effect) and allow UCA refill (PRF effect) (Table 
14.3).  The range of DFs capable of inducing an angiogenic response suggests that the optimal 
range for this parameter is on the order of 10-2% (Figure 14.6—14.8).  
 
Figure 14.6: Normalized capillary density at 0 DPE (light grey) and 5 DPE (dark grey) across DF 
(%) 
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Table 14.3: DF’s effect on US-UCA-induced bioeffects and angiogenesis 
DF (%) Normalized Capillary Density (0 DPE) 
Normalized EBD 
leakage (permeability) 
Normalized Capillary 
Density (5 DPE) VEGF (angiogenesis) 
5 x 10-3 1.0 ± 0.1 6.15 ± 0.3 1.0 ± 0.1 1.4 ± 0.2 
1 x 10-2* 0.9 ± 0.1 3.0 ± 0.2 1.3 ± 0.1 2.9 ± 0.4 
2 x 10-2 1.0 ± 0.1 2.2 ± 0.2 0.9 ± 0.1 0.9 ± 0.2 
4 x 10-2 1.3 ± 0.2 1.3 ± 0.3 0.8 ± 0.1 0.8 ± 0.2 
* average normalized value across parameter matched studies in Chapters 7-13. 
 
Figure 14.7: Normalized Evans blue dye as a marker for permeability at 0 DPE across DF (%). 
 
 
Figure 14.8: Relative VEGF expression (in fold change) across DF (%). 
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CHAPTER 15: CONCLUSIONS 
 
All of the data gathered herein lead to several conclusions: 1) UCAs increase the 
angiogenic response, 2) UCA collapse is required for the increased angiogenic response, 3) 
increases in vascular permeability occur acutely with collapse, 4) shear stresses during exposure 
are likely involved in the induction of acute bioeffects, 5) Prs equal to or greater than 1.3 MPa 
demonstrate a deleterious effect, and 6) the coincidence of increased VEGF expression and 
capillary density at 5 DPE corresponds relatively well to the increases in capillary permeability.  
These findings suggest there is an appropriate [UCA], Pr, PRF, and bioeffect level that yields 
optimal angiogenesis.  This compilation of studies not only provides some biophysical 
mechanistic information but also a bit of predictive information when determining appropriate 
settings for US-UCA induced angiogenesis. 
Ultrasound exposure has the potential to stimulate an angiogenic response.  When UCAs 
are added, the progression of the response is disturbed, particularly when collapse occurs. The 
results in chapter 6 suggested that a mechanical effect of US and UCAs elicit angiogenesis via 
inflammation and increased VEGF expression.  It, however, was of particular interest to 
determine the role that the [UCA] played in the response, because some of the responses of US-
UCA exposure were close to the control value. 
Chapter 7 indicated that [UCA] demonstrates a significant effect not only in the acute 
bioeffects, but also in the subsequent angiogenic response.  Both initial and angiogenic responses 
are positively correlated with the concentration of microbubbles (0x, 1x, 5x, and 10x, see 
Chapter 7) present during infusion. Beginning with a suggested mechanically induced 3 fold 
increase in permeability, almost a 20% increase in capillary density between the 0 DPE and 5 
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DPE group at 10x [UCA] and a 3 fold increase in VEGF expression was found (Figure 15.1).  
With these findings the acoustic pressure response was revisited in Chapter 8. 
 
Figure 15.1: Normalized EBD, VEGF, and capillary density mean values.  A value of 1 indicates 
the experimental group was equivalent to the control. Pr = 0.7 MPa, PRF = 10 Hz, PD = 10 µs, 
ED = 5 min. 
 
The angiogenic response is dependent upon Pr.  Once Pr approaches established mechanical 
index limits, the angiogenic response is stifled and shows reduced levels of VEGF expression.  
While acute capillary density was unaffected, increases in acute permeability seem to potentiate 
increases in capillary density at 5 DPE and increased VEGF expression at mid-range Prs (Figure 
15.2).  This study demonstrated up to a 9 fold increase in vascular permeability (EBD) that 
corresponded with decreases in VEGF expression at 1.9 MPa.  However when VEGF expression 
peaks, at 0.7 MPa, we also see a significant increase in the 5 DPE capillary density.  Because 
angiogenesis was measured at 0.7 MPa, but not 0.1 MPa this study suggests that a particular 
amount of UCA collapse is required.  Further investigation was required to examine the 
necessity of collapse.  
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Figure 15.2: Normalized EBD, VEGF, and capillary density mean values.  A value of 1 indicates 
the experimental group was equivalent to the control. [UCA] = 10x, PRF = 10 Hz, PD = 10 µs, 
ED = 5 min. 
Chapter 9 took a closer look at collapse by narrowing the range of Prs.  An increase in 
acute permeability does not necessarily mean that a measurable amount of angiogenesis will 
occur, however, the vascular permeability trend does agree with the collapse threshold of the 
UCA used in this study. This suggests that UCA collapse causes an increase in vascular 
permeability, and that it is collapse that mechanistically motivates the angiogenic response.  The 
angiogenic response was not detected until 0.7 MPa was reached, which suggests that the UCA 
collapse occurrence must reach approximately 60% for this therapeutic purpose.   The UCA 
collapse may produce minor disruption to the vascular endothelium, but it does not result in a 
decrease in capillary density. 
Also, in comparing the increases in VEGF and EBD at corresponding Pr, there is 
agreement between separate studies.  Whereas the normalized values for 0.1 MPa tend to cluster 
around the control value for all measurements, and 0.7 MPa demonstrates approximately a 3 fold 
increase in vascular permeability and VEGF expression.  When studying a range of Pr, it is 
important to ensure that temperature increases remain low.  Table 15.1 shows the approximate 
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maximal temperature increases with all of the pressures used.  The temperature estimates are 
calculated for the total time on and thus do not take into consideration the pulsed nature of the 
exposure.  The estimates also assume that there is no heat removal process which is not 
necessarily the case for a 5 minutes exposure.  Because UCAs are being infused, and the rat 
cardiac output is approximately 200 mL/min (Gotshall et al. 1987), there is about 500 mL of 
blood that passes the exposed region during the experiment.  
 
 
 
 
 
 
 
Table 15.1: ΔTmax for all pressures used in Chapters 6, 7, 8 and 9. 
 
Chapter 10 examined the biophysical mechanisms behind the acute bioeffects and 
angiogenic response, while relating biological events to specific UCA dynamics.  The trends for 
UCA collapse and vascular permeability were confirmed to be similar, and the onset of radial 
expansion beyond two, corresponded with the Pr where VEGF expression demonstrated 
significant decreases.  In an effort to correlate oscillation and collapse to tissue-level effects, a 
histological study was completed.  By looking at several time points one can not only gather 
information regarding a risk/benefit analysis, but also bioeffects that are not acutely present can 
be evaluated. 
Therefore, the next chapter measured the effects of US and UCA exposure at several time 
points. Chapter 11 showed a histological study assessing tissue effects at 0, 8, 16 and 24 HPE.  
Pr (MPa) ΔTmax (0C) 
0 0
0.1 0.01
0.3 0.09
0.5 0.24
0.7 0.47
0.9 0.78
1.3 1.62
1.9 3.45
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Coagulative necrosis, nucleus internalization and contraction bands were all present when Pr > 
1.3 MPa. This histological study confirmed the suggestions made by previous chapters in that 
there exists a range of US exposure parameters that facilitate angiogenesis induction, beyond 
which tissue-level damage becomes apparent.   
The exposures are pulsed; therefore pulse repetition frequency was tested to determine if 
it was an important modulator of bioeffects when UCAs are used.  Because research suggests, 
and Chapter 12 supports, that these bioeffects potentiate therapy, PRF may play an important 
role in the induction of an angiogenic response.  The data in Chapter 12 indicates that lower 
PRFs results in both higher acute permeability and VEGF expression at 5 DPE.  The data in 
Figure 15.4 is normalized to the 5 Hz data set because the objective was to determine if the PRF 
value was a significant factor.  The EBD leakage decreases with respect to 5 Hz when 10 Hz is 
used, but we can see that capillary density (5 DPE – 0 DPE) increases at this time point.  VEGF 
expression also declines with PRFs above 10 Hz (Figure 15.3).  Temperature estimates were also 
calculated for this study and are displayed in Table 15.2 below.   
 
PRF (Hz) ΔTmax (0C) 
5 0.23
10 0.47
20 0.94
40 1.88
Table 15.2: ΔTmax for all pressures used in Chapter 12. 
 
Chapter 13 focused on the exposure duration to investigate its effect on angiogenesis.  
This study showed that ED is not a significant parameter for US-UCA-induced angiogenesis.  
ED is, as reported by other studies, significant for eliciting bioeffects acutely, however.   
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Figure 15.3: Normalized EBD, VEGF, and capillary density mean values.  A value of 1 indicates 
the experimental group was equivalent to the control.  Pr = 0.7 MPa, [UCA] = 10x, PD = 10 µs, 
ED = 5 min. 
 
Figure 15.4 shows the trends in data with respect to the lowest time for exposure, 30 
seconds (0.5 min).  The EBD leakage increases at 2 min of exposure with respect to the 30 
second exposure, but the capillary density and VEGF expression do not reach significance. 
Because exposure duration also affects the maximal temperature increase, the estimates 
are reported in Table 15.3.  None are sufficient for effects to be attributable to heating. 
 
ED (s) ΔTmax (0C) 
30 0.05
60 0.09
120 0.20
240 0.38
Table 15.3: ΔTmax for all pressures used in Chapter 10. 
 
Finally, Chapter 14 discussed the total number of pulses and duty factor with respect to 
the acute and angiogenic responses.  For the studies conducted herein, the optimal window for 
the angiogenic response was a NP < 3000 and a DF on the order of 10-2%. 
161 
 
 
Figure 15.4: Normalized EBD, VEGF, and capillary density mean values.  A value of 1 indicates 
the experimental group was equivalent to the control.  Pr = 0.7 MPa, [UCA] = 10x, PD = 10 µs, 
PRF = 10 Hz. 
 
According to all findings, a Pr ~ 0.7 MPa, PRF ~ 10 Hz, and ED between 2 to 5 minutes 
demonstrates the greatest angiogenic response.  The theoretical simulations, in vitro experiments 
and in vivo angiogenic experiments agree that at pressures in excess of 0.9 MPa, vascular 
permeability increases significantly and VEGF expression decrease significantly.  Further, the 
histological study shows that once pressure levels reach 1.3 MPa there are significant deleterious 
effects.  Thus all the results support that it is not necessarily damage, but rather an increase in 
permeability, caused by a combination of  UCA oscillation and collapse eliciting mechanical 
disturbances to the vasculature, that potentiate the increases in VEGF expression (and capillary 
density at 5 DPE) noted herein.    
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CHAPTER 16: SPECULATION 
 The work presented herein verified that US and UCAs can be used to induce noninvasive 
and spatially specific an angiogenic response.  In doing so, the mechanisms of US-UCA-induced 
angiogenesis were explored connecting ultrasound, the underlying physics of the ultrasound 
contrast agents to the bioeffects and then relating those bioeffects to the end goal of an 
angiogenic response.  Thus, the work addressed two of the cited reasons for slow clinical 
transition: connection of the acute bioeffects to subsequent angiogenic response and exploring a 
physical mechanism.    
It was originally hypothesized that: [UCA] increases would increase (enhance) the 
angiogenic response above that of saline only infusion, that IC would acutely reduce capillary 
density cause hemorrhage and tissue damage leading to angiogenesis, that microstreaming would 
cause increases in permeability, but not angiogenesis, and that TNP, but not ED or PRF would be 
positively correlated to the angiogenic effect.  The study found that UCAs do, in fact, enhance 
the angiogenic response, and that IC is required for the response, but permeability, hemorrhage 
or tissue damage could elicit the angiogenic response.  It was also found that IC caused increased 
acute permeability, not necessarily microstreaming, though shear stresses from oscillation 
reached sufficiently high values to perturb vascular endothelial cells.  Pressure was also found to 
be correlated with the acute and angiogenic response with pressures greater than 1.3 MPa 
causing significant tissue damage.  Optimization parameters PRF and TNP, but not ED 
demonstrated significance for the angiogenic response. 
This examination also revealed two types of therapeutic treatments: one set of parameters 
optimal for drug delivery, demonstrating increased vascular permeability without significant 
tissue damage (low Pr), and another set of parameters optimal for secondary-wound healing 
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angiogenesis, where damage is created (at high Pr) (Figure 16.1).  These findings make the work 
relevant to not only researchers attaching growth factors, stem cells, and other therapeutic agents 
to contrast agents for site specific delivery, but also to those who use US and UCAs for ablation 
or cancer treatment applications. 
 
Figure 16.1: Two-fold flow of US-UCA induction of angiogenesis contingent upon UCA 
collapse. 
 
This work found that low pressures (0.3 to 0.7 MPa) increase vascular permeability, and 
this range of pressures were also correlated to 15 to 60% collapse, therefore it is speculated that 
low levels of inertial cavitation (or UCA collapse) is required for increased permeability.  This 
finding agrees with the work of Miao et al (2008) with generated stress exceeding capillary 
strength leading to vascular perturbation.  For drug delivery purposes, it is important to be able to 
either increase vessel porosity or increase the size of pores without destroying the tissue or the 
agent that is bound to the UCA.  Lower pressures could possibly facilitate uptake of therapeutic 
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agents into the desired location, and if the parameters are kept below the values used in this 
thesis, heating would not be a competing (perhaps deleterious?) factor. 
For secondary wound healing angiogenesis, pressures above 1.3 MPa should be used 
according to the findings herein.  The normal animal model was able to recover from the damage 
caused (hemorrhage, contraction bands, inflammatory infiltrate, and nucleus internalization).  
How a diseased model would react to the treatment was not tested, but if this treatment is applied 
to healthy tissue on the periphery of ischemic tissue, it could cause an ingrowth of capillaries to 
the hypoxic area.  Likewise, because angiogenesis is largely a system of checks and balances 
between pro- and anti-angiogenic factors, using US and UCAs to cause local, minor damage may 
be sufficient to offset the balance and boost the body’s normal response to injury. 
The benefit of therapeutic US over exiting clinical techniques to treat ischemia are 
plentiful.  US-UCA treatment is noninvasive, site specific, temporally specific, can be repeated 
with minimal additional risks, has been proven to increase vascularity up to 50% when growth 
factors or stem cells are used, and is associated with very low risk.  Surgical interventions carry 
the risk of death during operation, and, while initially minimally invasive, sometimes end in 
open heart by-pass surgery.  To demonstrate the amount of risk involved in this type of therapy 
with respect to cellular damage, intravascular hemolysis is considered with a relative relationship 
to levels of hemolysis occurring in endurance sports. 
Commonly in endurance sports like running intravascular hemolysis occurs, reportedly 
from impact with hard surfaces, as in the case of heel-strike (Telford et al. 2003).  Literature 
states that running for 1 hour causes a ~30% decrease in red blood cells (RBCs) due to 
intravascular hemolysis (Telford et al. 2003).  This decrease is commonly measured by a 
reduction in haptoglobin, a molecule that binds free hemoglobin released from damaged RBCs.  
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The number of RBCs injured when UCA collapse is the cause of intravascular hemolysis is a 
function of Pr, the focal region of the transducer and exposure duration.  Previously we 
established that the volume of blood in the rat is ~ 2 x 1014µm3, if we consider the volume of the 
rat approximated as an ellipsoid (with height = 8 in., width = 3.5 in, and depth = 2.5 in.), we find 
that the volume of the rat, Vrat = 5 x 1015 µm3.  From these quantities we can determine the 
percentage of the body that is blood. 
% ൌ	 ௕ܸ௟௢௢ௗ
௥ܸ௔௧
ሺ100ሻ 
where Vblood is the volume of blood in the rat.  (% = 4%).  Next we need to determine the 
ultrasound focal volume.  Approximated by a cylinder with radius of 2.5 mm and depth of 50 
mm (because the focus is aligned at the surface of the gracilis muscle, but the beam extends 
beyond the gracilis muscle), the US focal volume (USFV) is , Vfocus = 1.3 x 108 µm3.   
 With the calculations above we can assume that blood is equally and evenly distributed 
for any portion of the body, 4% of the body is blood and as established in Chapter 5, that 
0.00008% of blood is UCA.  Therefore 4% of Vfocus is blood in the USFV (B = 5 x 106 µm3), and 
0.00008% of the blood volume (5 x 106 µm3) is comprised of Definity® = 4 µm3.  So the 
maximum infusion at steady state: 5 x 10-3 microbubbles/min/ µm3 is multiplied by the volume 
of Definity® (4 µm3) to determine the number of microbubbles/minute there are in the USFV: 
ND-USFV = 2 x 10-2 microbubbles/min.  This is relative to the NR-USFV = 6.5 x 103 RBCs/min in the 
USFV. [This quantity was determined by multiplying B by the hematocrit, and dividing by the 
volume of one RBC.] 
 This is a simplified estimate of how the volume fraction of both UCAs and RBCs are 
distributed in vivo.  It should be noted that not every RBC is in contact with a UCA, thus 
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intravascular hemolysis as a result of inertial cavitation affects only a small percentage of RBCs 
(ND-USFV/NR-USFV = 0.0003%).  This percentage is significantly less than damage caused during 
intense exercise, which, as stated previously, causes a 30% decrease in RBCs with 60 minutes of 
exercise. For the 5 minute ED used in most of the studies presented, there would be an adjusted 
2.5% decrease in RBCs from running induced intravascular hemolysis.  [30%/60 min ≈ 2.5%/5 
min]. On a per-minute basis, running causes a 0.5% and US-UCA therapy causes a 0.0003% 
decrease in RBCs from intravascular hemolysis. 
 While these calculations do not take into consideration the Pr used during exposure, it 
does assume 100% collapse is occurring.  Therefore it is speculated that even at high Pr, the 
intravascular hemolysis attributable solely to IC is nominal.  Thus, while hemolysis does occur, 
it does not pose a substantial risk concern.   
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